{"protocolSection":{"identificationModule":{"nctId":"NCT02465515","orgStudyIdInfo":{"id":"116174"},"secondaryIdInfos":[{"id":"2014-001824-32","type":"EUDRACT_NUMBER"},{"id":"2014","type":"NIH","link":"https://reporter.nih.gov/quickSearch/2014"}],"organization":{"fullName":"GlaxoSmithKline","class":"INDUSTRY"},"briefTitle":"Effect of Albiglutide, When Added to Standard Blood Glucose Lowering Therapies, on Major Cardiovascular Events in Subjects With Type 2 Diabetes Mellitus","officialTitle":"A Long Term, Randomised, Double Blind, Placebo-controlled Study to Determine the Effect of Albiglutide, When Added to Standard Blood Glucose Lowering Therapies, on Major Cardiovascular Events in Patients With Type 2 Diabetes Mellitus"},"statusModule":{"statusVerifiedDate":"2019-02","overallStatus":"COMPLETED","expandedAccessInfo":{"hasExpandedAccess":false},"startDateStruct":{"date":"2015-07-01","type":"ACTUAL"},"primaryCompletionDateStruct":{"date":"2018-02-20","type":"ACTUAL"},"completionDateStruct":{"date":"2018-03-14","type":"ACTUAL"},"studyFirstSubmitDate":"2015-06-04","studyFirstSubmitQcDate":"2015-06-04","studyFirstPostDateStruct":{"date":"2015-06-08","type":"ESTIMATED"},"resultsFirstSubmitDate":"2019-02-11","resultsFirstSubmitQcDate":"2019-02-11","resultsFirstPostDateStruct":{"date":"2019-03-06","type":"ACTUAL"},"lastUpdateSubmitDate":"2019-02-11","lastUpdatePostDateStruct":{"date":"2019-03-06","type":"ACTUAL"}},"sponsorCollaboratorsModule":{"responsibleParty":{"type":"SPONSOR"},"leadSponsor":{"name":"GlaxoSmithKline","class":"INDUSTRY"},"collaborators":[{"name":"Duke Clinical Research Institute","class":"OTHER"}]},"oversightModule":{"oversightHasDmc":true},"descriptionModule":{"briefSummary":"Albiglutide is an analogue of glucagon-like peptide-1 (GLP-1), used to treat type 2 diabetes This study will test whether albiglutide affects the occurrence of major cardiovascular events such as heart attacks or strokes and other important medical outcomes in persons with type 2 diabetes, when used alone or added to other diabetes treatments."},"conditionsModule":{"conditions":["Diabetes Mellitus"],"keywords":["cardiovascular events /outcomes","Type 2 diabetes mellitus","albiglutide","glucagon-like peptide-1 receptor agonist"]},"designModule":{"studyType":"INTERVENTIONAL","phases":["PHASE4"],"designInfo":{"allocation":"RANDOMIZED","interventionModel":"PARALLEL","primaryPurpose":"TREATMENT","maskingInfo":{"masking":"QUADRUPLE","whoMasked":["PARTICIPANT","CARE_PROVIDER","INVESTIGATOR","OUTCOMES_ASSESSOR"]}},"enrollmentInfo":{"count":9463,"type":"ACTUAL"}},"armsInterventionsModule":{"armGroups":[{"label":"Albiglutide","type":"EXPERIMENTAL","description":"Albiglutide once weekly by subcutaneous injection. Starting dose 30 mg may be increased to 50 mg if needed. Albiglutide will be administered in addition to standard therapy for diabetes and cardiovascular health.","interventionNames":["Biological: Albiglutide 30 mg","Biological: Albiglutide 50 mg"]},{"label":"Placebo","type":"PLACEBO_COMPARATOR","description":"Placebo once weekly by subcutaneous injection. Placebo will be administered in addition to standard therapy for diabetes and cardiovascular health.","interventionNames":["Biological: Albiglutide matching placebo"]}],"interventions":[{"type":"BIOLOGICAL","name":"Albiglutide 30 mg","description":"Once weekly subcutaneous injection. Starting dose 30 mg may be increased to 50 mg if needed.","armGroupLabels":["Albiglutide"]},{"type":"BIOLOGICAL","name":"Albiglutide 50 mg","description":"Once weekly subcutaneous injection. Starting dose 30 mg may be increased to 50 mg if needed.","armGroupLabels":["Albiglutide"]},{"type":"BIOLOGICAL","name":"Albiglutide matching placebo","description":"Once weekly subcutaneous injection. Matched to 30 mg and 50 mg albiglutide.","armGroupLabels":["Placebo"]}]},"outcomesModule":{"primaryOutcomes":[{"measure":"Time to First Occurrence of Major Adverse Cardiovascular Events (MACE) During Cardiovascular (CV) Follow-up Time Period","description":"Time to MACE defined as the time to first occurrence of Cardiovascular Endpoint Committee (CEC)-adjudicated MACE (CV death, myocardial infarction \\[MI\\] or stroke) was analyzed using a Cox Proportional Hazards regression model with treatment group as the only covariate. The incidence rate per 100 person years (100\\*number of participants with at least 1 event)/first event person-years) is presented along with 95% confidence interval. First event person-years=(cumulative total time to first event for participants who have the event+cumulative total of censored time for participants without the event)/365.25, based on the CV follow-up time period. The analysis was performed on the Intent to Treat (ITT) Population which comprised of all randomized participants excluding participants who did not provide consent.","timeFrame":"Median of 1.65 person years for CV follow-up time period"}],"secondaryOutcomes":[{"measure":"Time to First Occurrence of MACE or Urgent Revascularization for Unstable Angina","description":"Time to first occurrence of CEC-adjudicated MACE (CV death, MI or stroke) or urgent revascularization for unstable angina was analyzed using a Cox Proportional Hazards regression model with treatment group as the only covariate. The incidence rate per 100 person years (100\\*number of participants with at least 1 event)/first event person-years) is presented along with 95% confidence interval. First event person-years=(cumulative total time to first event for participants who have the event+cumulative total of censored time for participants without the event)/365.25, based on the CV follow-up time period.","timeFrame":"Median of 1.65 person years for CV follow-up time period"},{"measure":"Time to Adjudicated CV Death","description":"Time to adjudicated CV death was analyzed using a Cox Proportional Hazards regression model with treatment group as the only covariate. The incidence rate per 100 person years (100\\*number of participants with at least 1 event)/first event person-years) is presented along with 95% confidence interval. First event person-years=(cumulative total time to first event for participants who have the event+cumulative total of censored time for participants without the event)/365.25, based on the CV follow-up time period.","timeFrame":"Median of 1.65 person years for the CV follow-up time period"},{"measure":"Time to First Occurrence of Adjudicated MI","description":"Time to first occurrence of adjudicated MI was analyzed using a Cox Proportional Hazards regression model with treatment group as the only covariate. The incidence rate per 100 person years (100\\*number of participants with at least 1 event)/first event person-years) is presented along with 95% confidence interval. First event person-years=(cumulative total time to first event for participants who have the event+cumulative total of censored time for participants without the event)/365.25, based on the CV follow-up time period.","timeFrame":"Median of 1.65 person years for CV follow-up time period"},{"measure":"Time to First Occurrence of Adjudicated Stroke","description":"Time to first occurrence of adjudicated stroke was analyzed using a Cox Proportional Hazards regression model with treatment group as the only covariate. The incidence rate per 100 person years (100\\*number of participants with at least 1 event)/first event person-years) is presented along with 95% confidence interval. First event person-years=(cumulative total time to first event for participants who have the event+cumulative total of censored time for participants without the event)/365.25, based on the CV follow-up time period.","timeFrame":"Median of 1.65 person years for CV follow-up time period"},{"measure":"Time to First Occurrence of Adjudicated CV Death or Hospitalization for Heart Failure (HF)","description":"Time to first occurrence of adjudicated CV death or hospitalization for HF was analyzed using a Cox Proportional Hazards regression model with treatment group as the only covariate. The incidence rate per 100 person years (100\\*number of participants with at least 1 event)/first event person-years) is presented along with 95% confidence interval. First event person-years=(cumulative total time to first event for participants who have the event+cumulative total of censored time for participants without the event)/365.25, based on the CV follow-up time period.","timeFrame":"Median of 1.65 person years for CV follow-up time period"},{"measure":"Time to Initiation of Insulin of More Than 3 Months Duration for Those Participants Not Treated With Insulin at Study Start","description":"Time to initiation of insulin of more than 3 months duration in participants not treated with insulin at study start was analyzed using a Cox Proportional Hazards regression model with treatment group as the only covariate. The incidence rate per 100 person years (100\\*number of participants with at least 1 event)/first event person-years) is presented along with 95% confidence interval. First event person-years=(cumulative total time to first event for participants who have the event+cumulative total of censored time for participants without the event)/365.25, based on the on-therapy and post-therapy AE time period. The analysis was performed on Non-Insulin Population which comprised of participants in the ITT Population who were not on insulin at Baseline.","timeFrame":"Up to 2.7 years"},{"measure":"Time to Initiation of Prandial Insulin in Those Participants on Basal Insulin at Study Start","description":"Time to initiation of prandial insulin in those participants on basal insulin at study start was analyzed using a Cox Proportional Hazards regression model with treatment group as the only covariate. The incidence rate per 100 person years (100\\*number of participants with at least 1 event)/first event person-years) is presented along with 95% confidence interval. First event person-years=(cumulative total time to first event for participants who have the event+cumulative total of censored time for participants without the event)/365.25, based on the on-therapy and post-therapy AE time period. The analysis was performed on Basal Insulin Population which comprised of participants in the ITT Population who were on basal insulin but not on other insulin at Baseline (i.e., will not include a participant on a mixed insulin or on a prandial-only insulin).","timeFrame":"Up to 2.7 years"},{"measure":"Percentage of Participants Achieving Composite Metabolic Endpoint","description":"Percentage of participants achieving composite metabolic endpoint defined as the percentage of participants achieving glycemic control (glycated hemoglobin \\[HbA1c\\] \\<=7% ) with no severe hypoglycemic incidents and weight gain \\< 5%. Final Assessment is the latest post-Baseline assessment of both HbA1c and weight.","timeFrame":"Months 8, 16, 24 and final assessment (up to 2.7 years)"},{"measure":"Time to First Occurrence of a Clinically Important Microvascular Event","description":"Clinically important microvascular events were defined as the following: need for renal transplant or dialysis, new diabetes-related blindness, and procedures (laser photocoagulation or anti-vascular endothelial growth factor treatment or vitrectomy for diabetic retinopathy/eye disease). Time to first occurrence of a clinically important microvascular event was analyzed using a Cox Proportional Hazards regression model with treatment group as the only covariate. The incidence rate per 100 person years (100\\*number of participants with at least 1 event)/first event person-years) is presented along with 95% confidence interval. First event person-years=(cumulative total time to first event for participants who have the event+cumulative total of censored time for participants without the event)/365.25, based on the on-therapy and post-therapy AE time period.","timeFrame":"Up to 2.7 years"},{"measure":"Change From Baseline in HbA1c","description":"Change from Baseline in HbA1c was analyzed using mixed model repeated measures (MMRM) including observed case data (does not impute any missing data). Baseline is the last non-missing value assessed on or before treatment start date. Change from Baseline is the value at specified time point minus the Baseline value. Change from Baseline in HbA1c using Baseline data from Local or Central Laboratory, and post-Baseline Central Laboratory data is presented.","timeFrame":"Baseline and Months 8 and 16"},{"measure":"Change From Baseline in Body Weight","description":"Change from Baseline in body weight was analyzed using mixed model repeated measures including observed case data (does not impute any missing data). Baseline is the last non-missing value assessed on or before treatment start date. Change from Baseline is the value at specified time point minus the Baseline value.","timeFrame":"Baseline and Months 8 and 16"},{"measure":"Change From Baseline in Treatment Related Impact Measures-Diabetes (TRIM-D) Total Score","description":"The TRIM-D is a 28 item treatment satisfaction measure with 5 domains assessing Treatment Burden, Daily Life, Diabetes Management, Compliance and Psychological Health. The raw score ranges for each subscale were: treatment burden (6 to 30), daily life (5 to 25), diabetes management (5 to 25), compliance (4 to 20) and psychological health (8 to 40), higher scores indicating better health state. Total raw score was determined by summing the raw scores for each of the subscales and the total score (transformed) was determined as \\[(raw score minus lowest possible raw score)/possible raw score range\\] x100. The possible total (transformed) score range is 0-100, where higher scores indicated better health state. Baseline is the last non-missing value assessed on or before treatment start date. Change from Baseline is the value at specified time point minus the Baseline value.","timeFrame":"Baseline and Months 8 and 16"},{"measure":"Change From Baseline in EuroQol- 5 Dimension (EQ-5D) Visual Analogue Scale (VAS) Score","description":"The EQ-5D is a standardized instrument used to evaluate generic health-related quality of life, comprising 5 domains: mobility, self-care, usual activities, pain/discomfort, and anxiety/depression. It provides a simple descriptive profile and a single index value for health status. The EQ-5D self-reported questionnaire includes a visual analog scale (VAS), which records the respondent's self-rated health status on a graduated (0-100) scale, where 0 represents the worst imaginable health state and 100 represents the best imaginable health state. Baseline is the last non-missing value assessed on or before treatment start date. Change from Baseline is the value at specified time point minus the Baseline value.","timeFrame":"Baseline and Months 8 and 16"},{"measure":"Time to Death","description":"Time to death was analyzed using a Cox Proportional Hazards regression model with treatment group as the only covariate. The incidence rate per 100 person years (100\\*number of participants who died/endpoint person-years) is presented along with 95% confidence interval. Endpoint person-years=(cumulative total time to event for participants who have the event+cumulative total of censored time for participants without the event)/365.25, based on the Vital Status follow-up time period.","timeFrame":"Median of 1.73 years for the Vital Status follow-up time period"},{"measure":"Number of Participants With Non-fatal Serious Adverse Events (SAEs)","description":"SAE is defined as any untoward medical occurrence that, at any dose: results in death; is life-threatening; requires hospitalization or prolongation of existing hospitalization; results in disability/incapacity; is a congenital anomaly/birth defect; other important medical events that may not be immediately life-threatening or result in death or hospitalization but may jeopardize the participant or may require medical or surgical intervention to prevent one of the other outcomes listed before; is associated with liver injury and impaired liver function. Number of participants with on-therapy non-fatal SAEs are presented. Safety Population comprised of all randomized participants who received at least one dose of study treatment.","timeFrame":"Up to 2.7 years"},{"measure":"Number of Participants With Adverse Events (AEs) Leading to Discontinuation of Investigational Product (AELD)","description":"The number of participants with on-therapy AEs leading to discontinuation of investigational product is reported.","timeFrame":"Up to 2.7 years"},{"measure":"Number of Participants With AEs of Special Interest","description":"The protocol defined AEs of special interest included: development of thyroid cancer; hematologic malignancy; pancreatic cancer; pancreatitis (investigator reported and pancreatitis positively adjudicated by the Pancreatic Adjudication Committee \\[PAC\\]); investigational product injection site reactions; immunological reactions; severe hypoglycemic events; hepatic events; hepatic enzyme elevations (including gamma glutamyl transferase \\[GGT\\]); serious gastrointestinal (GI) events; appendicitis; atrial fibrillation/flutter; pneumonia; worsening renal function and diabetic retinopathy. The number of participants with on-therapy AEs of special interest is reported.","timeFrame":"Up to 2.7 years"},{"measure":"Change in Estimated Glomerular Filtration Rate (eGFR) Calculated Using Modification of Diet in Renal Disease (MDRD) Formula","description":"Blood samples were collected for the measurement of serum creatinine. Serum creatinine values were used to calculate eGFR using the MDRD formula, eGFR=175 x (serum creatinine)\\^-1.154 x (Age)\\^-0.203 x (0.742 if female) x (1.212 if African American). Baseline is the last non-missing value assessed on or before treatment start date. Change from Baseline is the value at specified time point minus the Baseline value. Change from Baseline in eGFR using Baseline data from Local or Central Laboratory, and post-Baseline Central Laboratory data for the on-treatment time period is presented.","timeFrame":"Baseline and Months 8 and 16"},{"measure":"Change From Baseline in Blood Pressure","description":"Systolic blood pressure (SBP) and diastolic blood pressure (DBP) were taken with the participant in a semi-recumbent or seated position after at least a 5-minute rest period. Baseline is the last non-missing value assessed on or before treatment start date. Change from Baseline is the value at specified time point minus the Baseline value.","timeFrame":"Baseline and Months 8,16,24 and end of study (up to 2.7 years)"},{"measure":"Change From Baseline in Heart Rate","description":"Heart rate was measured with the participant in a semi-recumbent or seated position after at least a 5-minute rest period. Baseline is the last non-missing value assessed on or before treatment start date. Change from Baseline is the value at specified time point minus the Baseline value.","timeFrame":"Baseline and Months 8, 16, 24 and end of study (up to 2.7 years)"}]},"eligibilityModule":{"eligibilityCriteria":"Inclusion Criteria:\n\n* Men or women at least 40 years old. Women must be post-menopausal or using a highly effective method for avoidance of pregnancy.\n* Diagnosis of type 2 diabetes.\n* Established cardiovascular disease with at least one of the following: coronary artery disease, cerebrovascular disease, or peripheral arterial disease.\n* HbA1c \\>7.0% (53 mmol/mol) (based on the most recent documented laboratory measurement within 6 months).\n* Able and willing to provide informed consent.\n\nExclusion Criteria:\n\n* Severely reduced kidney function: eGFR \\<30 ml/min/1.73 m\\^2 (based on the last measured and documented laboratory measurement within 6 months) or renal replacement therapy.\n* Use of a GLP-1 receptor agonist at Screening.\n* Severe gastroparesis\n* History of pancreatitis or considered clinically at significant risk of developing pancreatitis during the course of the study.\n* Personal or family history of medullary carcinoma of the thyroid or subject with multiple endocrine neoplasia type 2 (MEN-2). Personal history of pancreatic neuroendocrine tumours.\n* Medical history which might limit the subject's ability to take trial treatments for the duration of the study or to otherwise complete the study.\n* Breastfeeding, pregnancy, or planning a pregnancy during the course of the study. Note: a pregnancy test will be performed on all women of child bearing potential prior to study entry.\n* Known allergy to any GLP-1 receptor agonist or excipients of albiglutide.\n* Use of another investigational product within 30 days or according to local regulations, or currently enrolled in a study of an investigational device.\n* Any other reason the investigator deems the subject to be unsuitable for the study.","healthyVolunteers":false,"sex":"ALL","minimumAge":"40 Years","stdAges":["ADULT","OLDER_ADULT"]},"contactsLocationsModule":{"overallOfficials":[{"name":"GSK Clinical Trials","affiliation":"GlaxoSmithKline (for GlaxoSmithKline; Human Genome Sciences Inc., a GSK Company; Sirtris, a GSK Company; Stiefel, a GSK Company; ViiV Healthcare)","role":"STUDY_DIRECTOR"}],"locations":[{"facility":"GSK Investigational Site","city":"Birmingham","state":"Alabama","zip":"35211","country":"United States","geoPoint":{"lat":33.52066,"lon":-86.80249}},{"facility":"GSK Investigational Site","city":"Birmingham","state":"Alabama","zip":"35235","country":"United States","geoPoint":{"lat":33.52066,"lon":-86.80249}},{"facility":"GSK Investigational Site","city":"Mobile","state":"Alabama","zip":"36608","country":"United States","geoPoint":{"lat":30.69436,"lon":-88.04305}},{"facility":"GSK Investigational Site","city":"Chandler","state":"Arizona","zip":"85284","country":"United States","geoPoint":{"lat":33.30616,"lon":-111.84125}},{"facility":"GSK Investigational Site","city":"Glendale","state":"Arizona","zip":"85308","country":"United States","geoPoint":{"lat":33.53865,"lon":-112.18599}},{"facility":"GSK Investigational Site","city":"Goodyear","state":"Arizona","zip":"85395","country":"United States","geoPoint":{"lat":33.43532,"lon":-112.35821}},{"facility":"GSK Investigational Site","city":"Tempe","state":"Arizona","zip":"85283","country":"United States","geoPoint":{"lat":33.41477,"lon":-111.90931}},{"facility":"GSK Investigational Site","city":"Tucson","state":"Arizona","zip":"85741","country":"United States","geoPoint":{"lat":32.22174,"lon":-110.92648}},{"facility":"GSK Investigational Site","city":"Tucson","state":"Arizona","zip":"85745","country":"United States","geoPoint":{"lat":32.22174,"lon":-110.92648}},{"facility":"GSK Investigational Site","city":"Little Rock","state":"Arkansas","zip":"72209","country":"United States","geoPoint":{"lat":34.74648,"lon":-92.28959}},{"facility":"GSK Investigational Site","city":"Searcy","state":"Arkansas","zip":"72143","country":"United States","geoPoint":{"lat":35.25064,"lon":-91.73625}},{"facility":"GSK Investigational Site","city":"Chula Vista","state":"California","zip":"91910","country":"United States","geoPoint":{"lat":32.64005,"lon":-117.0842}},{"facility":"GSK Investigational Site","city":"Lancaster","state":"California","zip":"93534","country":"United States","geoPoint":{"lat":34.69804,"lon":-118.13674}},{"facility":"GSK Investigational Site","city":"Lomita","state":"California","zip":"90717","country":"United States","geoPoint":{"lat":33.79224,"lon":-118.31507}},{"facility":"GSK Investigational Site","city":"Long Beach","state":"California","zip":"90807","country":"United States","geoPoint":{"lat":33.76696,"lon":-118.18923}},{"facility":"GSK Investigational Site","city":"Long Beach","state":"California","zip":"90822","country":"United States","geoPoint":{"lat":33.76696,"lon":-118.18923}},{"facility":"GSK Investigational Site","city":"Los Angeles","state":"California","zip":"90017","country":"United States","geoPoint":{"lat":34.05223,"lon":-118.24368}},{"facility":"GSK Investigational Site","city":"Los Angeles","state":"California","zip":"90073","country":"United States","geoPoint":{"lat":34.05223,"lon":-118.24368}},{"facility":"GSK Investigational Site","city":"Moreno Valley","state":"California","zip":"92555","country":"United States","geoPoint":{"lat":33.93752,"lon":-117.23059}},{"facility":"GSK Investigational Site","city":"Northridge","state":"California","zip":"91325","country":"United States","geoPoint":{"lat":34.22834,"lon":-118.53675}},{"facility":"GSK Investigational Site","city":"Oakland","state":"California","zip":"94607","country":"United States","geoPoint":{"lat":37.80437,"lon":-122.2708}},{"facility":"GSK Investigational Site","city":"San Diego","state":"California","zip":"92103","country":"United States","geoPoint":{"lat":32.71571,"lon":-117.16472}},{"facility":"GSK Investigational Site","city":"San Diego","state":"California","zip":"92117","country":"United States","geoPoint":{"lat":32.71571,"lon":-117.16472}},{"facility":"GSK Investigational Site","city":"San Marino","state":"California","zip":"91108","country":"United States","geoPoint":{"lat":34.1214,"lon":-118.10646}},{"facility":"GSK Investigational Site","city":"San Ramon","state":"California","zip":"94583","country":"United States","geoPoint":{"lat":37.77993,"lon":-121.97802}},{"facility":"GSK Investigational Site","city":"Simi Valley","state":"California","zip":"93065","country":"United States","geoPoint":{"lat":34.26945,"lon":-118.78148}},{"facility":"GSK Investigational Site","city":"Stanford","state":"California","zip":"94305","country":"United States","geoPoint":{"lat":37.42411,"lon":-122.16608}},{"facility":"GSK Investigational Site","city":"Torrance","state":"California","zip":"90502","country":"United States","geoPoint":{"lat":33.83585,"lon":-118.34063}},{"facility":"GSK Investigational Site","city":"Denver","state":"Colorado","zip":"80220","country":"United States","geoPoint":{"lat":39.73915,"lon":-104.9847}},{"facility":"GSK Investigational Site","city":"Littleton","state":"Colorado","zip":"80120","country":"United States","geoPoint":{"lat":39.61332,"lon":-105.01665}},{"facility":"GSK Investigational Site","city":"Littleton","state":"Colorado","zip":"80127","country":"United States","geoPoint":{"lat":39.61332,"lon":-105.01665}},{"facility":"GSK Investigational Site","city":"New Haven","state":"Connecticut","zip":"06511","country":"United States","geoPoint":{"lat":41.30815,"lon":-72.92816}},{"facility":"GSK Investigational Site","city":"Belle Glade","state":"Florida","zip":"33430","country":"United States","geoPoint":{"lat":26.68451,"lon":-80.66756}},{"facility":"GSK Investigational Site","city":"Bradenton","state":"Florida","zip":"34201","country":"United States","geoPoint":{"lat":27.49893,"lon":-82.57482}},{"facility":"GSK Investigational Site","city":"Bradenton","state":"Florida","zip":"34209","country":"United States","geoPoint":{"lat":27.49893,"lon":-82.57482}},{"facility":"GSK Investigational Site","city":"Coral Gables","state":"Florida","zip":"33134","country":"United States","geoPoint":{"lat":25.72149,"lon":-80.26838}},{"facility":"GSK Investigational Site","city":"Coral Springs","state":"Florida","zip":"33065","country":"United States","geoPoint":{"lat":26.27119,"lon":-80.2706}},{"facility":"GSK Investigational Site","city":"Fleming Island","state":"Florida","zip":"32003","country":"United States","geoPoint":{"lat":30.0933,"lon":-81.71898}},{"facility":"GSK Investigational Site","city":"Inverness","state":"Florida","zip":"34452","country":"United States","geoPoint":{"lat":28.83582,"lon":-82.33037}},{"facility":"GSK Investigational Site","city":"Jacksonville","state":"Florida","zip":"32216","country":"United States","geoPoint":{"lat":30.33218,"lon":-81.65565}},{"facility":"GSK Investigational Site","city":"Lake Worth","state":"Florida","zip":"33467","country":"United States","geoPoint":{"lat":26.61708,"lon":-80.07231}},{"facility":"GSK Investigational Site","city":"Lakeland","state":"Florida","zip":"33805","country":"United States","geoPoint":{"lat":28.03947,"lon":-81.9498}},{"facility":"GSK Investigational Site","city":"Miami","state":"Florida","zip":"33174","country":"United States","geoPoint":{"lat":25.77427,"lon":-80.19366}},{"facility":"GSK Investigational Site","city":"Ocala","state":"Florida","zip":"34471","country":"United States","geoPoint":{"lat":29.1872,"lon":-82.14009}},{"facility":"GSK Investigational Site","city":"Ponte Vedra","state":"Florida","zip":"32081","country":"United States","geoPoint":{"lat":30.22746,"lon":-81.38008}},{"facility":"GSK Investigational Site","city":"Port Charlotte","state":"Florida","zip":"33952","country":"United States","geoPoint":{"lat":26.97617,"lon":-82.09064}},{"facility":"GSK Investigational Site","city":"Port Orange","state":"Florida","zip":"32127","country":"United States","geoPoint":{"lat":29.13832,"lon":-80.99561}},{"facility":"GSK Investigational Site","city":"St. Petersburg","state":"Florida","zip":"33713","country":"United States","geoPoint":{"lat":27.77086,"lon":-82.67927}},{"facility":"GSK Investigational Site","city":"Vero Beach","state":"Florida","zip":"32960","country":"United States","geoPoint":{"lat":27.63864,"lon":-80.39727}},{"facility":"GSK Investigational Site","city":"Wellington","state":"Florida","zip":"33449","country":"United States","geoPoint":{"lat":26.65868,"lon":-80.24144}},{"facility":"GSK Investigational Site","city":"Atlanta","state":"Georgia","zip":"30318","country":"United States","geoPoint":{"lat":33.749,"lon":-84.38798}},{"facility":"GSK Investigational Site","city":"Atlanta","state":"Georgia","zip":"30342","country":"United States","geoPoint":{"lat":33.749,"lon":-84.38798}},{"facility":"GSK Investigational Site","city":"Conyers","state":"Georgia","zip":"30094","country":"United States","geoPoint":{"lat":33.66761,"lon":-84.01769}},{"facility":"GSK Investigational Site","city":"Cumming","state":"Georgia","zip":"30041","country":"United States","geoPoint":{"lat":34.20732,"lon":-84.14019}},{"facility":"GSK Investigational Site","city":"Decatur","state":"Georgia","zip":"30033","country":"United States","geoPoint":{"lat":33.77483,"lon":-84.29631}},{"facility":"GSK Investigational Site","city":"Dunwoody","state":"Georgia","zip":"30338","country":"United States","geoPoint":{"lat":33.94621,"lon":-84.33465}},{"facility":"GSK Investigational Site","city":"Snellville","state":"Georgia","zip":"30078","country":"United States","geoPoint":{"lat":33.85733,"lon":-84.01991}},{"facility":"GSK Investigational Site","city":"Tucker","state":"Georgia","zip":"30084","country":"United States","geoPoint":{"lat":33.85455,"lon":-84.21714}},{"facility":"GSK Investigational Site","city":"Aurora","state":"Illinois","zip":"60504","country":"United States","geoPoint":{"lat":41.76058,"lon":-88.32007}},{"facility":"GSK Investigational Site","city":"Champaign","state":"Illinois","zip":"61820","country":"United States","geoPoint":{"lat":40.11642,"lon":-88.24338}},{"facility":"GSK Investigational Site","city":"Gurnee","state":"Illinois","zip":"60031","country":"United States","geoPoint":{"lat":42.3703,"lon":-87.90202}},{"facility":"GSK Investigational Site","city":"Moline","state":"Illinois","zip":"61265","country":"United States","geoPoint":{"lat":41.5067,"lon":-90.51513}},{"facility":"GSK Investigational Site","city":"Avon","state":"Indiana","zip":"46123","country":"United States","geoPoint":{"lat":39.76282,"lon":-86.39972}},{"facility":"GSK Investigational Site","city":"Franklin","state":"Indiana","zip":"46131","country":"United States","geoPoint":{"lat":39.48061,"lon":-86.05499}},{"facility":"GSK Investigational Site","city":"Greenfield","state":"Indiana","zip":"46140","country":"United States","geoPoint":{"lat":39.78504,"lon":-85.76942}},{"facility":"GSK Investigational Site","city":"Muncie","state":"Indiana","zip":"47304-","country":"United States","geoPoint":{"lat":40.19338,"lon":-85.38636}},{"facility":"GSK Investigational Site","city":"Munster","state":"Indiana","zip":"46321","country":"United States","geoPoint":{"lat":41.56448,"lon":-87.51254}},{"facility":"GSK Investigational Site","city":"West Des Moines","state":"Iowa","zip":"50265","country":"United States","geoPoint":{"lat":41.57721,"lon":-93.71133}},{"facility":"GSK Investigational Site","city":"Topeka","state":"Kansas","zip":"66606","country":"United States","geoPoint":{"lat":39.04833,"lon":-95.67804}},{"facility":"GSK Investigational Site","city":"Lexington","state":"Kentucky","zip":"40503","country":"United States","geoPoint":{"lat":37.98869,"lon":-84.47772}},{"facility":"GSK Investigational Site","city":"Louisville","state":"Kentucky","zip":"40213","country":"United States","geoPoint":{"lat":38.25424,"lon":-85.75941}},{"facility":"GSK Investigational Site","city":"New Orleans","state":"Louisiana","zip":"70115","country":"United States","geoPoint":{"lat":29.95465,"lon":-90.07507}},{"facility":"GSK Investigational Site","city":"Lewiston","state":"Maine","zip":"04240","country":"United States","geoPoint":{"lat":44.10035,"lon":-70.21478}},{"facility":"GSK Investigational Site","city":"Annapolis","state":"Maryland","zip":"21401","country":"United States","geoPoint":{"lat":38.97859,"lon":-76.49184}},{"facility":"GSK Investigational Site","city":"Saint Cloud","state":"Minnesota","zip":"56303","country":"United States","geoPoint":{"lat":45.5608,"lon":-94.16249}},{"facility":"GSK Investigational Site","city":"Saint Paul","state":"Minnesota","zip":"55102","country":"United States","geoPoint":{"lat":44.94441,"lon":-93.09327}},{"facility":"GSK Investigational Site","city":"St Louis","state":"Missouri","zip":"63136","country":"United States","geoPoint":{"lat":38.62727,"lon":-90.19789}},{"facility":"GSK Investigational Site","city":"Omaha","state":"Nebraska","zip":"68124","country":"United States","geoPoint":{"lat":41.25626,"lon":-95.94043}},{"facility":"GSK Investigational Site","city":"Las Vegas","state":"Nevada","zip":"89086","country":"United States","geoPoint":{"lat":36.17497,"lon":-115.13722}},{"facility":"GSK Investigational Site","city":"Camden","state":"New Jersey","zip":"08103","country":"United States","geoPoint":{"lat":39.92595,"lon":-75.11962}},{"facility":"GSK Investigational Site","city":"Haddon Heights","state":"New Jersey","zip":"08035","country":"United States","geoPoint":{"lat":39.87734,"lon":-75.06462}},{"facility":"GSK Investigational Site","city":"Albuquerque","state":"New Mexico","zip":"87102","country":"United States","geoPoint":{"lat":35.08449,"lon":-106.65114}},{"facility":"GSK Investigational Site","city":"Brooklyn","state":"New York","zip":"11215","country":"United States","geoPoint":{"lat":40.6501,"lon":-73.94958}},{"facility":"GSK Investigational Site","city":"North Massapequa","state":"New York","zip":"11758","country":"United States","geoPoint":{"lat":40.70093,"lon":-73.46207}},{"facility":"GSK Investigational Site","city":"Charlotte","state":"North Carolina","zip":"28207","country":"United States","geoPoint":{"lat":35.22709,"lon":-80.84313}},{"facility":"GSK Investigational Site","city":"Charlotte","state":"North Carolina","zip":"28209","country":"United States","geoPoint":{"lat":35.22709,"lon":-80.84313}},{"facility":"GSK Investigational Site","city":"Charlotte","state":"North Carolina","zip":"28277","country":"United States","geoPoint":{"lat":35.22709,"lon":-80.84313}},{"facility":"GSK Investigational Site","city":"Hickory","state":"North Carolina","zip":"28601","country":"United States","geoPoint":{"lat":35.73319,"lon":-81.3412}},{"facility":"GSK Investigational Site","city":"Rocky Mount","state":"North Carolina","zip":"27804","country":"United States","geoPoint":{"lat":35.93821,"lon":-77.79053}},{"facility":"GSK Investigational Site","city":"Salisbury","state":"North Carolina","zip":"28144","country":"United States","geoPoint":{"lat":35.67097,"lon":-80.47423}},{"facility":"GSK Investigational Site","city":"Statesville","state":"North Carolina","zip":"28625","country":"United States","geoPoint":{"lat":35.78264,"lon":-80.8873}},{"facility":"GSK Investigational Site","city":"Wilmington","state":"North Carolina","zip":"28401","country":"United States","geoPoint":{"lat":34.23556,"lon":-77.94604}},{"facility":"GSK Investigational Site","city":"Winston-Salem","state":"North Carolina","zip":"27157","country":"United States","geoPoint":{"lat":36.09986,"lon":-80.24422}},{"facility":"GSK Investigational Site","city":"Fargo","state":"North Dakota","zip":"58103","country":"United States","geoPoint":{"lat":46.87719,"lon":-96.7898}},{"facility":"GSK Investigational Site","city":"Cleveland","state":"Ohio","zip":"44122","country":"United States","geoPoint":{"lat":41.4995,"lon":-81.69541}},{"facility":"GSK Investigational Site","city":"Columbus","state":"Ohio","zip":"43210","country":"United States","geoPoint":{"lat":39.96118,"lon":-82.99879}},{"facility":"GSK Investigational Site","city":"Sandusky","state":"Ohio","zip":"44870","country":"United States","geoPoint":{"lat":41.44894,"lon":-82.70796}},{"facility":"GSK Investigational Site","city":"Springfield","state":"Ohio","zip":"45504","country":"United States","geoPoint":{"lat":39.92423,"lon":-83.80882}},{"facility":"GSK Investigational Site","city":"Toledo","state":"Ohio","zip":"43614","country":"United States","geoPoint":{"lat":41.66394,"lon":-83.55521}},{"facility":"GSK Investigational Site","city":"Camp Hill","state":"Pennsylvania","zip":"17011","country":"United States","geoPoint":{"lat":40.23981,"lon":-76.91997}},{"facility":"GSK Investigational Site","city":"Feasterville","state":"Pennsylvania","zip":"19053","country":"United States","geoPoint":{"lat":40.15,"lon":-74.997}},{"facility":"GSK Investigational Site","city":"Harleysville","state":"Pennsylvania","zip":"19438","country":"United States","geoPoint":{"lat":40.27955,"lon":-75.38712}},{"facility":"GSK Investigational Site","city":"Jersey Shore","state":"Pennsylvania","zip":"17740","country":"United States","geoPoint":{"lat":41.20202,"lon":-77.26442}},{"facility":"GSK Investigational Site","city":"Lansdale","state":"Pennsylvania","zip":"19446","country":"United States","geoPoint":{"lat":40.2415,"lon":-75.28379}},{"facility":"GSK Investigational Site","city":"Newport","state":"Pennsylvania","zip":"17074","country":"United States","geoPoint":{"lat":40.47786,"lon":-77.13054}},{"facility":"GSK Investigational Site","city":"Penndel","state":"Pennsylvania","zip":"19047","country":"United States","geoPoint":{"lat":40.15205,"lon":-74.91656}},{"facility":"GSK Investigational Site","city":"Pittsburgh","state":"Pennsylvania","zip":"15212","country":"United States","geoPoint":{"lat":40.44062,"lon":-79.99589}},{"facility":"GSK Investigational Site","city":"Pittsburgh","state":"Pennsylvania","zip":"15240","country":"United States","geoPoint":{"lat":40.44062,"lon":-79.99589}},{"facility":"GSK Investigational Site","city":"Sellersville","state":"Pennsylvania","zip":"18960","country":"United States","geoPoint":{"lat":40.35399,"lon":-75.3049}},{"facility":"GSK Investigational Site","city":"Pawtucket","state":"Rhode Island","zip":"02860","country":"United States","geoPoint":{"lat":41.87871,"lon":-71.38256}},{"facility":"GSK Investigational Site","city":"Anderson","state":"South Carolina","zip":"29621","country":"United States","geoPoint":{"lat":34.50344,"lon":-82.65013}},{"facility":"GSK Investigational Site","city":"Columbia","state":"South Carolina","zip":"29223","country":"United States","geoPoint":{"lat":34.00071,"lon":-81.03481}},{"facility":"GSK Investigational Site","city":"Myrtle Beach","state":"South Carolina","zip":"29572","country":"United States","geoPoint":{"lat":33.68906,"lon":-78.88669}},{"facility":"GSK Investigational Site","city":"Rapid City","state":"South Dakota","zip":"57701","country":"United States","geoPoint":{"lat":44.08054,"lon":-103.23101}},{"facility":"GSK Investigational Site","city":"Rapid City","state":"South Dakota","zip":"57702","country":"United States","geoPoint":{"lat":44.08054,"lon":-103.23101}},{"facility":"GSK Investigational Site","city":"Bristol","state":"Tennessee","zip":"37620","country":"United States","geoPoint":{"lat":36.59511,"lon":-82.18874}},{"facility":"GSK Investigational Site","city":"Kingsport","state":"Tennessee","zip":"37660","country":"United States","geoPoint":{"lat":36.54843,"lon":-82.56182}},{"facility":"GSK Investigational Site","city":"Memphis","state":"Tennessee","zip":"38104","country":"United States","geoPoint":{"lat":35.14953,"lon":-90.04898}},{"facility":"GSK Investigational Site","city":"Memphis","state":"Tennessee","zip":"38119","country":"United States","geoPoint":{"lat":35.14953,"lon":-90.04898}},{"facility":"GSK Investigational Site","city":"Nashville","state":"Tennessee","zip":"37203","country":"United States","geoPoint":{"lat":36.16589,"lon":-86.78444}},{"facility":"GSK Investigational Site","city":"Nashville","state":"Tennessee","zip":"37212","country":"United States","geoPoint":{"lat":36.16589,"lon":-86.78444}},{"facility":"GSK Investigational Site","city":"Arlington","state":"Texas","zip":"76014","country":"United States","geoPoint":{"lat":32.73569,"lon":-97.10807}},{"facility":"GSK Investigational Site","city":"Austin","state":"Texas","zip":"78731","country":"United States","geoPoint":{"lat":30.26715,"lon":-97.74306}},{"facility":"GSK Investigational Site","city":"Bellaire","state":"Texas","zip":"77401","country":"United States","geoPoint":{"lat":29.70579,"lon":-95.45883}},{"facility":"GSK Investigational Site","city":"Dallas","state":"Texas","zip":"75216","country":"United States","geoPoint":{"lat":32.78306,"lon":-96.80667}},{"facility":"GSK Investigational Site","city":"Dallas","state":"Texas","zip":"75231","country":"United States","geoPoint":{"lat":32.78306,"lon":-96.80667}},{"facility":"GSK Investigational Site","city":"Dallas","state":"Texas","zip":"75234","country":"United States","geoPoint":{"lat":32.78306,"lon":-96.80667}},{"facility":"GSK Investigational Site","city":"Dallas","state":"Texas","country":"United States","geoPoint":{"lat":32.78306,"lon":-96.80667}},{"facility":"GSK Investigational Site","city":"El Paso","state":"Texas","zip":"79925","country":"United States","geoPoint":{"lat":31.75872,"lon":-106.48693}},{"facility":"GSK Investigational Site","city":"Georgetown","state":"Texas","zip":"78626","country":"United States","geoPoint":{"lat":30.63269,"lon":-97.67723}},{"facility":"GSK Investigational Site","city":"Houston","state":"Texas","zip":"77070","country":"United States","geoPoint":{"lat":29.76328,"lon":-95.36327}},{"facility":"GSK Investigational Site","city":"Huntsville","state":"Texas","zip":"77340","country":"United States","geoPoint":{"lat":30.72353,"lon":-95.55078}},{"facility":"GSK Investigational Site","city":"Kingwood","state":"Texas","zip":"77339","country":"United States","geoPoint":{"lat":30.05691,"lon":-95.18349}},{"facility":"GSK Investigational Site","city":"Plano","state":"Texas","zip":"75093","country":"United States","geoPoint":{"lat":33.01984,"lon":-96.69889}},{"facility":"GSK Investigational Site","city":"San Antonio","state":"Texas","zip":"78229","country":"United States","geoPoint":{"lat":29.42412,"lon":-98.49363}},{"facility":"GSK Investigational Site","city":"San Antonio","state":"Texas","zip":"78258","country":"United States","geoPoint":{"lat":29.42412,"lon":-98.49363}},{"facility":"GSK Investigational Site","city":"Schertz","state":"Texas","zip":"78154","country":"United States","geoPoint":{"lat":29.55217,"lon":-98.26973}},{"facility":"GSK Investigational Site","city":"Suite 101","state":"Texas","zip":"76132","country":"United States"},{"facility":"GSK Investigational Site","city":"Tyler","state":"Texas","zip":"75708","country":"United States","geoPoint":{"lat":32.35126,"lon":-95.30106}},{"facility":"GSK Investigational Site","city":"Layton","state":"Utah","zip":"84401","country":"United States","geoPoint":{"lat":41.06022,"lon":-111.97105}},{"facility":"GSK Investigational Site","city":"Manassas","state":"Virginia","zip":"20109","country":"United States","geoPoint":{"lat":38.75095,"lon":-77.47527}},{"facility":"GSK Investigational Site","city":"Federal Way","state":"Washington","zip":"98003","country":"United States","geoPoint":{"lat":47.32232,"lon":-122.31262}},{"facility":"GSK Investigational Site","city":"Spokane","state":"Washington","zip":"99208","country":"United States","geoPoint":{"lat":47.65966,"lon":-117.42908}},{"facility":"GSK Investigational Site","city":"Tacoma","state":"Washington","zip":"98405","country":"United States","geoPoint":{"lat":47.25288,"lon":-122.44429}},{"facility":"GSK Investigational Site","city":"Wenatchee","state":"Washington","zip":"98801","country":"United States","geoPoint":{"lat":47.42346,"lon":-120.31035}},{"facility":"GSK Investigational Site","city":"Madison","state":"Wisconsin","zip":"53713","country":"United States","geoPoint":{"lat":43.07305,"lon":-89.40123}},{"facility":"GSK Investigational Site","city":"Adrogué","state":"Buenos Aires","zip":"B1846DSK","country":"Argentina","geoPoint":{"lat":-34.80041,"lon":-58.38384}},{"facility":"GSK Investigational Site","city":"Bahía Blanca","state":"Buenos Aires","zip":"B8000FTD","country":"Argentina","geoPoint":{"lat":-38.7176,"lon":-62.26545}},{"facility":"GSK Investigational Site","city":"Ciudad Autonoma de Buenos Aires","state":"Buenos Aires","zip":"1205","country":"Argentina"},{"facility":"GSK Investigational Site","city":"Ciudad Autonoma de Buenos Aires","state":"Buenos Aires","zip":"C1179AAB","country":"Argentina"},{"facility":"GSK Investigational Site","city":"Ciudad Autónoma de Buenos Aires","state":"Buenos Aires","zip":"C141AH","country":"Argentina"},{"facility":"GSK Investigational Site","city":"Mar del Plata","state":"Buenos Aires","zip":"B7600FZN","country":"Argentina","geoPoint":{"lat":-38.00042,"lon":-57.5562}},{"facility":"GSK Investigational Site","city":"Mar del Plata","state":"Buenos Aires","country":"Argentina","geoPoint":{"lat":-38.00042,"lon":-57.5562}},{"facility":"GSK Investigational Site","city":"Pergamino","state":"Buenos Aires","zip":"B2700CPM","country":"Argentina","geoPoint":{"lat":-33.89101,"lon":-60.57462}},{"facility":"GSK Investigational Site","city":"Córdoba","state":"Córdoba Province","zip":"5000","country":"Argentina","geoPoint":{"lat":-31.40648,"lon":-64.18853}},{"facility":"GSK Investigational Site","city":"Godoy Cruz","state":"Mendoza Province","zip":"M5501ARP","country":"Argentina","geoPoint":{"lat":-32.92533,"lon":-68.84428}},{"facility":"GSK Investigational Site","city":"San Rafael","state":"Mendoza Province","zip":"5600","country":"Argentina","geoPoint":{"lat":-34.61531,"lon":-68.33238}},{"facility":"GSK Investigational Site","city":"Rosario","state":"Santa Fe Province","zip":"2000","country":"Argentina","geoPoint":{"lat":-32.94682,"lon":-60.63932}},{"facility":"GSK Investigational Site","city":"Rosario","state":"Santa Fe Province","zip":"S2000C","country":"Argentina","geoPoint":{"lat":-32.94682,"lon":-60.63932}},{"facility":"GSK Investigational Site","city":"Berazategui","zip":"1886","country":"Argentina","geoPoint":{"lat":-34.76531,"lon":-58.21278}},{"facility":"GSK Investigational Site","city":"Buenos Aires","zip":"1093","country":"Argentina","geoPoint":{"lat":-34.61315,"lon":-58.37723}},{"facility":"GSK Investigational Site","city":"Buenos Aires","zip":"1407","country":"Argentina","geoPoint":{"lat":-34.61315,"lon":-58.37723}},{"facility":"GSK Investigational Site","city":"Buenos Aires","zip":"C1056ABJ","country":"Argentina","geoPoint":{"lat":-34.61315,"lon":-58.37723}},{"facility":"GSK Investigational Site","city":"Buenos Aires","zip":"C1061ABD","country":"Argentina","geoPoint":{"lat":-34.61315,"lon":-58.37723}},{"facility":"GSK Investigational Site","city":"Buenos Aires","zip":"C1128A","country":"Argentina","geoPoint":{"lat":-34.61315,"lon":-58.37723}},{"facility":"GSK Investigational Site","city":"Buenos Aires","zip":"C1180A","country":"Argentina","geoPoint":{"lat":-34.61315,"lon":-58.37723}},{"facility":"GSK Investigational Site","city":"Buenos Aires","zip":"C1406BOA","country":"Argentina","geoPoint":{"lat":-34.61315,"lon":-58.37723}},{"facility":"GSK Investigational Site","city":"Buenos Aires","zip":"C1425AGC","country":"Argentina","geoPoint":{"lat":-34.61315,"lon":-58.37723}},{"facility":"GSK Investigational Site","city":"Buenos Aires","zip":"C1426A","country":"Argentina","geoPoint":{"lat":-34.61315,"lon":-58.37723}},{"facility":"GSK Investigational Site","city":"Buenos Aires","zip":"C1428D","country":"Argentina","geoPoint":{"lat":-34.61315,"lon":-58.37723}},{"facility":"GSK Investigational Site","city":"Buenos Aires","country":"Argentina","geoPoint":{"lat":-34.61315,"lon":-58.37723}},{"facility":"GSK Investigational Site","city":"Córdoba","zip":"5016","country":"Argentina","geoPoint":{"lat":-31.40648,"lon":-64.18853}},{"facility":"GSK Investigational Site","city":"La Plata","zip":"B1902C","country":"Argentina","geoPoint":{"lat":-34.92126,"lon":-57.95442}},{"facility":"GSK Investigational Site","city":"Mendoza","zip":"5500","country":"Argentina","geoPoint":{"lat":-32.88946,"lon":-68.84582}},{"facility":"GSK Investigational Site","city":"Mendoza","zip":"M5500CCE","country":"Argentina","geoPoint":{"lat":-32.88946,"lon":-68.84582}},{"facility":"GSK Investigational Site","city":"Mendoza","zip":"M5500C","country":"Argentina","geoPoint":{"lat":-32.88946,"lon":-68.84582}},{"facility":"GSK Investigational Site","city":"Santa Fe","zip":"3000","country":"Argentina","geoPoint":{"lat":-31.64881,"lon":-60.70868}},{"facility":"GSK Investigational Site","city":"Bonheiden","zip":"2820","country":"Belgium","geoPoint":{"lat":51.02261,"lon":4.54714}},{"facility":"GSK Investigational Site","city":"Brussels","zip":"1070","country":"Belgium","geoPoint":{"lat":50.85045,"lon":4.34878}},{"facility":"GSK Investigational Site","city":"Brussels","zip":"1090","country":"Belgium","geoPoint":{"lat":50.85045,"lon":4.34878}},{"facility":"GSK Investigational Site","city":"Edegem","zip":"2650","country":"Belgium","geoPoint":{"lat":51.15662,"lon":4.44504}},{"facility":"GSK Investigational Site","city":"Leuven","zip":"3000","country":"Belgium","geoPoint":{"lat":50.87959,"lon":4.70093}},{"facility":"GSK Investigational Site","city":"Liège","zip":"4000","country":"Belgium","geoPoint":{"lat":50.63373,"lon":5.56749}},{"facility":"GSK Investigational Site","city":"Roeselare","zip":"8800","country":"Belgium","geoPoint":{"lat":50.94653,"lon":3.12269}},{"facility":"GSK Investigational Site","city":"Byala","zip":"7100","country":"Bulgaria","geoPoint":{"lat":42.87426,"lon":27.88865}},{"facility":"GSK Investigational Site","city":"Gabrovo","zip":"5300","country":"Bulgaria","geoPoint":{"lat":42.87419,"lon":25.31823}},{"facility":"GSK Investigational Site","city":"Montana","country":"Bulgaria","geoPoint":{"lat":43.41285,"lon":23.22174}},{"facility":"GSK Investigational Site","city":"Sevlievo","zip":"5400","country":"Bulgaria","geoPoint":{"lat":43.02295,"lon":25.10364}},{"facility":"GSK Investigational Site","city":"Sofia","zip":"1202","country":"Bulgaria","geoPoint":{"lat":42.69751,"lon":23.32415}},{"facility":"GSK Investigational Site","city":"Sofia","zip":"1407","country":"Bulgaria","geoPoint":{"lat":42.69751,"lon":23.32415}},{"facility":"GSK Investigational Site","city":"Sofia","zip":"1632","country":"Bulgaria","geoPoint":{"lat":42.69751,"lon":23.32415}},{"facility":"GSK Investigational Site","city":"Stara Zagora","zip":"6000","country":"Bulgaria","geoPoint":{"lat":42.43205,"lon":25.64262}},{"facility":"GSK Investigational Site","city":"Kelowna","state":"British Columbia","zip":"V1Y 1V6","country":"Canada","geoPoint":{"lat":49.88307,"lon":-119.48568}},{"facility":"GSK Investigational Site","city":"Surrey","state":"British Columbia","zip":"V3V 0C6","country":"Canada","geoPoint":{"lat":49.10635,"lon":-122.82509}},{"facility":"GSK Investigational Site","city":"Victoria","state":"British Columbia","zip":"V8R 4R2","country":"Canada","geoPoint":{"lat":48.4359,"lon":-123.35155}},{"facility":"GSK Investigational Site","city":"Victoria","state":"British Columbia","zip":"V8V 4A","country":"Canada","geoPoint":{"lat":48.4359,"lon":-123.35155}},{"facility":"GSK Investigational Site","city":"Winnipeg","state":"Manitoba","zip":"3P","country":"Canada","geoPoint":{"lat":49.8844,"lon":-97.14704}},{"facility":"GSK Investigational Site","city":"Moncton","state":"New Brunswick","zip":"E1G 1A7","country":"Canada","geoPoint":{"lat":46.09454,"lon":-64.7965}},{"facility":"GSK Investigational Site","city":"St. John's","state":"Newfoundland and Labrador","zip":"A1B 3V6","country":"Canada","geoPoint":{"lat":47.56494,"lon":-52.70931}},{"facility":"GSK Investigational Site","city":"Halifax","state":"Nova Scotia","zip":"B3H 1V7","country":"Canada","geoPoint":{"lat":44.64269,"lon":-63.57688}},{"facility":"GSK Investigational Site","city":"Truro","state":"Nova Scotia","zip":"B2N 1L2","country":"Canada","geoPoint":{"lat":45.36685,"lon":-63.26538}},{"facility":"GSK Investigational Site","city":"Brampton","state":"Ontario","zip":"L6Z 4N5","country":"Canada","geoPoint":{"lat":43.68341,"lon":-79.76633}},{"facility":"GSK Investigational Site","city":"Burlington","state":"Ontario","zip":"L7M 4Y","country":"Canada","geoPoint":{"lat":43.38621,"lon":-79.83713}},{"facility":"GSK Investigational Site","city":"Cambridge","state":"Ontario","zip":"N1R 7R1","country":"Canada","geoPoint":{"lat":43.3601,"lon":-80.31269}},{"facility":"GSK Investigational Site","city":"Cornwall","state":"Ontario","zip":"K6H4M4","country":"Canada","geoPoint":{"lat":45.01809,"lon":-74.72815}},{"facility":"GSK Investigational Site","city":"Corunna","state":"Ontario","zip":"N0N 1G","country":"Canada","geoPoint":{"lat":42.88338,"lon":-82.43313}},{"facility":"GSK Investigational Site","city":"Greater Sudbury","state":"Ontario","zip":"P3A 5H","country":"Canada","geoPoint":{"lat":46.49,"lon":-80.99001}},{"facility":"GSK Investigational Site","city":"Hamilton","state":"Ontario","zip":"L8L 2X2","country":"Canada","geoPoint":{"lat":43.25011,"lon":-79.84963}},{"facility":"GSK Investigational Site","city":"London","state":"Ontario","zip":"N5W 6A","country":"Canada","geoPoint":{"lat":42.98339,"lon":-81.23304}},{"facility":"GSK Investigational Site","city":"London","state":"Ontario","zip":"N6A 4V2","country":"Canada","geoPoint":{"lat":42.98339,"lon":-81.23304}},{"facility":"GSK Investigational Site","city":"Sarnia","state":"Ontario","zip":"N7T 4X","country":"Canada","geoPoint":{"lat":42.97866,"lon":-82.40407}},{"facility":"GSK Investigational Site","city":"Smiths Falls","state":"Ontario","zip":"K7A 4W8","country":"Canada","geoPoint":{"lat":44.90452,"lon":-76.02333}},{"facility":"GSK Investigational Site","city":"Toronto","state":"Ontario","zip":"M9V 4B","country":"Canada","geoPoint":{"lat":43.70643,"lon":-79.39864}},{"facility":"GSK Investigational Site","city":"Brossard","state":"Quebec","zip":"J4Z 2K","country":"Canada","geoPoint":{"lat":45.45008,"lon":-73.46583}},{"facility":"GSK Investigational Site","city":"Chicoutimi","state":"Quebec","zip":"G7H 7K9","country":"Canada","geoPoint":{"lat":48.41963,"lon":-71.06369}},{"facility":"GSK Investigational Site","city":"Greenfield Park","state":"Quebec","zip":"J4V 2G","country":"Canada","geoPoint":{"lat":45.48649,"lon":-73.46223}},{"facility":"GSK Investigational Site","city":"Greenfield Park","state":"Quebec","zip":"J4V 2H1","country":"Canada","geoPoint":{"lat":45.48649,"lon":-73.46223}},{"facility":"GSK Investigational Site","city":"Laval","state":"Quebec","zip":"H7T 2P5","country":"Canada","geoPoint":{"lat":45.56995,"lon":-73.692}},{"facility":"GSK Investigational Site","city":"Lévis","state":"Quebec","zip":"G6V 4Z5","country":"Canada","geoPoint":{"lat":46.80326,"lon":-71.17793}},{"facility":"GSK Investigational Site","city":"Montreal","state":"Quebec","zip":"H4N 2W","country":"Canada","geoPoint":{"lat":45.50884,"lon":-73.58781}},{"facility":"GSK Investigational Site","city":"Saint-Charles-Borromée","state":"Quebec","zip":"J6E 6J2","country":"Canada","geoPoint":{"lat":46.05007,"lon":-73.46586}},{"facility":"GSK Investigational Site","city":"Saint-Lambert","state":"Quebec","zip":"J4P 2J","country":"Canada","geoPoint":{"lat":45.50008,"lon":-73.51028}},{"facility":"GSK Investigational Site","city":"Sherbrooke","state":"Quebec","zip":"J1J 2E3","country":"Canada","geoPoint":{"lat":45.40008,"lon":-71.89908}},{"facility":"GSK Investigational Site","city":"Trois-Rivières","state":"Quebec","zip":"G8T 7A1","country":"Canada","geoPoint":{"lat":46.34515,"lon":-72.5477}},{"facility":"GSK Investigational Site","city":"Beroun","zip":"266 01","country":"Czechia","geoPoint":{"lat":49.96382,"lon":14.072}},{"facility":"GSK Investigational Site","city":"Krnov","zip":"794 01","country":"Czechia","geoPoint":{"lat":50.08967,"lon":17.70385}},{"facility":"GSK Investigational Site","city":"Olomouc","zip":"772 00","country":"Czechia","geoPoint":{"lat":49.59552,"lon":17.25175}},{"facility":"GSK Investigational Site","city":"Ostrava","zip":"702 00","country":"Czechia","geoPoint":{"lat":49.83465,"lon":18.28204}},{"facility":"GSK Investigational Site","city":"Prague","zip":"100 00","country":"Czechia","geoPoint":{"lat":50.08804,"lon":14.42076}},{"facility":"GSK Investigational Site","city":"Prague","zip":"116 94","country":"Czechia","geoPoint":{"lat":50.08804,"lon":14.42076}},{"facility":"GSK Investigational Site","city":"Prague","zip":"128 08","country":"Czechia","geoPoint":{"lat":50.08804,"lon":14.42076}},{"facility":"GSK Investigational Site","city":"Prague","zip":"149 00","country":"Czechia","geoPoint":{"lat":50.08804,"lon":14.42076}},{"facility":"GSK Investigational Site","city":"Prague","zip":"150 00","country":"Czechia","geoPoint":{"lat":50.08804,"lon":14.42076}},{"facility":"GSK Investigational Site","city":"Příbram","zip":"261 01","country":"Czechia","geoPoint":{"lat":49.68988,"lon":14.01043}},{"facility":"GSK Investigational Site","city":"Uherské Hradiště","zip":"686 01","country":"Czechia","geoPoint":{"lat":49.06975,"lon":17.45969}},{"facility":"GSK Investigational Site","city":"Ústí nad Labem","zip":"401 13","country":"Czechia","geoPoint":{"lat":50.6607,"lon":14.03227}},{"facility":"GSK Investigational Site","city":"Zlín","zip":"760 01","country":"Czechia","geoPoint":{"lat":49.22645,"lon":17.67065}},{"facility":"GSK Investigational Site","city":"Copenhagen","zip":"2100","country":"Denmark","geoPoint":{"lat":55.67594,"lon":12.56553}},{"facility":"GSK Investigational Site","city":"Esbjerg","zip":"6700","country":"Denmark","geoPoint":{"lat":55.47028,"lon":8.45187}},{"facility":"GSK Investigational Site","city":"Frederikssund","zip":"DK-3600","country":"Denmark","geoPoint":{"lat":55.83956,"lon":12.06896}},{"facility":"GSK Investigational Site","city":"Hellerup","zip":"2900","country":"Denmark","geoPoint":{"lat":55.73204,"lon":12.57093}},{"facility":"GSK Investigational Site","city":"Herlev","zip":"DK-273","country":"Denmark","geoPoint":{"lat":55.72366,"lon":12.43998}},{"facility":"GSK Investigational Site","city":"Holbæk","zip":"DK-430","country":"Denmark","geoPoint":{"lat":55.7175,"lon":11.71279}},{"facility":"GSK Investigational Site","city":"Hvidovre","zip":"2650","country":"Denmark","geoPoint":{"lat":55.64297,"lon":12.47708}},{"facility":"GSK Investigational Site","city":"København NV","zip":"2400","country":"Denmark","geoPoint":{"lat":55.71258,"lon":12.52343}},{"facility":"GSK Investigational Site","city":"København S","zip":"DK-230","country":"Denmark","geoPoint":{"lat":55.65059,"lon":12.5978}},{"facility":"GSK Investigational Site","city":"Roskilde","zip":"DK-400","country":"Denmark","geoPoint":{"lat":55.64152,"lon":12.08035}},{"facility":"GSK Investigational Site","city":"Amiens","zip":"80054","country":"France","geoPoint":{"lat":49.9,"lon":2.3}},{"facility":"GSK Investigational Site","city":"Broglie","zip":"27270","country":"France","geoPoint":{"lat":49.00911,"lon":0.52915}},{"facility":"GSK Investigational Site","city":"Corbeil-Essonnes","zip":"91106","country":"France","geoPoint":{"lat":48.60603,"lon":2.48757}},{"facility":"GSK Investigational Site","city":"La Rochelle","zip":"17019","country":"France","geoPoint":{"lat":46.16308,"lon":-1.15222}},{"facility":"GSK Investigational Site","city":"Nantes","zip":"44277","country":"France","geoPoint":{"lat":47.21725,"lon":-1.55336}},{"facility":"GSK Investigational Site","city":"Narbonne","zip":"11100","country":"France","geoPoint":{"lat":43.18396,"lon":3.00141}},{"facility":"GSK Investigational Site","city":"Paris","zip":"75010","country":"France","geoPoint":{"lat":48.85341,"lon":2.3488}},{"facility":"GSK Investigational Site","city":"Pau","zip":"64046","country":"France","geoPoint":{"lat":43.31117,"lon":-0.35583}},{"facility":"GSK Investigational Site","city":"Pierre-Bénite","zip":"69310","country":"France","geoPoint":{"lat":45.70359,"lon":4.82424}},{"facility":"GSK Investigational Site","city":"Strasbourg","zip":"67091","country":"France","geoPoint":{"lat":48.58392,"lon":7.74553}},{"facility":"GSK Investigational Site","city":"Vandœuvre-lès-Nancy","zip":"54511","country":"France","geoPoint":{"lat":48.66115,"lon":6.17114}},{"facility":"GSK Investigational Site","city":"Deggingen","state":"Baden-Wurttemberg","zip":"73326","country":"Germany","geoPoint":{"lat":48.5971,"lon":9.71891}},{"facility":"GSK Investigational Site","city":"Freiburg im Breisgau","state":"Baden-Wurttemberg","zip":"79106","country":"Germany","geoPoint":{"lat":47.9959,"lon":7.85222}},{"facility":"GSK Investigational Site","city":"Güglingen","state":"Baden-Wurttemberg","zip":"74363","country":"Germany","geoPoint":{"lat":49.06642,"lon":9.00175}},{"facility":"GSK Investigational Site","city":"Karlsruhe","state":"Baden-Wurttemberg","zip":"76199","country":"Germany","geoPoint":{"lat":49.00937,"lon":8.40444}},{"facility":"GSK Investigational Site","city":"Ludwigsburg","state":"Baden-Wurttemberg","zip":"71640","country":"Germany","geoPoint":{"lat":48.89731,"lon":9.19161}},{"facility":"GSK Investigational Site","city":"Stuttgart","state":"Baden-Wurttemberg","zip":"70199","country":"Germany","geoPoint":{"lat":48.78232,"lon":9.17702}},{"facility":"GSK Investigational Site","city":"Stuttgart","state":"Baden-Wurttemberg","zip":"70378","country":"Germany","geoPoint":{"lat":48.78232,"lon":9.17702}},{"facility":"GSK Investigational Site","city":"Villingen-Schwenningen","state":"Baden-Wurttemberg","zip":"78048","country":"Germany","geoPoint":{"lat":48.06226,"lon":8.49358}},{"facility":"GSK Investigational Site","city":"Wangen","state":"Baden-Wurttemberg","zip":"88239","country":"Germany","geoPoint":{"lat":47.6895,"lon":9.83247}},{"facility":"GSK Investigational Site","city":"Aschaffenburg","state":"Bavaria","zip":"63739","country":"Germany","geoPoint":{"lat":49.97704,"lon":9.15214}},{"facility":"GSK Investigational Site","city":"Dachau","state":"Bavaria","zip":"85221","country":"Germany","geoPoint":{"lat":48.26,"lon":11.43402}},{"facility":"GSK Investigational Site","city":"Haag","state":"Bavaria","zip":"83527","country":"Germany","geoPoint":{"lat":50.30379,"lon":12.07614}},{"facility":"GSK Investigational Site","city":"Künzing","state":"Bavaria","zip":"94550","country":"Germany","geoPoint":{"lat":48.66667,"lon":13.08333}},{"facility":"GSK Investigational Site","city":"Rednitzhembach","state":"Bavaria","zip":"91126","country":"Germany","geoPoint":{"lat":49.30095,"lon":11.07997}},{"facility":"GSK Investigational Site","city":"Wallerfing","state":"Bavaria","zip":"94574","country":"Germany","geoPoint":{"lat":48.68416,"lon":12.88035}},{"facility":"GSK Investigational Site","city":"Elsterwerda","state":"Brandenburg","zip":"04910","country":"Germany","geoPoint":{"lat":51.46043,"lon":13.52001}},{"facility":"GSK Investigational Site","city":"Falkensee","state":"Brandenburg","zip":"14612","country":"Germany","geoPoint":{"lat":52.56014,"lon":13.0927}},{"facility":"GSK Investigational Site","city":"Potsdam","state":"Brandenburg","zip":"14469","country":"Germany","geoPoint":{"lat":52.39886,"lon":13.06566}},{"facility":"GSK Investigational Site","city":"Flörsheim","state":"Hesse","zip":"65439","country":"Germany","geoPoint":{"lat":50.01311,"lon":8.42779}},{"facility":"GSK Investigational Site","city":"Gelnhausen","state":"Hesse","zip":"63571","country":"Germany","geoPoint":{"lat":50.20164,"lon":9.18742}},{"facility":"GSK Investigational Site","city":"Hildesheim","state":"Lower Saxony","zip":"31139","country":"Germany","geoPoint":{"lat":52.15077,"lon":9.95112}},{"facility":"GSK Investigational Site","city":"Stuhr","state":"Lower Saxony","zip":"28816","country":"Germany","geoPoint":{"lat":53.03333,"lon":8.75}},{"facility":"GSK Investigational Site","city":"Wardenburg","state":"Lower Saxony","zip":"26203","country":"Germany","geoPoint":{"lat":53.05938,"lon":8.19669}},{"facility":"GSK Investigational Site","city":"Bad Oeynhausen","state":"North Rhine-Westphalia","zip":"32545","country":"Germany","geoPoint":{"lat":52.20699,"lon":8.80365}},{"facility":"GSK Investigational Site","city":"Bochum","state":"North Rhine-Westphalia","zip":"44791","country":"Germany","geoPoint":{"lat":51.48165,"lon":7.21648}},{"facility":"GSK Investigational Site","city":"Bochum","state":"North Rhine-Westphalia","zip":"44869","country":"Germany","geoPoint":{"lat":51.48165,"lon":7.21648}},{"facility":"GSK Investigational Site","city":"Cologne","state":"North Rhine-Westphalia","zip":"51069","country":"Germany","geoPoint":{"lat":50.93333,"lon":6.95}},{"facility":"GSK Investigational Site","city":"Essen","state":"North Rhine-Westphalia","zip":"45136","country":"Germany","geoPoint":{"lat":51.45657,"lon":7.01228}},{"facility":"GSK Investigational Site","city":"Essen","state":"North Rhine-Westphalia","zip":"45329","country":"Germany","geoPoint":{"lat":51.45657,"lon":7.01228}},{"facility":"GSK Investigational Site","city":"Essen","state":"North Rhine-Westphalia","zip":"45359","country":"Germany","geoPoint":{"lat":51.45657,"lon":7.01228}},{"facility":"GSK Investigational Site","city":"Kleve","state":"North Rhine-Westphalia","zip":"47533","country":"Germany","geoPoint":{"lat":51.78826,"lon":6.13865}},{"facility":"GSK Investigational Site","city":"Münster","state":"North Rhine-Westphalia","zip":"48145","country":"Germany","geoPoint":{"lat":51.96236,"lon":7.62571}},{"facility":"GSK Investigational Site","city":"Witten","state":"North Rhine-Westphalia","zip":"58455","country":"Germany","geoPoint":{"lat":51.44362,"lon":7.35258}},{"facility":"GSK Investigational Site","city":"Bad Kreuznach","state":"Rhineland-Palatinate","zip":"55545","country":"Germany","geoPoint":{"lat":49.8414,"lon":7.86713}},{"facility":"GSK Investigational Site","city":"Ludwigshafen am Rhein","state":"Rhineland-Palatinate","zip":"67059","country":"Germany","geoPoint":{"lat":49.48121,"lon":8.44641}},{"facility":"GSK Investigational Site","city":"Mainz","state":"Rhineland-Palatinate","zip":"55116","country":"Germany","geoPoint":{"lat":49.98185,"lon":8.28008}},{"facility":"GSK Investigational Site","city":"Sankt Ingbert","state":"Saarland","zip":"66386","country":"Germany","geoPoint":{"lat":49.27697,"lon":7.11672}},{"facility":"GSK Investigational Site","city":"Chemnitz","state":"Saxony","zip":"09113","country":"Germany","geoPoint":{"lat":50.8357,"lon":12.92922}},{"facility":"GSK Investigational Site","city":"Delitzsch","state":"Saxony","zip":"04509","country":"Germany","geoPoint":{"lat":51.52546,"lon":12.34284}},{"facility":"GSK Investigational Site","city":"Dresden","state":"Saxony","zip":"01069","country":"Germany","geoPoint":{"lat":51.05089,"lon":13.73832}},{"facility":"GSK Investigational Site","city":"Dresden","state":"Saxony","zip":"01219","country":"Germany","geoPoint":{"lat":51.05089,"lon":13.73832}},{"facility":"GSK Investigational Site","city":"Dresden","state":"Saxony","zip":"01279","country":"Germany","geoPoint":{"lat":51.05089,"lon":13.73832}},{"facility":"GSK Investigational Site","city":"Dresden","state":"Saxony","zip":"01307","country":"Germany","geoPoint":{"lat":51.05089,"lon":13.73832}},{"facility":"GSK Investigational Site","city":"Leipzg","state":"Saxony","zip":"04109","country":"Germany"},{"facility":"GSK Investigational Site","city":"Leipzig","state":"Saxony","zip":"04109","country":"Germany","geoPoint":{"lat":51.33962,"lon":12.37129}},{"facility":"GSK Investigational Site","city":"Leipzig","state":"Saxony","zip":"04249","country":"Germany","geoPoint":{"lat":51.33962,"lon":12.37129}},{"facility":"GSK Investigational Site","city":"Oschatz","state":"Saxony","zip":"04758","country":"Germany","geoPoint":{"lat":51.30001,"lon":13.10984}},{"facility":"GSK Investigational Site","city":"Pirna","state":"Saxony","zip":"01796","country":"Germany","geoPoint":{"lat":50.95843,"lon":13.93702}},{"facility":"GSK Investigational Site","city":"Riesa","state":"Saxony","zip":"01587","country":"Germany","geoPoint":{"lat":51.30777,"lon":13.29168}},{"facility":"GSK Investigational Site","city":"Schkeuditz","state":"Saxony","zip":"04435","country":"Germany","geoPoint":{"lat":51.39678,"lon":12.22141}},{"facility":"GSK Investigational Site","city":"Hohenmölsen","state":"Saxony-Anhalt","zip":"06679","country":"Germany","geoPoint":{"lat":51.15769,"lon":12.1}},{"facility":"GSK Investigational Site","city":"Jerichow","state":"Saxony-Anhalt","zip":"39319","country":"Germany","geoPoint":{"lat":52.50049,"lon":12.02383}},{"facility":"GSK Investigational Site","city":"Magdeburg","state":"Saxony-Anhalt","zip":"39112","country":"Germany","geoPoint":{"lat":52.13129,"lon":11.63189}},{"facility":"GSK Investigational Site","city":"Berlin","zip":"10117","country":"Germany","geoPoint":{"lat":52.52437,"lon":13.41053}},{"facility":"GSK Investigational Site","city":"Berlin","zip":"10409","country":"Germany","geoPoint":{"lat":52.52437,"lon":13.41053}},{"facility":"GSK Investigational Site","city":"Berlin","zip":"10789","country":"Germany","geoPoint":{"lat":52.52437,"lon":13.41053}},{"facility":"GSK Investigational Site","city":"Berlin","zip":"12157","country":"Germany","geoPoint":{"lat":52.52437,"lon":13.41053}},{"facility":"GSK Investigational Site","city":"Berlin","zip":"13405","country":"Germany","geoPoint":{"lat":52.52437,"lon":13.41053}},{"facility":"GSK Investigational Site","city":"Dortmund","zip":"44137","country":"Germany","geoPoint":{"lat":51.51494,"lon":7.466}},{"facility":"GSK Investigational Site","city":"Hamburg","zip":"20099","country":"Germany","geoPoint":{"lat":53.55073,"lon":9.99302}},{"facility":"GSK Investigational Site","city":"Hamburg","zip":"21073","country":"Germany","geoPoint":{"lat":53.55073,"lon":9.99302}},{"facility":"GSK Investigational Site","city":"Hamburg","zip":"22041","country":"Germany","geoPoint":{"lat":53.55073,"lon":9.99302}},{"facility":"GSK Investigational Site","city":"Mannheim","zip":"68163","country":"Germany","geoPoint":{"lat":49.4891,"lon":8.46694}},{"facility":"GSK Investigational Site","city":"München","zip":"80809","country":"Germany","geoPoint":{"lat":51.60698,"lon":13.31243}},{"facility":"GSK Investigational Site","city":"Alexandroupoli","zip":"68 100","country":"Greece","geoPoint":{"lat":40.84995,"lon":25.87644}},{"facility":"GSK Investigational Site","city":"Athens","zip":"11 527","country":"Greece","geoPoint":{"lat":37.98376,"lon":23.72784}},{"facility":"GSK Investigational Site","city":"Athens","zip":"11521","country":"Greece","geoPoint":{"lat":37.98376,"lon":23.72784}},{"facility":"GSK Investigational Site","city":"Athens","zip":"11528","country":"Greece","geoPoint":{"lat":37.98376,"lon":23.72784}},{"facility":"GSK Investigational Site","city":"Haidari, Athens","zip":"12462","country":"Greece","geoPoint":{"lat":37.98376,"lon":23.72784}},{"facility":"GSK Investigational Site","city":"Heraklion, Crete","zip":"71409","country":"Greece","geoPoint":{"lat":35.32787,"lon":25.14341}},{"facility":"GSK Investigational Site","city":"Ioannina","zip":"45500","country":"Greece","geoPoint":{"lat":39.66341,"lon":20.85187}},{"facility":"GSK Investigational Site","city":"Lamia","zip":"35100","country":"Greece","geoPoint":{"lat":38.89947,"lon":22.4335}},{"facility":"GSK Investigational Site","city":"Nikaia Piraeus","zip":"184 54","country":"Greece"},{"facility":"GSK Investigational Site","city":"Piraeus","zip":"18536","country":"Greece","geoPoint":{"lat":37.94203,"lon":23.64619}},{"facility":"GSK Investigational Site","city":"Thessaloniki","zip":"546 36","country":"Greece","geoPoint":{"lat":40.64072,"lon":22.93493}},{"facility":"GSK Investigational Site","city":"Thessaloniki","zip":"546 42","country":"Greece","geoPoint":{"lat":40.64072,"lon":22.93493}},{"facility":"GSK Investigational Site","city":"Thessaloniki","zip":"54642","country":"Greece","geoPoint":{"lat":40.64072,"lon":22.93493}},{"facility":"GSK Investigational Site","city":"Thessaloniki","zip":"564 29","country":"Greece","geoPoint":{"lat":40.64072,"lon":22.93493}},{"facility":"GSK Investigational Site","city":"Thessaloniki","zip":"570 01","country":"Greece","geoPoint":{"lat":40.64072,"lon":22.93493}},{"facility":"GSK Investigational Site","city":"Thessaloniki","zip":"570 10","country":"Greece","geoPoint":{"lat":40.64072,"lon":22.93493}},{"facility":"GSK Investigational Site","city":"Hong Kong","country":"Hong Kong","geoPoint":{"lat":22.27832,"lon":114.17469}},{"facility":"GSK Investigational Site","city":"Shatin","country":"Hong Kong","geoPoint":{"lat":22.38333,"lon":114.18333}},{"facility":"GSK Investigational Site","city":"Baja","zip":"6500","country":"Hungary","geoPoint":{"lat":46.18299,"lon":18.95307}},{"facility":"GSK Investigational Site","city":"Budapest","zip":"1036","country":"Hungary","geoPoint":{"lat":47.49835,"lon":19.04045}},{"facility":"GSK Investigational Site","city":"Budapest","zip":"1135","country":"Hungary","geoPoint":{"lat":47.49835,"lon":19.04045}},{"facility":"GSK Investigational Site","city":"Debrecen","zip":"4026","country":"Hungary","geoPoint":{"lat":47.53167,"lon":21.62444}},{"facility":"GSK Investigational Site","city":"Debrecen","zip":"4031","country":"Hungary","geoPoint":{"lat":47.53167,"lon":21.62444}},{"facility":"GSK Investigational Site","city":"Eger","zip":"3300","country":"Hungary","geoPoint":{"lat":47.90265,"lon":20.37329}},{"facility":"GSK Investigational Site","city":"Gödöllő","zip":"2100","country":"Hungary","geoPoint":{"lat":47.59657,"lon":19.35515}},{"facility":"GSK Investigational Site","city":"Hatvan","zip":"3000","country":"Hungary","geoPoint":{"lat":47.66667,"lon":19.68333}},{"facility":"GSK Investigational Site","city":"Komárom","zip":"2900","country":"Hungary","geoPoint":{"lat":47.74318,"lon":18.11913}},{"facility":"GSK Investigational Site","city":"Miskolc","zip":"3529","country":"Hungary","geoPoint":{"lat":48.10327,"lon":20.77806}},{"facility":"GSK Investigational Site","city":"Sátoraljaújhely","zip":"3980","country":"Hungary","geoPoint":{"lat":48.39492,"lon":21.65871}},{"facility":"GSK Investigational Site","city":"Chieti","state":"Abruzzo","zip":"66100","country":"Italy","geoPoint":{"lat":42.34827,"lon":14.16494}},{"facility":"GSK Investigational Site","city":"Bari","state":"Apulia","zip":"70124","country":"Italy","geoPoint":{"lat":41.12066,"lon":16.86982}},{"facility":"GSK Investigational Site","city":"San Giovanni Rotondo (FG)","state":"Apulia","zip":"71013","country":"Italy","geoPoint":{"lat":41.70643,"lon":15.7277}},{"facility":"GSK Investigational Site","city":"Catanzaro","state":"Calabria","zip":"88100","country":"Italy","geoPoint":{"lat":38.88247,"lon":16.60086}},{"facility":"GSK Investigational Site","city":"Naples","state":"Campania","zip":"80131","country":"Italy","geoPoint":{"lat":40.85216,"lon":14.26811}},{"facility":"GSK Investigational Site","city":"Naples","state":"Campania","zip":"80138","country":"Italy","geoPoint":{"lat":40.85216,"lon":14.26811}},{"facility":"GSK Investigational Site","city":"Bologna","state":"Emilia-Romagna","zip":"40138","country":"Italy","geoPoint":{"lat":44.49381,"lon":11.33875}},{"facility":"GSK Investigational Site","city":"Parma","state":"Emilia-Romagna","zip":"43100","country":"Italy","geoPoint":{"lat":44.79935,"lon":10.32618}},{"facility":"GSK Investigational Site","city":"Ravenna","state":"Emilia-Romagna","zip":"48121","country":"Italy","geoPoint":{"lat":44.41344,"lon":12.20121}},{"facility":"GSK Investigational Site","city":"Rome","state":"Lazio","zip":"00133","country":"Italy","geoPoint":{"lat":41.89193,"lon":12.51133}},{"facility":"GSK Investigational Site","city":"Rome","state":"Lazio","zip":"00168","country":"Italy","geoPoint":{"lat":41.89193,"lon":12.51133}},{"facility":"GSK Investigational Site","city":"Rome","state":"Lazio","zip":"00186","country":"Italy","geoPoint":{"lat":41.89193,"lon":12.51133}},{"facility":"GSK Investigational Site","city":"Arenzano (GE)","state":"Liguria","zip":"16011","country":"Italy","geoPoint":{"lat":44.40521,"lon":8.68315}},{"facility":"GSK Investigational Site","city":"Bergamo","state":"Lombardy","zip":"24127","country":"Italy","geoPoint":{"lat":45.69601,"lon":9.66721}},{"facility":"GSK Investigational Site","city":"Milan","state":"Lombardy","zip":"20122","country":"Italy","geoPoint":{"lat":45.46427,"lon":9.18951}},{"facility":"GSK Investigational Site","city":"Milan","state":"Lombardy","zip":"20132","country":"Italy","geoPoint":{"lat":45.46427,"lon":9.18951}},{"facility":"GSK Investigational Site","city":"Milan","state":"Lombardy","zip":"20142","country":"Italy","geoPoint":{"lat":45.46427,"lon":9.18951}},{"facility":"GSK Investigational Site","city":"Vigevano (PV)","state":"Lombardy","zip":"27029","country":"Italy","geoPoint":{"lat":45.31407,"lon":8.85437}},{"facility":"GSK Investigational Site","city":"Olbia (OT)","state":"Sardinia","zip":"07026","country":"Italy","geoPoint":{"lat":40.92337,"lon":9.49802}},{"facility":"GSK Investigational Site","city":"Ancona","state":"The Marches","zip":"60131","country":"Italy","geoPoint":{"lat":43.60717,"lon":13.5103}},{"facility":"GSK Investigational Site","city":"Ascoli Piceno","state":"The Marches","zip":"63100","country":"Italy","geoPoint":{"lat":42.85351,"lon":13.57395}},{"facility":"GSK Investigational Site","city":"Siena","state":"Tuscany","zip":"53100","country":"Italy","geoPoint":{"lat":43.31822,"lon":11.33064}},{"facility":"GSK Investigational Site","city":"S.Andrea Delle Fratte - S. Sisto (PG)","state":"Umbria","zip":"06132","country":"Italy"},{"facility":"GSK Investigational Site","city":"Padova","state":"Veneto","zip":"35128","country":"Italy","geoPoint":{"lat":45.26618,"lon":11.77208}},{"facility":"GSK Investigational Site","city":"Aguascalientes, Ags","state":"Aguascalientes","zip":"20127","country":"Mexico","geoPoint":{"lat":21.88262,"lon":-102.2843}},{"facility":"GSK Investigational Site","city":"Guadalajara","state":"Jalisco","zip":"44150","country":"Mexico","geoPoint":{"lat":20.67738,"lon":-103.34749}},{"facility":"GSK Investigational Site","city":"Guadalajara","state":"Jalisco","zip":"44600","country":"Mexico","geoPoint":{"lat":20.67738,"lon":-103.34749}},{"facility":"GSK Investigational Site","city":"Guadalajara","state":"Jalisco","zip":"45116","country":"Mexico","geoPoint":{"lat":20.67738,"lon":-103.34749}},{"facility":"GSK Investigational Site","city":"Tlaquepaque","state":"Jalisco","zip":"45510","country":"Mexico","geoPoint":{"lat":20.64121,"lon":-103.29342}},{"facility":"GSK Investigational Site","city":"Monterrey","state":"Nuevo León","zip":"64460","country":"Mexico","geoPoint":{"lat":25.68435,"lon":-100.31721}},{"facility":"GSK Investigational Site","city":"Monterrey NL","state":"Nuevo León","zip":"64718","country":"Mexico"},{"facility":"GSK Investigational Site","city":"Querétaro City","state":"Querétaro","zip":"76000","country":"Mexico","geoPoint":{"lat":20.58806,"lon":-100.38806}},{"facility":"GSK Investigational Site","city":"Mazatlán","state":"Sinaloa","zip":"82126","country":"Mexico","geoPoint":{"lat":23.22163,"lon":-106.41885}},{"facility":"GSK Investigational Site","city":"Mazatlán","state":"Sinaloa","country":"Mexico","geoPoint":{"lat":23.22163,"lon":-106.41885}},{"facility":"GSK Investigational Site","city":"Mérida","state":"Yucatán","zip":"97129","country":"Mexico","geoPoint":{"lat":20.967,"lon":-89.62318}},{"facility":"GSK Investigational Site","city":"Aguascalientes","zip":"20230","country":"Mexico","geoPoint":{"lat":21.88262,"lon":-102.2843}},{"facility":"GSK Investigational Site","city":"Mexico City","zip":"11650","country":"Mexico","geoPoint":{"lat":19.42847,"lon":-99.12766}},{"facility":"GSK Investigational Site","city":"Alkmaar","zip":"1815 JD","country":"Netherlands","geoPoint":{"lat":52.63167,"lon":4.74861}},{"facility":"GSK Investigational Site","city":"Amsterdam","zip":"1061 A","country":"Netherlands","geoPoint":{"lat":52.37403,"lon":4.88969}},{"facility":"GSK Investigational Site","city":"Eindhoven","zip":"5631 BM","country":"Netherlands","geoPoint":{"lat":51.44083,"lon":5.47778}},{"facility":"GSK Investigational Site","city":"Gouda","zip":"2803 H","country":"Netherlands","geoPoint":{"lat":52.01667,"lon":4.70833}},{"facility":"GSK Investigational Site","city":"Hardenberg","zip":"7772 SE","country":"Netherlands","geoPoint":{"lat":52.57583,"lon":6.61944}},{"facility":"GSK Investigational Site","city":"Heerlen","zip":"6419 PC","country":"Netherlands","geoPoint":{"lat":50.88365,"lon":5.98154}},{"facility":"GSK Investigational Site","city":"Hoogeveen","zip":"7909 A","country":"Netherlands","geoPoint":{"lat":52.7225,"lon":6.47639}},{"facility":"GSK Investigational Site","city":"Meppel","zip":"7943 K","country":"Netherlands","geoPoint":{"lat":52.69583,"lon":6.19444}},{"facility":"GSK Investigational Site","city":"Rotterdam","zip":"3051 G","country":"Netherlands","geoPoint":{"lat":51.9225,"lon":4.47917}},{"facility":"GSK Investigational Site","city":"Sneek","zip":"8601 Z","country":"Netherlands","geoPoint":{"lat":53.03297,"lon":5.6589}},{"facility":"GSK Investigational Site","city":"Hoenefoss","zip":"3513","country":"Norway"},{"facility":"GSK Investigational Site","city":"Kolbjørnsvik","zip":"4816","country":"Norway","geoPoint":{"lat":58.45306,"lon":8.77056}},{"facility":"GSK Investigational Site","city":"Oslo","zip":"0319","country":"Norway","geoPoint":{"lat":59.91273,"lon":10.74609}},{"facility":"GSK Investigational Site","city":"Oslo","zip":"0586","country":"Norway","geoPoint":{"lat":59.91273,"lon":10.74609}},{"facility":"GSK Investigational Site","city":"Stavanger","zip":"4011","country":"Norway","geoPoint":{"lat":58.97005,"lon":5.73332}},{"facility":"GSK Investigational Site","city":"Trujillo","state":"La Libertad","zip":"13001","country":"Peru","geoPoint":{"lat":-8.11599,"lon":-79.02998}},{"facility":"GSK Investigational Site","city":"San Martín de Porres","state":"Lima region","zip":"Lima 33","country":"Peru","geoPoint":{"lat":-11.10028,"lon":-77.43306}},{"facility":"GSK Investigational Site","city":"Callao","state":"Lima","zip":"Callao 2","country":"Peru"},{"facility":"GSK Investigational Site","city":"Arequipa","country":"Peru","geoPoint":{"lat":-16.39899,"lon":-71.53747}},{"facility":"GSK Investigational Site","city":"Lima","zip":"01","country":"Peru","geoPoint":{"lat":-12.04318,"lon":-77.02824}},{"facility":"GSK Investigational Site","city":"Lima","zip":"17","country":"Peru","geoPoint":{"lat":-12.04318,"lon":-77.02824}},{"facility":"GSK Investigational Site","city":"Lima","zip":"Lima 14","country":"Peru","geoPoint":{"lat":-12.04318,"lon":-77.02824}},{"facility":"GSK Investigational Site","city":"Lima","zip":"Lima 29","country":"Peru","geoPoint":{"lat":-12.04318,"lon":-77.02824}},{"facility":"GSK Investigational Site","city":"Lima","zip":"Lima 32","country":"Peru","geoPoint":{"lat":-12.04318,"lon":-77.02824}},{"facility":"GSK Investigational Site","city":"Piura","zip":"20001","country":"Peru","geoPoint":{"lat":-5.18192,"lon":-80.65715}},{"facility":"GSK Investigational Site","city":"Cebu City","zip":"6000","country":"Philippines","geoPoint":{"lat":10.31672,"lon":123.89071}},{"facility":"GSK Investigational Site","city":"Iloilo City","zip":"5000","country":"Philippines","geoPoint":{"lat":10.69694,"lon":122.56444}},{"facility":"GSK Investigational Site","city":"Laoag","zip":"2900","country":"Philippines","geoPoint":{"lat":18.1978,"lon":120.5957}},{"facility":"GSK Investigational Site","city":"Bialystok","zip":"15-435","country":"Poland","geoPoint":{"lat":53.13333,"lon":23.16433}},{"facility":"GSK Investigational Site","city":"Bydgoszcz","zip":"85-231","country":"Poland","geoPoint":{"lat":53.1235,"lon":18.00762}},{"facility":"GSK Investigational Site","city":"Bydgoszcz","zip":"85-863","country":"Poland","geoPoint":{"lat":53.1235,"lon":18.00762}},{"facility":"GSK Investigational Site","city":"Gdansk","zip":"80-858","country":"Poland","geoPoint":{"lat":54.35227,"lon":18.64912}},{"facility":"GSK Investigational Site","city":"Gniewkowo","zip":"88-140","country":"Poland","geoPoint":{"lat":52.89461,"lon":18.40785}},{"facility":"GSK Investigational Site","city":"Katowice","zip":"40-081","country":"Poland","geoPoint":{"lat":50.2597,"lon":19.02173}},{"facility":"GSK Investigational Site","city":"Katowice","zip":"40-772","country":"Poland","geoPoint":{"lat":50.2597,"lon":19.02173}},{"facility":"GSK Investigational Site","city":"Krakow","zip":"30-539","country":"Poland","geoPoint":{"lat":50.06143,"lon":19.93658}},{"facility":"GSK Investigational Site","city":"Krakow","zip":"31-261","country":"Poland","geoPoint":{"lat":50.06143,"lon":19.93658}},{"facility":"GSK Investigational Site","city":"Krakow","zip":"31-530","country":"Poland","geoPoint":{"lat":50.06143,"lon":19.93658}},{"facility":"GSK Investigational Site","city":"Lublin","zip":"20-538","country":"Poland","geoPoint":{"lat":51.25058,"lon":22.57009}},{"facility":"GSK Investigational Site","city":"Poznan","zip":"60-111","country":"Poland","geoPoint":{"lat":52.40692,"lon":16.92993}},{"facility":"GSK Investigational Site","city":"Poznan","zip":"61-655","country":"Poland","geoPoint":{"lat":52.40692,"lon":16.92993}},{"facility":"GSK Investigational Site","city":"Sopot","zip":"81- 71","country":"Poland","geoPoint":{"lat":54.4418,"lon":18.56003}},{"facility":"GSK Investigational Site","city":"Warsaw","zip":"00-465","country":"Poland","geoPoint":{"lat":52.22977,"lon":21.01178}},{"facility":"GSK Investigational Site","city":"Wierzchosławice","zip":"33-122","country":"Poland","geoPoint":{"lat":50.02478,"lon":20.85677}},{"facility":"GSK Investigational Site","city":"Wroclaw","zip":"50-127","country":"Poland","geoPoint":{"lat":51.10286,"lon":17.03006}},{"facility":"GSK Investigational Site","city":"Wroclaw","zip":"50-981","country":"Poland","geoPoint":{"lat":51.10286,"lon":17.03006}},{"facility":"GSK Investigational Site","city":"Wroclaw","zip":"54-239","country":"Poland","geoPoint":{"lat":51.10286,"lon":17.03006}},{"facility":"GSK Investigational Site","city":"Arkhangelsk","zip":"163045","country":"Russia","geoPoint":{"lat":64.5461,"lon":40.55183}},{"facility":"GSK Investigational Site","city":"Barnaul","zip":"656 045","country":"Russia","geoPoint":{"lat":53.36199,"lon":83.72786}},{"facility":"GSK Investigational Site","city":"Chelyabinsk","zip":"454021","country":"Russia","geoPoint":{"lat":55.1611,"lon":61.42877}},{"facility":"GSK Investigational Site","city":"Chelyabinsk","zip":"454047","country":"Russia","geoPoint":{"lat":55.1611,"lon":61.42877}},{"facility":"GSK Investigational Site","city":"Ivanovo","zip":"153005","country":"Russia","geoPoint":{"lat":56.99988,"lon":40.97257}},{"facility":"GSK Investigational Site","city":"Kemerovo","zip":"650000","country":"Russia","geoPoint":{"lat":55.35417,"lon":86.10435}},{"facility":"GSK Investigational Site","city":"Kemerovo","zip":"650002","country":"Russia","geoPoint":{"lat":55.35417,"lon":86.10435}},{"facility":"GSK Investigational Site","city":"Krasnodar","zip":"350086","country":"Russia","geoPoint":{"lat":45.04534,"lon":38.98178}},{"facility":"GSK Investigational Site","city":"Moscow","zip":"117 036","country":"Russia","geoPoint":{"lat":55.75204,"lon":37.61781}},{"facility":"GSK Investigational Site","city":"Moscow","zip":"117 03","country":"Russia","geoPoint":{"lat":55.75204,"lon":37.61781}},{"facility":"GSK Investigational Site","city":"Moscow","zip":"117292","country":"Russia","geoPoint":{"lat":55.75204,"lon":37.61781}},{"facility":"GSK Investigational Site","city":"Moscow","zip":"119435","country":"Russia","geoPoint":{"lat":55.75204,"lon":37.61781}},{"facility":"GSK Investigational Site","city":"Moscow","zip":"119992","country":"Russia","geoPoint":{"lat":55.75204,"lon":37.61781}},{"facility":"GSK Investigational Site","city":"Moscow","zip":"127411","country":"Russia","geoPoint":{"lat":55.75204,"lon":37.61781}},{"facility":"GSK Investigational Site","city":"Moscow","zip":"129110","country":"Russia","geoPoint":{"lat":55.75204,"lon":37.61781}},{"facility":"GSK Investigational Site","city":"Nizhny Novgorod","zip":"603003","country":"Russia","geoPoint":{"lat":56.32867,"lon":44.00205}},{"facility":"GSK Investigational Site","city":"Nizhny Novgorod","zip":"603126","country":"Russia","geoPoint":{"lat":56.32867,"lon":44.00205}},{"facility":"GSK Investigational Site","city":"Novosibirsk","zip":"630047","country":"Russia","geoPoint":{"lat":55.02259,"lon":82.93175}},{"facility":"GSK Investigational Site","city":"Novosibirsk","zip":"630091","country":"Russia","geoPoint":{"lat":55.02259,"lon":82.93175}},{"facility":"GSK Investigational Site","city":"Perm","zip":"614097","country":"Russia","geoPoint":{"lat":58.01046,"lon":56.25017}},{"facility":"GSK Investigational Site","city":"Rostov-on-Don","zip":"344022","country":"Russia","geoPoint":{"lat":47.21997,"lon":39.70769}},{"facility":"GSK Investigational Site","city":"Ryazan","zip":"390039","country":"Russia","geoPoint":{"lat":54.62696,"lon":39.70415}},{"facility":"GSK Investigational Site","city":"Saint Petersburg","zip":"195257","country":"Russia","geoPoint":{"lat":59.93863,"lon":30.31413}},{"facility":"GSK Investigational Site","city":"Samara","zip":"443067","country":"Russia","geoPoint":{"lat":53.20767,"lon":50.13553}},{"facility":"GSK Investigational Site","city":"Saratov","zip":"410053","country":"Russia","geoPoint":{"lat":51.54048,"lon":45.9901}},{"facility":"GSK Investigational Site","city":"Tomsk","zip":"634012","country":"Russia","geoPoint":{"lat":56.50049,"lon":84.98216}},{"facility":"GSK Investigational Site","city":"Tomsk","zip":"634041","country":"Russia","geoPoint":{"lat":56.50049,"lon":84.98216}},{"facility":"GSK Investigational Site","city":"Tomsk","zip":"634050","country":"Russia","geoPoint":{"lat":56.50049,"lon":84.98216}},{"facility":"GSK Investigational Site","city":"Voronezh","zip":"394018","country":"Russia","geoPoint":{"lat":51.66833,"lon":39.19204}},{"facility":"GSK Investigational Site","city":"Yaroslavl","zip":"150000","country":"Russia","geoPoint":{"lat":57.62987,"lon":39.87368}},{"facility":"GSK Investigational Site","city":"Yaroslavl","zip":"150003","country":"Russia","geoPoint":{"lat":57.62987,"lon":39.87368}},{"facility":"GSK Investigational Site","city":"Yaroslavl","zip":"150010","country":"Russia","geoPoint":{"lat":57.62987,"lon":39.87368}},{"facility":"GSK Investigational Site","city":"Yaroslavl","zip":"150030","country":"Russia","geoPoint":{"lat":57.62987,"lon":39.87368}},{"facility":"GSK Investigational Site","city":"Yekaterinburg","zip":"620039","country":"Russia","geoPoint":{"lat":56.85733,"lon":60.61529}},{"facility":"GSK Investigational Site","city":"Yekaterinburg","zip":"620149","country":"Russia","geoPoint":{"lat":56.85733,"lon":60.61529}},{"facility":"GSK Investigational Site","city":"Bloemfontein","state":"Free State","zip":"9301","country":"South Africa","geoPoint":{"lat":-29.12107,"lon":26.214}},{"facility":"GSK Investigational Site","city":"Tongaat","state":"KwaZulu-Natal","zip":"4400","country":"South Africa","geoPoint":{"lat":-29.57366,"lon":31.11552}},{"facility":"GSK Investigational Site","city":"Bloemfontein","zip":"9301","country":"South Africa","geoPoint":{"lat":-29.12107,"lon":26.214}},{"facility":"GSK Investigational Site","city":"Cape Town","zip":"7500","country":"South Africa","geoPoint":{"lat":-33.92584,"lon":18.42322}},{"facility":"GSK Investigational Site","city":"Houghton Estate","zip":"2198","country":"South Africa","geoPoint":{"lat":-26.16253,"lon":28.0614}},{"facility":"GSK Investigational Site","city":"Kuilsrivier","zip":"7580","country":"South Africa","geoPoint":{"lat":-25.15,"lon":29.15}},{"facility":"GSK Investigational Site","city":"Paarl","zip":"7646","country":"South Africa","geoPoint":{"lat":-33.73378,"lon":18.97523}},{"facility":"GSK Investigational Site","city":"Pinelands","zip":"7405","country":"South Africa","geoPoint":{"lat":-29.83333,"lon":30.85}},{"facility":"GSK Investigational Site","city":"Umhlanga","zip":"4319","country":"South Africa","geoPoint":{"lat":-29.72528,"lon":31.08583}},{"facility":"GSK Investigational Site","city":"Daegu","zip":"42415","country":"South Korea","geoPoint":{"lat":35.87028,"lon":128.59111}},{"facility":"GSK Investigational Site","city":"Daegu","zip":"700-71","country":"South Korea","geoPoint":{"lat":35.87028,"lon":128.59111}},{"facility":"GSK Investigational Site","city":"Gyeonggi-do","zip":"463-70","country":"South Korea","geoPoint":{"lat":37.58944,"lon":126.76917}},{"facility":"GSK Investigational Site","city":"Gyeonggido","zip":"420-717","country":"South Korea"},{"facility":"GSK Investigational Site","city":"Kangwondo","zip":"220-701","country":"South Korea"},{"facility":"GSK Investigational Site","city":"Pusan","zip":"602-73","country":"South Korea","geoPoint":{"lat":36.3809,"lon":128.3681}},{"facility":"GSK Investigational Site","city":"Seoul","zip":"110-744","country":"South Korea","geoPoint":{"lat":37.566,"lon":126.9784}},{"facility":"GSK Investigational Site","city":"Seoul","zip":"120-752","country":"South Korea","geoPoint":{"lat":37.566,"lon":126.9784}},{"facility":"GSK Investigational Site","city":"Seoul","zip":"134-72","country":"South Korea","geoPoint":{"lat":37.566,"lon":126.9784}},{"facility":"GSK Investigational Site","city":"Seoul","zip":"135-71","country":"South Korea","geoPoint":{"lat":37.566,"lon":126.9784}},{"facility":"GSK Investigational Site","city":"Seoul","zip":"135-72","country":"South Korea","geoPoint":{"lat":37.566,"lon":126.9784}},{"facility":"GSK Investigational Site","city":"Seoul","zip":"137-70","country":"South Korea","geoPoint":{"lat":37.566,"lon":126.9784}},{"facility":"GSK Investigational Site","city":"Seoul","zip":"150-95","country":"South Korea","geoPoint":{"lat":37.566,"lon":126.9784}},{"facility":"GSK Investigational Site","city":"Seoul","zip":"152-703","country":"South Korea","geoPoint":{"lat":37.566,"lon":126.9784}},{"facility":"GSK Investigational Site","city":"Seoul","zip":"411-70","country":"South Korea","geoPoint":{"lat":37.566,"lon":126.9784}},{"facility":"GSK Investigational Site","city":"Suwon","zip":"442-723","country":"South Korea","geoPoint":{"lat":37.29111,"lon":127.00889}},{"facility":"GSK Investigational Site","city":"Suwon, Kyonggi-do","zip":"443-72","country":"South Korea","geoPoint":{"lat":37.29111,"lon":127.00889}},{"facility":"GSK Investigational Site","city":"A Coruña","zip":"15006","country":"Spain","geoPoint":{"lat":43.37135,"lon":-8.396}},{"facility":"GSK Investigational Site","city":"Alicante","zip":"03004","country":"Spain","geoPoint":{"lat":38.34517,"lon":-0.48149}},{"facility":"GSK Investigational Site","city":"Almería","zip":"4001","country":"Spain","geoPoint":{"lat":36.83814,"lon":-2.45974}},{"facility":"GSK Investigational Site","city":"Alzira/Valencia","zip":"46600","country":"Spain"},{"facility":"GSK Investigational Site","city":"Badalona","zip":"08916","country":"Spain","geoPoint":{"lat":41.45004,"lon":2.24741}},{"facility":"GSK Investigational Site","city":"Badalona / Barcelona","zip":"08917","country":"Spain"},{"facility":"GSK Investigational Site","city":"Barcelona","zip":"08003","country":"Spain","geoPoint":{"lat":41.38879,"lon":2.15899}},{"facility":"GSK Investigational Site","city":"Barcelona","zip":"08006","country":"Spain","geoPoint":{"lat":41.38879,"lon":2.15899}},{"facility":"GSK Investigational Site","city":"Barcelona","zip":"08026","country":"Spain","geoPoint":{"lat":41.38879,"lon":2.15899}},{"facility":"GSK Investigational Site","city":"Barcelona","zip":"08907","country":"Spain","geoPoint":{"lat":41.38879,"lon":2.15899}},{"facility":"GSK Investigational Site","city":"Boadilla Del Monte (Madrid)","zip":"28660","country":"Spain","geoPoint":{"lat":40.405,"lon":-3.87835}},{"facility":"GSK Investigational Site","city":"Canet de Mar - Barcelona","zip":"08360","country":"Spain"},{"facility":"GSK Investigational Site","city":"Cangas Del Narcea/Asturias","zip":"33800","country":"Spain"},{"facility":"GSK Investigational Site","city":"Centelles (Barcelona)","zip":"08540","country":"Spain","geoPoint":{"lat":41.79746,"lon":2.21902}},{"facility":"GSK Investigational Site","city":"Córdoba","zip":"14004","country":"Spain","geoPoint":{"lat":37.89155,"lon":-4.77275}},{"facility":"GSK Investigational Site","city":"Elche","zip":"03293","country":"Spain","geoPoint":{"lat":38.26218,"lon":-0.70107}},{"facility":"GSK Investigational Site","city":"Granada","zip":"18012","country":"Spain","geoPoint":{"lat":37.18817,"lon":-3.60667}},{"facility":"GSK Investigational Site","city":"León","zip":"24071","country":"Spain","geoPoint":{"lat":42.60003,"lon":-5.57032}},{"facility":"GSK Investigational Site","city":"Madrid","zip":"28006","country":"Spain","geoPoint":{"lat":40.4165,"lon":-3.70256}},{"facility":"GSK Investigational Site","city":"Madrid","zip":"28034","country":"Spain","geoPoint":{"lat":40.4165,"lon":-3.70256}},{"facility":"GSK Investigational Site","city":"Madrid","zip":"28040","country":"Spain","geoPoint":{"lat":40.4165,"lon":-3.70256}},{"facility":"GSK Investigational Site","city":"Madrid","zip":"28046","country":"Spain","geoPoint":{"lat":40.4165,"lon":-3.70256}},{"facility":"GSK Investigational Site","city":"Madrid","zip":"28050","country":"Spain","geoPoint":{"lat":40.4165,"lon":-3.70256}},{"facility":"GSK Investigational Site","city":"Málaga","zip":"29010","country":"Spain","geoPoint":{"lat":36.72016,"lon":-4.42034}},{"facility":"GSK Investigational Site","city":"Palma de Mallorca","zip":"07010","country":"Spain","geoPoint":{"lat":39.56939,"lon":2.65024}},{"facility":"GSK Investigational Site","city":"Palma de Mallorca","zip":"07198","country":"Spain","geoPoint":{"lat":39.56939,"lon":2.65024}},{"facility":"GSK Investigational Site","city":"Pontevedra","zip":"36071","country":"Spain","geoPoint":{"lat":42.431,"lon":-8.64435}},{"facility":"GSK Investigational Site","city":"Pozuelo de Alarcón/Madrid","zip":"28223","country":"Spain"},{"facility":"GSK Investigational Site","city":"Sagunto/Valencia","zip":"46520","country":"Spain"},{"facility":"GSK Investigational Site","city":"San Juan (Alicante)","zip":"03550","country":"Spain","geoPoint":{"lat":43.13072,"lon":-2.43912}},{"facility":"GSK Investigational Site","city":"Sanlucar de Barrameda - Cádiz","zip":"11540","country":"Spain"},{"facility":"GSK Investigational Site","city":"Santa Coloma de Gramanet (Barcelona)","zip":"08923","country":"Spain"},{"facility":"GSK Investigational Site","city":"Santiago de Compostela","zip":"15706","country":"Spain","geoPoint":{"lat":42.88052,"lon":-8.54569}},{"facility":"GSK Investigational Site","city":"Seville","zip":"41014","country":"Spain","geoPoint":{"lat":37.38283,"lon":-5.97317}},{"facility":"GSK Investigational Site","city":"Tarrasa, Barcelona","zip":"08221","country":"Spain","geoPoint":{"lat":41.38879,"lon":2.15899}},{"facility":"GSK Investigational Site","city":"Valencia","zip":"46010","country":"Spain","geoPoint":{"lat":39.47391,"lon":-0.37966}},{"facility":"GSK Investigational Site","city":"Valencia","zip":"46017","country":"Spain","geoPoint":{"lat":39.47391,"lon":-0.37966}},{"facility":"GSK Investigational Site","city":"Valencia","zip":"46026","country":"Spain","geoPoint":{"lat":39.47391,"lon":-0.37966}},{"facility":"GSK Investigational Site","city":"Vigo-Pontevedra","zip":"36312","country":"Spain"},{"facility":"GSK Investigational Site","city":"Borås","zip":"SE-506","country":"Sweden","geoPoint":{"lat":57.72101,"lon":12.9401}},{"facility":"GSK Investigational Site","city":"Eksjö","zip":"SE-575 35","country":"Sweden","geoPoint":{"lat":57.66643,"lon":14.97205}},{"facility":"GSK Investigational Site","city":"Gothenburg","zip":"SE-413 45","country":"Sweden","geoPoint":{"lat":57.70716,"lon":11.96679}},{"facility":"GSK Investigational Site","city":"Härnösand","zip":"SE-871","country":"Sweden","geoPoint":{"lat":62.63228,"lon":17.93794}},{"facility":"GSK Investigational Site","city":"Helsingborg","zip":"SE-252","country":"Sweden","geoPoint":{"lat":56.04673,"lon":12.69437}},{"facility":"GSK Investigational Site","city":"Karlskrona","zip":"SE-371 41","country":"Sweden","geoPoint":{"lat":56.16156,"lon":15.58661}},{"facility":"GSK Investigational Site","city":"Kristianstad","zip":"SE-291 85","country":"Sweden","geoPoint":{"lat":56.03129,"lon":14.15242}},{"facility":"GSK Investigational Site","city":"Linköping","zip":"SE-587 58","country":"Sweden","geoPoint":{"lat":58.41086,"lon":15.62157}},{"facility":"GSK Investigational Site","city":"Ljungby","zip":"SE-341","country":"Sweden","geoPoint":{"lat":56.83324,"lon":13.94082}},{"facility":"GSK Investigational Site","city":"Malmö","zip":"SE-205 02","country":"Sweden","geoPoint":{"lat":55.60587,"lon":13.00073}},{"facility":"GSK Investigational Site","city":"Örebro","zip":"SE-703 62","country":"Sweden","geoPoint":{"lat":59.27412,"lon":15.2066}},{"facility":"GSK Investigational Site","city":"Rättvik","zip":"SE-795 30","country":"Sweden","geoPoint":{"lat":60.88632,"lon":15.11787}},{"facility":"GSK Investigational Site","city":"Stockholm","zip":"SE-111","country":"Sweden","geoPoint":{"lat":59.32938,"lon":18.06871}},{"facility":"GSK Investigational Site","city":"Stockholm","zip":"SE-113 61","country":"Sweden","geoPoint":{"lat":59.32938,"lon":18.06871}},{"facility":"GSK Investigational Site","city":"Stockholm","zip":"SE-182 88","country":"Sweden","geoPoint":{"lat":59.32938,"lon":18.06871}},{"facility":"GSK Investigational Site","city":"Umeå","zip":"SE-901 85","country":"Sweden","geoPoint":{"lat":63.82842,"lon":20.25972}},{"facility":"GSK Investigational Site","city":"Uppsala","zip":"SE-752","country":"Sweden","geoPoint":{"lat":59.85882,"lon":17.63889}},{"facility":"GSK Investigational Site","city":"Changhua","zip":"500","country":"Taiwan","geoPoint":{"lat":24.0692,"lon":120.5512}},{"facility":"GSK Investigational Site","city":"Hualien City","zip":"970","country":"Taiwan","geoPoint":{"lat":23.97694,"lon":121.60444}},{"facility":"GSK Investigational Site","city":"Kaohsiung City","zip":"833","country":"Taiwan","geoPoint":{"lat":22.61626,"lon":120.31333}},{"facility":"GSK Investigational Site","city":"Taichung","zip":"433","country":"Taiwan","geoPoint":{"lat":24.1469,"lon":120.6839}},{"facility":"GSK Investigational Site","city":"Tainan","zip":"71004","country":"Taiwan","geoPoint":{"lat":22.99083,"lon":120.21333}},{"facility":"GSK Investigational Site","city":"Taipei","zip":"10002","country":"Taiwan","geoPoint":{"lat":25.05306,"lon":121.52639}},{"facility":"GSK Investigational Site","city":"Taipei","zip":"112","country":"Taiwan","geoPoint":{"lat":25.05306,"lon":121.52639}},{"facility":"GSK Investigational Site","city":"Bangkok","zip":"10330","country":"Thailand","geoPoint":{"lat":13.75398,"lon":100.50144}},{"facility":"GSK Investigational Site","city":"Bangkok","zip":"10400","country":"Thailand","geoPoint":{"lat":13.75398,"lon":100.50144}},{"facility":"GSK Investigational Site","city":"Chiang Mai","zip":"50200","country":"Thailand","geoPoint":{"lat":18.79038,"lon":98.98468}},{"facility":"GSK Investigational Site","city":"Pathum Thani","zip":"12120","country":"Thailand","geoPoint":{"lat":14.01346,"lon":100.53049}},{"facility":"GSK Investigational Site","city":"Songkhla","zip":"90110","country":"Thailand","geoPoint":{"lat":7.19882,"lon":100.5951}},{"facility":"GSK Investigational Site","city":"Chernivtsi","zip":"58022","country":"Ukraine","geoPoint":{"lat":48.29045,"lon":25.93241}},{"facility":"GSK Investigational Site","city":"Dnipropetrovsk","zip":"49038","country":"Ukraine","geoPoint":{"lat":48.46664,"lon":35.04066}},{"facility":"GSK Investigational Site","city":"Kharkiv","zip":"61058","country":"Ukraine","geoPoint":{"lat":49.98177,"lon":36.25475}},{"facility":"GSK Investigational Site","city":"Kharkiv","zip":"61070","country":"Ukraine","geoPoint":{"lat":49.98177,"lon":36.25475}},{"facility":"GSK Investigational Site","city":"Kherson","zip":"73000","country":"Ukraine","geoPoint":{"lat":46.63695,"lon":32.61458}},{"facility":"GSK Investigational Site","city":"Kyiv","zip":"01004","country":"Ukraine","geoPoint":{"lat":50.45466,"lon":30.5238}},{"facility":"GSK Investigational Site","city":"Kyiv","zip":"01021","country":"Ukraine","geoPoint":{"lat":50.45466,"lon":30.5238}},{"facility":"GSK Investigational Site","city":"Kyiv","zip":"02091","country":"Ukraine","geoPoint":{"lat":50.45466,"lon":30.5238}},{"facility":"GSK Investigational Site","city":"Kyiv","zip":"03049","country":"Ukraine","geoPoint":{"lat":50.45466,"lon":30.5238}},{"facility":"GSK Investigational Site","city":"Kyiv","zip":"04050","country":"Ukraine","geoPoint":{"lat":50.45466,"lon":30.5238}},{"facility":"GSK Investigational Site","city":"Kyiv","zip":"04114","country":"Ukraine","geoPoint":{"lat":50.45466,"lon":30.5238}},{"facility":"GSK Investigational Site","city":"Mykolaiv","zip":"54003","country":"Ukraine","geoPoint":{"lat":50.34135,"lon":24.97731}},{"facility":"GSK Investigational Site","city":"Odesa","zip":"65025","country":"Ukraine","geoPoint":{"lat":46.48572,"lon":30.74383}},{"facility":"GSK Investigational Site","city":"Poltava","zip":"36011","country":"Ukraine","geoPoint":{"lat":49.58925,"lon":34.55367}},{"facility":"GSK Investigational Site","city":"Uzhhorod","zip":"88000","country":"Ukraine","geoPoint":{"lat":48.6242,"lon":22.2947}},{"facility":"GSK Investigational Site","city":"Vinnytsia","zip":"21010","country":"Ukraine","geoPoint":{"lat":49.2322,"lon":28.46871}},{"facility":"GSK Investigational Site","city":"Zaporizhzhya","zip":"69001","country":"Ukraine","geoPoint":{"lat":47.85167,"lon":35.11714}},{"facility":"GSK Investigational Site","city":"Soham","state":"Cambridgeshire","zip":"CB7 5J","country":"United Kingdom","geoPoint":{"lat":52.33543,"lon":0.33654}},{"facility":"GSK Investigational Site","city":"Chesterfield","state":"Derbyshire","zip":"S40 4AAA","country":"United Kingdom","geoPoint":{"lat":53.25,"lon":-1.41667}},{"facility":"GSK Investigational Site","city":"Romford","state":"Essex","zip":"RM1 3P","country":"United Kingdom","geoPoint":{"lat":51.57515,"lon":0.18582}},{"facility":"GSK Investigational Site","city":"Northwood","state":"Middlesex","zip":"HA6 2R","country":"United Kingdom","geoPoint":{"lat":51.61162,"lon":-0.42454}},{"facility":"GSK Investigational Site","city":"Edinburgh","state":"Midlothian","zip":"EH4 2XU","country":"United Kingdom","geoPoint":{"lat":55.95206,"lon":-3.19648}},{"facility":"GSK Investigational Site","city":"Trowbridge","state":"Wiltshire","zip":"BA14 8","country":"United Kingdom","geoPoint":{"lat":51.31889,"lon":-2.20861}},{"facility":"GSK Investigational Site","city":"Aberdeen","zip":"AB25 2","country":"United Kingdom","geoPoint":{"lat":57.14369,"lon":-2.09814}},{"facility":"GSK Investigational Site","city":"Axbridge, Somerset","zip":"BS26 2","country":"United Kingdom","geoPoint":{"lat":51.28466,"lon":-2.82078}},{"facility":"GSK Investigational Site","city":"Ayr","zip":"KA6 6D","country":"United Kingdom","geoPoint":{"lat":55.46273,"lon":-4.63393}},{"facility":"GSK Investigational Site","city":"Blackpool","zip":"FY3 8NR","country":"United Kingdom","geoPoint":{"lat":53.81667,"lon":-3.05}},{"facility":"GSK Investigational Site","city":"Bristol","zip":"BS10 5","country":"United Kingdom","geoPoint":{"lat":51.45523,"lon":-2.59665}},{"facility":"GSK Investigational Site","city":"Dumfries","zip":"DG1 4AP","country":"United Kingdom","geoPoint":{"lat":55.06959,"lon":-3.61139}},{"facility":"GSK Investigational Site","city":"Dundee","zip":"DD1 9S","country":"United Kingdom","geoPoint":{"lat":56.46913,"lon":-2.97489}},{"facility":"GSK Investigational Site","city":"Dundee","zip":"DD4 6Q","country":"United Kingdom","geoPoint":{"lat":56.46913,"lon":-2.97489}},{"facility":"GSK Investigational Site","city":"Dundee","zip":"DD5 4LX","country":"United Kingdom","geoPoint":{"lat":56.46913,"lon":-2.97489}},{"facility":"GSK Investigational Site","city":"Fife","zip":"KY14 7AW","country":"United Kingdom"},{"facility":"GSK Investigational Site","city":"Fife","zip":"KY2 5A","country":"United Kingdom"},{"facility":"GSK Investigational Site","city":"Gloucester","zip":"GL1 3N","country":"United Kingdom","geoPoint":{"lat":51.86568,"lon":-2.2431}},{"facility":"GSK Investigational Site","city":"Lancaster","zip":"LA1 4R","country":"United Kingdom","geoPoint":{"lat":54.04649,"lon":-2.79988}},{"facility":"GSK Investigational Site","city":"Manchester","zip":"M23 9LT","country":"United Kingdom","geoPoint":{"lat":53.48095,"lon":-2.23743}},{"facility":"GSK Investigational Site","city":"Newport","zip":"PO30 5","country":"United Kingdom","geoPoint":{"lat":51.58774,"lon":-2.99835}},{"facility":"GSK Investigational Site","city":"Oxford","zip":"OX3 7L","country":"United Kingdom","geoPoint":{"lat":51.75222,"lon":-1.25596}},{"facility":"GSK Investigational Site","city":"Rotherham","zip":"S60 2UD","country":"United Kingdom","geoPoint":{"lat":53.43012,"lon":-1.35678}},{"facility":"GSK Investigational Site","city":"Sidcup, Kent","zip":"DA14 6","country":"United Kingdom"},{"facility":"GSK Investigational Site","city":"Trowbridge","zip":"BA14 9","country":"United Kingdom","geoPoint":{"lat":51.31889,"lon":-2.20861}},{"facility":"GSK Investigational Site","city":"Wigan","zip":"WN1 2NN","country":"United Kingdom","geoPoint":{"lat":53.54296,"lon":-2.63706}}]},"referencesModule":{"references":[{"type":"BACKGROUND","citation":"John McMurray, Stefano Del Prato, Adrian Hernandez, Larry Leiter, Chris Granger, Ralph D'Agostino, Jennifer Green, Kristina Sigmon, Anne Rosenberg Nigel Jones, Karl Thorpe, Matt Somerville, Salim Janmohamed. Albiglutide and Cardiovascular Outcomes in Patients with Type 2 Diabetes and Cardiovascular Disease. Lancet. 2018"},{"pmid":"41906117","type":"DERIVED","citation":"Umapathysivam MM, Araldi E, Hastoy B, Dawed AY, Vatandaslar H, Mayrhofer JE, Lindquist P, Silva PN, Goga A, Trullinger GO, Godbersen S, Sengupta S, Kaufmann A, Thomsen SK, Hartmann B, Chen YC, Jonsson AE, Kabakci H, Thaman S, Grarup N, Have CT, Pallo LP, Faerch K, Gjesing AP, Nawaz S, Cheeseman J, Neville MJ, Pedersen O, Walker M, Sun H, Jennison C, Hattersley AT, Rehfeld JF, Holman RR, Verchere BC, Hansen T, Karpe F, Holst JJ, Rosenkilde MM, Jones AG, Ristow M, McCarthy MI, Pearson ER, Stoffel M, Gloyn AL. Type 2 diabetes risk alleles in peptidyl-glycine alpha-amidating monooxygenase influence GLP-1 levels and response to GLP-1 receptor agonists. Genome Med. 2026 Mar 29;18(1):40. doi: 10.1186/s13073-026-01630-0."},{"pmid":"39963952","type":"DERIVED","citation":"Natale P, Green SC, Tunnicliffe DJ, Pellegrino G, Toyama T, Strippoli GF. Glucagon-like peptide 1 (GLP-1) receptor agonists for people with chronic kidney disease and diabetes. Cochrane Database Syst Rev. 2025 Feb 18;2(2):CD015849. doi: 10.1002/14651858.CD015849.pub2."},{"pmid":"38317618","type":"DERIVED","citation":"Gilbert MP, Skelly J, Hernandez AF, Green JB, Krychtiuk KA, Granger CB, Leiter LA, McMurray JJV, Del Prato S, Pratley RE. Effect of albiglutide on cardiovascular outcomes in older adults: A post hoc analysis of a randomized controlled trial. Diabetes Obes Metab. 2024 May;26(5):1714-1722. doi: 10.1111/dom.15479. Epub 2024 Feb 6."},{"pmid":"34281607","type":"DERIVED","citation":"O'Brien EC, Raman SR, Ellis A, Hammill BG, Berdan LG, Rorick T, Janmohamed S, Lampron Z, Hernandez AF, Curtis LH. The use of electronic health records for recruitment in clinical trials: a mixed methods analysis of the Harmony Outcomes Electronic Health Record Ancillary Study. Trials. 2021 Jul 19;22(1):465. doi: 10.1186/s13063-021-05397-0."},{"pmid":"30291013","type":"DERIVED","citation":"Hernandez AF, Green JB, Janmohamed S, D'Agostino RB Sr, Granger CB, Jones NP, Leiter LA, Rosenberg AE, Sigmon KN, Somerville MC, Thorpe KM, McMurray JJV, Del Prato S; Harmony Outcomes committees and investigators. Albiglutide and cardiovascular outcomes in patients with type 2 diabetes and cardiovascular disease (Harmony Outcomes): a double-blind, randomised placebo-controlled trial. Lancet. 2018 Oct 27;392(10157):1519-1529. doi: 10.1016/S0140-6736(18)32261-X. Epub 2018 Oct 2."},{"pmid":"30015066","type":"DERIVED","citation":"Green JB, Hernandez AF, D'Agostino RB, Granger CB, Janmohamed S, Jones NP, Leiter LA, Noronha D, Russell R, Sigmon K, Del Prato S, McMurray JJV. Harmony Outcomes: A randomized, double-blind, placebo-controlled trial of the effect of albiglutide on major cardiovascular events in patients with type 2 diabetes mellitus-Rationale, design, and baseline characteristics. Am Heart J. 2018 Sep;203:30-38. doi: 10.1016/j.ahj.2018.03.030. Epub 2018 Jun 12."},{"pmid":"29693361","type":"DERIVED","citation":"Wittbrodt ET, Eudicone JM, Bell KF, Enhoffer DM, Latham K, Green JB. Generalizability of glucagon-like peptide-1 receptor agonist cardiovascular outcome trials enrollment criteria to the US type 2 diabetes population. Am J Manag Care. 2018 Apr;24(8 Suppl):S146-S155."}]}},"resultsSection":{"participantFlowModule":{"preAssignmentDetails":"A total of 10793 participants were screened of which 1330 failed screening and 9463 participants were randomized in a 1:1 ratio to receive either once weekly albiglutide or matching placebo subcutaneous injections. The study was conducted in 28 countries","recruitmentDetails":"This was a randomized, double-blind, parallel group, placebo-controlled study in participants with Type 2 diabetes having a previous history of cardiovascular disease and not having optimal glycemic control.","groups":[{"id":"FG000","title":"Placebo","description":"Albiglutide matching placebo was administered once weekly as subcutaneous injection in the abdomen, thigh or upper arm region in addition to the standard of care therapy for diabetes and cardiovascular health."},{"id":"FG001","title":"Albiglutide","description":"Albiglutide was administered once weekly as subcutaneous injection in the abdomen, thigh or upper arm region. Participants were administered albiglutide at a dose of 30 milligrams (mg) or 50 mg once weekly in addition to the standard of care therapy for diabetes and cardiovascular health."}],"periods":[{"title":"Overall Study","milestones":[{"type":"STARTED","achievements":[{"groupId":"FG000","numSubjects":"4732"},{"groupId":"FG001","numSubjects":"4731"}]},{"type":"COMPLETED","achievements":[{"groupId":"FG000","numSubjects":"4578"},{"groupId":"FG001","numSubjects":"4620"}]},{"type":"NOT COMPLETED","achievements":[{"groupId":"FG000","numSubjects":"154"},{"groupId":"FG001","numSubjects":"111"}]}],"dropWithdraws":[{"type":"Investigator site closed","reasons":[{"groupId":"FG000","numSubjects":"4"},{"groupId":"FG001","numSubjects":"5"}]},{"type":"Withdrawal by Subject","reasons":[{"groupId":"FG000","numSubjects":"74"},{"groupId":"FG001","numSubjects":"43"}]},{"type":"Physician Decision","reasons":[{"groupId":"FG000","numSubjects":"8"},{"groupId":"FG001","numSubjects":"12"}]},{"type":"Lost to Follow-up","reasons":[{"groupId":"FG000","numSubjects":"68"},{"groupId":"FG001","numSubjects":"51"}]}]}]},"baselineCharacteristicsModule":{"groups":[{"id":"BG000","title":"Placebo","description":"Albiglutide matching placebo was administered once weekly as subcutaneous injection in the abdomen, thigh or upper arm region in addition to the standard of care therapy for diabetes and cardiovascular health."},{"id":"BG001","title":"Albiglutide","description":"Albiglutide was administered once weekly as subcutaneous injection in the abdomen, thigh or upper arm region. Participants were administered albiglutide at a dose of 30 milligrams (mg) or 50 mg once weekly in addition to the standard of care therapy for diabetes and cardiovascular health.."},{"id":"BG002","title":"Total","description":"Total of all reporting groups"}],"denoms":[{"units":"Participants","counts":[{"groupId":"BG000","value":"4732"},{"groupId":"BG001","value":"4731"},{"groupId":"BG002","value":"9463"}]}],"measures":[{"title":"Age, Continuous","paramType":"MEAN","dispersionType":"STANDARD_DEVIATION","unitOfMeasure":"Years","classes":[{"categories":[{"measurements":[{"groupId":"BG000","value":"64.2","spread":"8.65"},{"groupId":"BG001","value":"64.1","spread":"8.71"},{"groupId":"BG002","value":"64.1","spread":"8.68"}]}]}]},{"title":"Sex: Female, Male","paramType":"COUNT_OF_PARTICIPANTS","unitOfMeasure":"Participants","classes":[{"categories":[{"title":"Female","measurements":[{"groupId":"BG000","value":"1467"},{"groupId":"BG001","value":"1427"},{"groupId":"BG002","value":"2894"}]},{"title":"Male","measurements":[{"groupId":"BG000","value":"3265"},{"groupId":"BG001","value":"3304"},{"groupId":"BG002","value":"6569"}]}]}]},{"title":"Race/Ethnicity, Customized","paramType":"COUNT_OF_PARTICIPANTS","unitOfMeasure":"Participants","classes":[{"title":"Race, customized","categories":[{"title":"American Indian (Amer. Ind.) or Alaska Native","measurements":[{"groupId":"BG000","value":"238"},{"groupId":"BG001","value":"280"},{"groupId":"BG002","value":"518"}]},{"title":"Central/South Asian Heritage (Her.)","measurements":[{"groupId":"BG000","value":"27"},{"groupId":"BG001","value":"25"},{"groupId":"BG002","value":"52"}]},{"title":"Japanese Her./East Asian Her/South East Asian Her.","measurements":[{"groupId":"BG000","value":"215"},{"groupId":"BG001","value":"204"},{"groupId":"BG002","value":"419"}]},{"title":"Black or African American (Amer.)","measurements":[{"groupId":"BG000","value":"118"},{"groupId":"BG001","value":"121"},{"groupId":"BG002","value":"239"}]},{"title":"Native Hawaiian or Other Pacific Islander","measurements":[{"groupId":"BG000","value":"2"},{"groupId":"BG001","value":"3"},{"groupId":"BG002","value":"5"}]},{"title":"White","measurements":[{"groupId":"BG000","value":"4024"},{"groupId":"BG001","value":"4006"},{"groupId":"BG002","value":"8030"}]},{"title":"Amer Ind. or Alaska Native & Black or African Amer","measurements":[{"groupId":"BG000","value":"1"},{"groupId":"BG001","value":"3"},{"groupId":"BG002","value":"4"}]},{"title":"Asian & Black or African Amer.","measurements":[{"groupId":"BG000","value":"1"},{"groupId":"BG001","value":"0"},{"groupId":"BG002","value":"1"}]},{"title":"Asian & White","measurements":[{"groupId":"BG000","value":"0"},{"groupId":"BG001","value":"1"},{"groupId":"BG002","value":"1"}]},{"title":"Black or African Amer. & White","measurements":[{"groupId":"BG000","value":"81"},{"groupId":"BG001","value":"67"},{"groupId":"BG002","value":"148"}]},{"title":"Unknown","measurements":[{"groupId":"BG000","value":"1"},{"groupId":"BG001","value":"1"},{"groupId":"BG002","value":"2"}]},{"title":"Amer. Ind. or Alaska Native & White","measurements":[{"groupId":"BG000","value":"24"},{"groupId":"BG001","value":"20"},{"groupId":"BG002","value":"44"}]}]}]}]},"outcomeMeasuresModule":{"outcomeMeasures":[{"type":"PRIMARY","title":"Time to First Occurrence of Major Adverse Cardiovascular Events (MACE) During Cardiovascular (CV) Follow-up Time Period","description":"Time to MACE defined as the time to first occurrence of Cardiovascular Endpoint Committee (CEC)-adjudicated MACE (CV death, myocardial infarction \\[MI\\] or stroke) was analyzed using a Cox Proportional Hazards regression model with treatment group as the only covariate. The incidence rate per 100 person years (100\\*number of participants with at least 1 event)/first event person-years) is presented along with 95% confidence interval. First event person-years=(cumulative total time to first event for participants who have the event+cumulative total of censored time for participants without the event)/365.25, based on the CV follow-up time period. The analysis was performed on the Intent to Treat (ITT) Population which comprised of all randomized participants excluding participants who did not provide consent.","populationDescription":"ITT Population","reportingStatus":"POSTED","paramType":"NUMBER","dispersionType":"95% Confidence Interval","unitOfMeasure":"Events per 100 person years","timeFrame":"Median of 1.65 person years for CV follow-up time period","groups":[{"id":"OG000","title":"Placebo","description":"Albiglutide matching placebo was administered once weekly as subcutaneous injection in the abdomen, thigh or upper arm region in addition to the standard of care therapy for diabetes and cardiovascular health."},{"id":"OG001","title":"Albiglutide","description":"Albiglutide was administered once weekly as subcutaneous injection in the abdomen, thigh or upper arm region. Participants were administered albiglutide at a dose of 30 milligrams (mg) or 50 mg once weekly in addition to the standard of care therapy for diabetes and cardiovascular health."}],"denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"4732"},{"groupId":"OG001","value":"4731"}]}],"classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"5.87","lowerLimit":"5.33","upperLimit":"6.45"},{"groupId":"OG001","value":"4.57","lowerLimit":"4.10","upperLimit":"5.08"}]}]}],"analyses":[{"groupIds":["OG000","OG001"],"nonInferiorityType":"NON_INFERIORITY","nonInferiorityComment":"Non-inferiority was determined by testing the hypothesis that the observed hazard ratio is significantly different from the null margin of 1.3 (a one-sided p \\<0.025 for such a test with result in appropriate direction being equivalent to the upper 95% confidence limit for the hazard ratio being less than 1.3)","pValue":"<0.0001","pValueComment":"One-sided p-value based on Wald test of hazard ratio (HR) \\>=1.3 versus HR \\<1.3.","statisticalMethod":"Wald test","paramType":"Hazard Ratio (HR)","paramValue":"0.78","ciPctValue":"95","ciNumSides":"TWO_SIDED","ciLowerLimit":"0.68","ciUpperLimit":"0.90","estimateComment":"Hazard ratio is estimated using a Cox proportional hazard regression model with treatment as the only covariate"},{"groupIds":["OG000","OG001"],"nonInferiorityType":"SUPERIORITY","pValue":"<0.001","pValueComment":"Two-sided p-value based on Wald test of HR=1 versus HR not equal to 1","statisticalMethod":"Wald test"}]},{"type":"SECONDARY","title":"Time to First Occurrence of MACE or Urgent Revascularization for Unstable Angina","description":"Time to first occurrence of CEC-adjudicated MACE (CV death, MI or stroke) or urgent revascularization for unstable angina was analyzed using a Cox Proportional Hazards regression model with treatment group as the only covariate. The incidence rate per 100 person years (100\\*number of participants with at least 1 event)/first event person-years) is presented along with 95% confidence interval. First event person-years=(cumulative total time to first event for participants who have the event+cumulative total of censored time for participants without the event)/365.25, based on the CV follow-up time period.","populationDescription":"ITT Population","reportingStatus":"POSTED","paramType":"NUMBER","dispersionType":"95% Confidence Interval","unitOfMeasure":"Events per 100 person years","timeFrame":"Median of 1.65 person years for CV follow-up time period","groups":[{"id":"OG000","title":"Placebo","description":"Albiglutide matching placebo was administered once weekly as subcutaneous injection in the abdomen, thigh or upper arm region in addition to the standard of care therapy for diabetes and cardiovascular health."},{"id":"OG001","title":"Albiglutide","description":"Albiglutide was administered once weekly as subcutaneous injection in the abdomen, thigh or upper arm region. Participants were administered albiglutide at a dose of 30 milligrams (mg) or 50 mg once weekly in addition to the standard of care therapy for diabetes and cardiovascular health."}],"denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"4732"},{"groupId":"OG001","value":"4731"}]}],"classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"6.45","lowerLimit":"5.88","upperLimit":"7.06"},{"groupId":"OG001","value":"5.06","lowerLimit":"4.56","upperLimit":"5.60"}]}]}],"analyses":[{"groupIds":["OG000","OG001"],"nonInferiorityType":"OTHER","pValue":"<0.001","pValueComment":"Two-sided p-value based on the Wald statistic.","statisticalMethod":"Wald statistic","paramType":"Hazard Ratio (HR)","paramValue":"0.78","ciPctValue":"95","ciNumSides":"TWO_SIDED","ciLowerLimit":"0.69","ciUpperLimit":"0.90","estimateComment":"Hazard ratio is estimated using a Cox proportional hazard regression model with treatment as the only covariate."}]},{"type":"SECONDARY","title":"Time to Adjudicated CV Death","description":"Time to adjudicated CV death was analyzed using a Cox Proportional Hazards regression model with treatment group as the only covariate. The incidence rate per 100 person years (100\\*number of participants with at least 1 event)/first event person-years) is presented along with 95% confidence interval. First event person-years=(cumulative total time to first event for participants who have the event+cumulative total of censored time for participants without the event)/365.25, based on the CV follow-up time period.","populationDescription":"ITT Population","reportingStatus":"POSTED","paramType":"NUMBER","dispersionType":"95% Confidence Interval","unitOfMeasure":"Events per 100 person years","timeFrame":"Median of 1.65 person years for the CV follow-up time period","groups":[{"id":"OG000","title":"Placebo","description":"Albiglutide matching placebo was administered once weekly as subcutaneous injection in the abdomen, thigh or upper arm region in addition to the standard of care therapy for diabetes and cardiovascular health."},{"id":"OG001","title":"Albiglutide","description":"Albiglutide was administered once weekly as subcutaneous injection in the abdomen, thigh or upper arm region. Participants were administered albiglutide at a dose of 30 milligrams (mg) or 50 mg once weekly in addition to the standard of care therapy for diabetes and cardiovascular health."}],"denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"4732"},{"groupId":"OG001","value":"4731"}]}],"classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"1.72","lowerLimit":"1.44","upperLimit":"2.04"},{"groupId":"OG001","value":"1.61","lowerLimit":"1.33","upperLimit":"1.92"}]}]}],"analyses":[{"groupIds":["OG000","OG001"],"nonInferiorityType":"OTHER","pValue":"0.578","pValueComment":"Two-sided p-value based on the Wald statistic","statisticalMethod":"Wald statistic","paramType":"Hazard Ratio (HR)","paramValue":"0.93","ciPctValue":"95","ciNumSides":"TWO_SIDED","ciLowerLimit":"0.73","ciUpperLimit":"1.19","estimateComment":"Hazard ratio is estimated using a Cox proportional hazard regression model with treatment as the only covariate"}]},{"type":"SECONDARY","title":"Time to First Occurrence of Adjudicated MI","description":"Time to first occurrence of adjudicated MI was analyzed using a Cox Proportional Hazards regression model with treatment group as the only covariate. The incidence rate per 100 person years (100\\*number of participants with at least 1 event)/first event person-years) is presented along with 95% confidence interval. First event person-years=(cumulative total time to first event for participants who have the event+cumulative total of censored time for participants without the event)/365.25, based on the CV follow-up time period.","populationDescription":"ITT Population","reportingStatus":"POSTED","paramType":"NUMBER","dispersionType":"95% Confidence Interval","unitOfMeasure":"Events per 100 person years","timeFrame":"Median of 1.65 person years for CV follow-up time period","groups":[{"id":"OG000","title":"Placebo","description":"Albiglutide matching placebo was administered once weekly as subcutaneous injection in the abdomen, thigh or upper arm region in addition to the standard of care therapy for diabetes and cardiovascular health."},{"id":"OG001","title":"Albiglutide","description":"Albiglutide was administered once weekly as subcutaneous injection in the abdomen, thigh or upper arm region. Participants were administered albiglutide at a dose of 30 milligrams (mg) or 50 mg once weekly in addition to the standard of care therapy for diabetes and cardiovascular health."}],"denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"4732"},{"groupId":"OG001","value":"4731"}]}],"classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"3.26","lowerLimit":"2.86","upperLimit":"3.70"},{"groupId":"OG001","value":"2.43","lowerLimit":"2.09","upperLimit":"2.81"}]}]}],"analyses":[{"groupIds":["OG000","OG001"],"nonInferiorityType":"OTHER","pValue":"0.003","pValueComment":"Two-sided p-value based on the Wald statistic.","statisticalMethod":"Wald statistic","paramType":"Hazard Ratio (HR)","paramValue":"0.75","ciPctValue":"95","ciNumSides":"TWO_SIDED","ciLowerLimit":"0.61","ciUpperLimit":"0.90","estimateComment":"Hazard ratio is estimated using a Cox proportional hazard regression model with treatment as the only covariate."}]},{"type":"SECONDARY","title":"Time to First Occurrence of Adjudicated Stroke","description":"Time to first occurrence of adjudicated stroke was analyzed using a Cox Proportional Hazards regression model with treatment group as the only covariate. The incidence rate per 100 person years (100\\*number of participants with at least 1 event)/first event person-years) is presented along with 95% confidence interval. First event person-years=(cumulative total time to first event for participants who have the event+cumulative total of censored time for participants without the event)/365.25, based on the CV follow-up time period.","populationDescription":"ITT Population","reportingStatus":"POSTED","paramType":"NUMBER","dispersionType":"95% Confidence Interval","unitOfMeasure":"Events per 100 person years","timeFrame":"Median of 1.65 person years for CV follow-up time period","groups":[{"id":"OG000","title":"Placebo","description":"Albiglutide matching placebo was administered once weekly as subcutaneous injection in the abdomen, thigh or upper arm region in addition to the standard of care therapy for diabetes and cardiovascular health."},{"id":"OG001","title":"Albiglutide","description":"Albiglutide was administered once weekly as subcutaneous injection in the abdomen, thigh or upper arm region. Participants were administered albiglutide at a dose of 30 milligrams (mg) or 50 mg once weekly in addition to the standard of care therapy for diabetes and cardiovascular health."}],"denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"4732"},{"groupId":"OG001","value":"4731"}]}],"classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"1.45","lowerLimit":"1.19","upperLimit":"1.74"},{"groupId":"OG001","value":"1.25","lowerLimit":"1.01","upperLimit":"1.53"}]}]}],"analyses":[{"groupIds":["OG000","OG001"],"nonInferiorityType":"OTHER","pValue":"0.300","pValueComment":"Two-sided p-value based on the Wald statistic.","statisticalMethod":"Wald statistic","paramType":"Hazard Ratio (HR)","paramValue":"0.86","ciPctValue":"95","ciNumSides":"TWO_SIDED","ciLowerLimit":"0.66","ciUpperLimit":"1.14","estimateComment":"Hazard ratio is estimated using a Cox proportional hazard regression model with treatment as the only covariate."}]},{"type":"SECONDARY","title":"Time to First Occurrence of Adjudicated CV Death or Hospitalization for Heart Failure (HF)","description":"Time to first occurrence of adjudicated CV death or hospitalization for HF was analyzed using a Cox Proportional Hazards regression model with treatment group as the only covariate. The incidence rate per 100 person years (100\\*number of participants with at least 1 event)/first event person-years) is presented along with 95% confidence interval. First event person-years=(cumulative total time to first event for participants who have the event+cumulative total of censored time for participants without the event)/365.25, based on the CV follow-up time period.","populationDescription":"ITT Population","reportingStatus":"POSTED","paramType":"NUMBER","dispersionType":"95% Confidence Interval","unitOfMeasure":"Events per 100 person years","timeFrame":"Median of 1.65 person years for CV follow-up time period","groups":[{"id":"OG000","title":"Placebo","description":"Albiglutide matching placebo was administered once weekly as subcutaneous injection in the abdomen, thigh or upper arm region in addition to the standard of care therapy for diabetes and cardiovascular health."},{"id":"OG001","title":"Albiglutide","description":"Albiglutide was administered once weekly as subcutaneous injection in the abdomen, thigh or upper arm region. Participants were administered albiglutide at a dose of 30 milligrams (mg) or 50 mg once weekly in addition to the standard of care therapy for diabetes and cardiovascular health."}],"denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"4732"},{"groupId":"OG001","value":"4731"}]}],"classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"2.92","lowerLimit":"2.55","upperLimit":"3.34"},{"groupId":"OG001","value":"2.49","lowerLimit":"2.15","upperLimit":"2.88"}]}]}],"analyses":[{"groupIds":["OG000","OG001"],"nonInferiorityType":"OTHER","pValue":"0.113","pValueComment":"Two-sided p-value based on the Wald statistic.","statisticalMethod":"Wald statistic","paramType":"Hazard Ratio (HR)","paramValue":"0.85","ciPctValue":"95","ciNumSides":"TWO_SIDED","ciLowerLimit":"0.70","ciUpperLimit":"1.04","estimateComment":"Hazard ratio is estimated using a Cox proportional hazard regression model with treatment as the only covariate."}]},{"type":"SECONDARY","title":"Time to Initiation of Insulin of More Than 3 Months Duration for Those Participants Not Treated With Insulin at Study Start","description":"Time to initiation of insulin of more than 3 months duration in participants not treated with insulin at study start was analyzed using a Cox Proportional Hazards regression model with treatment group as the only covariate. The incidence rate per 100 person years (100\\*number of participants with at least 1 event)/first event person-years) is presented along with 95% confidence interval. First event person-years=(cumulative total time to first event for participants who have the event+cumulative total of censored time for participants without the event)/365.25, based on the on-therapy and post-therapy AE time period. The analysis was performed on Non-Insulin Population which comprised of participants in the ITT Population who were not on insulin at Baseline.","populationDescription":"Non-Insulin Population","reportingStatus":"POSTED","paramType":"NUMBER","dispersionType":"95% Confidence Interval","unitOfMeasure":"Events per 100 person years","timeFrame":"Up to 2.7 years","groups":[{"id":"OG000","title":"Placebo","description":"Albiglutide matching placebo was administered once weekly as subcutaneous injection in the abdomen, thigh or upper arm region in addition to the standard of care therapy for diabetes and cardiovascular health."},{"id":"OG001","title":"Albiglutide","description":"Albiglutide was administered once weekly as subcutaneous injection in the abdomen, thigh or upper arm region. Participants were administered albiglutide at a dose of 30 milligrams (mg) or 50 mg once weekly in addition to the standard of care therapy for diabetes and cardiovascular health."}],"denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"1995"},{"groupId":"OG001","value":"1871"}]}],"classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"8.58","lowerLimit":"7.56","upperLimit":"9.70"},{"groupId":"OG001","value":"3.56","lowerLimit":"2.92","upperLimit":"4.31"}]}]}],"analyses":[{"groupIds":["OG000","OG001"],"nonInferiorityType":"SUPERIORITY","pValue":"<0.001","pValueComment":"Two-sided p-value based on Wald test of HR=1 versus HR not equal to 1.","statisticalMethod":"Wald test","paramType":"Hazard Ratio (HR)","paramValue":"0.42","ciPctValue":"95","ciNumSides":"TWO_SIDED","ciLowerLimit":"0.33","ciUpperLimit":"0.53","estimateComment":"Hazard ratio is estimated using a Cox proportional hazard regression model with treatment as the only covariate."}]},{"type":"SECONDARY","title":"Time to Initiation of Prandial Insulin in Those Participants on Basal Insulin at Study Start","description":"Time to initiation of prandial insulin in those participants on basal insulin at study start was analyzed using a Cox Proportional Hazards regression model with treatment group as the only covariate. The incidence rate per 100 person years (100\\*number of participants with at least 1 event)/first event person-years) is presented along with 95% confidence interval. First event person-years=(cumulative total time to first event for participants who have the event+cumulative total of censored time for participants without the event)/365.25, based on the on-therapy and post-therapy AE time period. The analysis was performed on Basal Insulin Population which comprised of participants in the ITT Population who were on basal insulin but not on other insulin at Baseline (i.e., will not include a participant on a mixed insulin or on a prandial-only insulin).","populationDescription":"Basal Insulin Population","reportingStatus":"POSTED","paramType":"NUMBER","dispersionType":"95% Confidence Interval","unitOfMeasure":"Events per 100 person years","timeFrame":"Up to 2.7 years","groups":[{"id":"OG000","title":"Placebo","description":"Albiglutide matching placebo was administered once weekly as subcutaneous injection in the abdomen, thigh or upper arm region in addition to the standard of care therapy for diabetes and cardiovascular health."},{"id":"OG001","title":"Albiglutide","description":"Albiglutide was administered once weekly as subcutaneous injection in the abdomen, thigh or upper arm region. Participants were administered albiglutide at a dose of 30 milligrams (mg) or 50 mg once weekly in addition to the standard of care therapy for diabetes and cardiovascular health."}],"denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"1040"},{"groupId":"OG001","value":"1028"}]}],"classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"5.09","lowerLimit":"4.06","upperLimit":"6.31"},{"groupId":"OG001","value":"3.59","lowerLimit":"2.73","upperLimit":"4.63"}]}]}],"analyses":[{"groupIds":["OG000","OG001"],"nonInferiorityType":"SUPERIORITY","pValue":"0.043","pValueComment":"Two-sided p-value based on Wald test of HR=1 versus HR not equal to 1.","statisticalMethod":"Wald test","paramType":"Hazard Ratio (HR)","paramValue":"0.71","ciPctValue":"95","ciNumSides":"TWO_SIDED","ciLowerLimit":"0.51","ciUpperLimit":"0.99","estimateComment":"Hazard ratio is estimated using a Cox proportional hazard regression model with treatment as the only covariate."}]},{"type":"SECONDARY","title":"Percentage of Participants Achieving Composite Metabolic Endpoint","description":"Percentage of participants achieving composite metabolic endpoint defined as the percentage of participants achieving glycemic control (glycated hemoglobin \\[HbA1c\\] \\<=7% ) with no severe hypoglycemic incidents and weight gain \\< 5%. Final Assessment is the latest post-Baseline assessment of both HbA1c and weight.","populationDescription":"ITT Population. Only those participants with HbA1c and weight values at Baseline and at the specified visits were analyzed (represented by n=X in category titles)","reportingStatus":"POSTED","paramType":"NUMBER","unitOfMeasure":"Percentage of participants","timeFrame":"Months 8, 16, 24 and final assessment (up to 2.7 years)","groups":[{"id":"OG000","title":"Placebo","description":"Albiglutide matching placebo was administered once weekly as subcutaneous injection in the abdomen, thigh or upper arm region in addition to the standard of care therapy for diabetes and cardiovascular health."},{"id":"OG001","title":"Albiglutide","description":"Albiglutide was administered once weekly as subcutaneous injection in the abdomen, thigh or upper arm region. Participants were administered albiglutide at a dose of 30 milligrams (mg) or 50 mg once weekly in addition to the standard of care therapy for diabetes and cardiovascular health."}],"denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"4732"},{"groupId":"OG001","value":"4731"}]}],"classes":[{"title":"Month 8, n=4127, 4195","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"4127"},{"groupId":"OG001","value":"4195"}]}],"categories":[{"measurements":[{"groupId":"OG000","value":"15.4"},{"groupId":"OG001","value":"32.2"}]}]},{"title":"Month 16, n=3026, 3118","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"3026"},{"groupId":"OG001","value":"3118"}]}],"categories":[{"measurements":[{"groupId":"OG000","value":"16.5"},{"groupId":"OG001","value":"28.7"}]}]},{"title":"Month 24, n=1119, 1173","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"1119"},{"groupId":"OG001","value":"1173"}]}],"categories":[{"measurements":[{"groupId":"OG000","value":"17.8"},{"groupId":"OG001","value":"28.6"}]}]},{"title":"Final assessment, n=4401, 4455","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"4401"},{"groupId":"OG001","value":"4455"}]}],"categories":[{"measurements":[{"groupId":"OG000","value":"15.1"},{"groupId":"OG001","value":"26.0"}]}]}],"analyses":[{"groupIds":["OG000","OG001"],"nonInferiorityType":"OTHER","pValue":"<0.001","pValueComment":"P-value based on the covariate-adjusted extended Mantel-Haenszel test. Covariates include Baseline HbA1c (\\<8.0% versus \\>= 8.0%) and Baseline diabetes therapy (diet and exercise alone versus all other therapies).","statisticalMethod":"Mantel Haenszel","statisticalComment":"Month 8"},{"groupIds":["OG000","OG001"],"nonInferiorityType":"OTHER","pValue":"<0.001","pValueComment":"P-value based on the covariate-adjusted extended Mantel-Haenszel test. Covariates include Baseline HbA1c (\\<8.0% versus \\>= 8.0%) and Baseline diabetes therapy (diet and exercise alone versus all other therapies).","statisticalMethod":"Mantel Haenszel","statisticalComment":"Month 16"},{"groupIds":["OG000","OG001"],"nonInferiorityType":"OTHER","pValue":"<0.001","pValueComment":"P-value based on the covariate-adjusted extended Mantel-Haenszel test. Covariates include Baseline HbA1c (\\<8.0% versus \\>= 8.0%) and Baseline diabetes therapy (diet and exercise alone versus all other therapies).","statisticalMethod":"Mantel Haenszel","statisticalComment":"Month 24"},{"groupIds":["OG000","OG001"],"nonInferiorityType":"OTHER","pValue":"<0.001","pValueComment":"P-value based on the covariate-adjusted extended Mantel-Haenszel test. Covariates include Baseline HbA1c (\\<8.0% versus \\>= 8.0%) and Baseline diabetes therapy (diet and exercise alone versus all other therapies).","statisticalMethod":"Mantel Haenszel","statisticalComment":"Final assessment"}]},{"type":"SECONDARY","title":"Time to First Occurrence of a Clinically Important Microvascular Event","description":"Clinically important microvascular events were defined as the following: need for renal transplant or dialysis, new diabetes-related blindness, and procedures (laser photocoagulation or anti-vascular endothelial growth factor treatment or vitrectomy for diabetic retinopathy/eye disease). Time to first occurrence of a clinically important microvascular event was analyzed using a Cox Proportional Hazards regression model with treatment group as the only covariate. The incidence rate per 100 person years (100\\*number of participants with at least 1 event)/first event person-years) is presented along with 95% confidence interval. First event person-years=(cumulative total time to first event for participants who have the event+cumulative total of censored time for participants without the event)/365.25, based on the on-therapy and post-therapy AE time period.","populationDescription":"ITT Population","reportingStatus":"POSTED","paramType":"NUMBER","dispersionType":"95% Confidence Interval","unitOfMeasure":"Events per 100 person years","timeFrame":"Up to 2.7 years","groups":[{"id":"OG000","title":"Placebo","description":"Albiglutide matching placebo was administered once weekly as subcutaneous injection in the abdomen, thigh or upper arm region in addition to the standard of care therapy for diabetes and cardiovascular health."},{"id":"OG001","title":"Albiglutide","description":"Albiglutide was administered once weekly as subcutaneous injection in the abdomen, thigh or upper arm region. Participants were administered albiglutide at a dose of 30 milligrams (mg) or 50 mg once weekly in addition to the standard of care therapy for diabetes and cardiovascular health."}],"denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"4732"},{"groupId":"OG001","value":"4731"}]}],"classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"0.69","lowerLimit":"0.52","upperLimit":"0.90"},{"groupId":"OG001","value":"0.46","lowerLimit":"0.32","upperLimit":"0.63"}]}]}],"analyses":[{"groupIds":["OG000","OG001"],"nonInferiorityType":"SUPERIORITY","pValue":"0.055","pValueComment":"Two-sided p-value based on Wald test of HR=1 versus HR not equal to 1","statisticalMethod":"Wald test","paramType":"Hazard Ratio (HR)","paramValue":"0.66","ciPctValue":"95","ciNumSides":"TWO_SIDED","ciLowerLimit":"0.43","ciUpperLimit":"1.01","estimateComment":"Hazard ratio is estimated using a Cox proportional hazard regression model with treatment as the only covariate."}]},{"type":"SECONDARY","title":"Change From Baseline in HbA1c","description":"Change from Baseline in HbA1c was analyzed using mixed model repeated measures (MMRM) including observed case data (does not impute any missing data). Baseline is the last non-missing value assessed on or before treatment start date. Change from Baseline is the value at specified time point minus the Baseline value. Change from Baseline in HbA1c using Baseline data from Local or Central Laboratory, and post-Baseline Central Laboratory data is presented.","populationDescription":"ITT Population. Only those participants with value at Baseline and at the specified visit is presented (represented by n=X in category titles)","reportingStatus":"POSTED","paramType":"LEAST_SQUARES_MEAN","dispersionType":"Standard Error","unitOfMeasure":"Percentage of HbA1c","timeFrame":"Baseline and Months 8 and 16","groups":[{"id":"OG000","title":"Placebo","description":"Albiglutide matching placebo was administered once weekly as subcutaneous injection in the abdomen, thigh or upper arm region in addition to the standard of care therapy for diabetes and cardiovascular health."},{"id":"OG001","title":"Albiglutide","description":"Albiglutide was administered once weekly as subcutaneous injection in the abdomen, thigh or upper arm region. Participants were administered albiglutide at a dose of 30 milligrams (mg) or 50 mg once weekly in addition to the standard of care therapy for diabetes and cardiovascular health."}],"denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"4732"},{"groupId":"OG001","value":"4731"}]}],"classes":[{"title":"Month 8, n=4211, 4289","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"4211"},{"groupId":"OG001","value":"4289"}]}],"categories":[{"measurements":[{"groupId":"OG000","value":"-0.28","spread":"0.020"},{"groupId":"OG001","value":"-0.92","spread":"0.019"}]}]},{"title":"Month 16, n=3066, 3163","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"3066"},{"groupId":"OG001","value":"3163"}]}],"categories":[{"measurements":[{"groupId":"OG000","value":"-0.31","spread":"0.023"},{"groupId":"OG001","value":"-0.83","spread":"0.022"}]}]}],"analyses":[{"groupIds":["OG000","OG001"],"nonInferiorityType":"OTHER","pValue":"<0.001","pValueComment":"P-value from a two-sided t-test to test whether the difference of least square means (Albiglutide - Placebo) is equal to zero","statisticalMethod":"t-test, 2 sided","paramType":"Mean Difference (Net)","paramValue":"-0.63","ciPctValue":"95","ciNumSides":"TWO_SIDED","ciLowerLimit":"-0.69","ciUpperLimit":"-0.58","estimateComment":"Based on MMRM model: Change=Baseline HbA1c+Treatment+Visit+Treatment-by-Visit Interaction+Baseline HbA1c-by-Visit Interaction. Difference of least squares means (Albiglutide-Placebo) is from MMRM model for Month 8"},{"groupIds":["OG000","OG001"],"nonInferiorityType":"OTHER","pValue":"<0.001","pValueComment":"P-value from a two-sided t-test to test whether the difference of least square means (Albiglutide - Placebo) is equal to zero","statisticalMethod":"t-test, 2 sided","paramType":"Mean Difference (Net)","paramValue":"-0.52","ciPctValue":"95","ciNumSides":"TWO_SIDED","ciLowerLimit":"-0.58","ciUpperLimit":"-0.45","estimateComment":"Based on MMRM model: Change=Baseline HbA1c+Treatment+Visit+Treatment-by-Visit Interaction+Baseline HbA1c-by-Visit Interaction. Difference of least squares means (Albiglutide-Placebo) is from MMRM model for Month 16"}]},{"type":"SECONDARY","title":"Change From Baseline in Body Weight","description":"Change from Baseline in body weight was analyzed using mixed model repeated measures including observed case data (does not impute any missing data). Baseline is the last non-missing value assessed on or before treatment start date. Change from Baseline is the value at specified time point minus the Baseline value.","populationDescription":"ITT Population. Only those participants with value at Baseline and at the specified visit is presented (represented by n=X in category titles)","reportingStatus":"POSTED","paramType":"LEAST_SQUARES_MEAN","dispersionType":"Standard Error","unitOfMeasure":"Kilograms","timeFrame":"Baseline and Months 8 and 16","groups":[{"id":"OG000","title":"Placebo","description":"Albiglutide matching placebo was administered once weekly as subcutaneous injection in the abdomen, thigh or upper arm region in addition to the standard of care therapy for diabetes and cardiovascular health."},{"id":"OG001","title":"Albiglutide","description":"Albiglutide was administered once weekly as subcutaneous injection in the abdomen, thigh or upper arm region. Participants were administered albiglutide at a dose of 30 milligrams (mg) or 50 mg once weekly in addition to the standard of care therapy for diabetes and cardiovascular health."}],"denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"4732"},{"groupId":"OG001","value":"4731"}]}],"classes":[{"title":"Month 8, n=4217, 4286","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"4217"},{"groupId":"OG001","value":"4286"}]}],"categories":[{"measurements":[{"groupId":"OG000","value":"-0.36","spread":"0.062"},{"groupId":"OG001","value":"-1.02","spread":"0.061"}]}]},{"title":"Month 16, n=3068, 3173","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"3068"},{"groupId":"OG001","value":"3173"}]}],"categories":[{"measurements":[{"groupId":"OG000","value":"-0.53","spread":"0.084"},{"groupId":"OG001","value":"-1.36","spread":"0.083"}]}]}],"analyses":[{"groupIds":["OG000","OG001"],"nonInferiorityType":"OTHER","pValue":"<0.001","pValueComment":"P-value from a two-sided t-test to test whether the difference of least square means (Albiglutide-Placebo) is equal to zero","statisticalMethod":"t-test, 2 sided","paramType":"Mean Difference (Net)","paramValue":"-0.66","ciPctValue":"95","ciNumSides":"TWO_SIDED","ciLowerLimit":"-0.83","ciUpperLimit":"-0.49","estimateComment":"Based on MMRM model: Change=Baseline Body Weight+Treatment+Visit+Treatment-by-Visit Interaction+Baseline Body Weight-by-Visit Interaction. Difference of least squares means (Albiglutide-Placebo) is from MMRM model for Month 8"},{"groupIds":["OG000","OG001"],"nonInferiorityType":"OTHER","pValue":"<0.001","pValueComment":"P-value from a two-sided t-test to test whether the difference of least square means (Albiglutide - Placebo) is equal to zero","statisticalMethod":"t-test, 2 sided","paramType":"Mean Difference (Net)","paramValue":"-0.83","ciPctValue":"95","ciNumSides":"TWO_SIDED","ciLowerLimit":"-1.06","ciUpperLimit":"-0.60","estimateComment":"Based on MMRM model: Change=Baseline Body Weight+Treatment+Visit+Treatment-by-Visit Interaction+Baseline Body weight-by-Visit Interaction. Difference of least squares means (Albiglutide-Placebo) is from MMRM model for Month 16"}]},{"type":"SECONDARY","title":"Change From Baseline in Treatment Related Impact Measures-Diabetes (TRIM-D) Total Score","description":"The TRIM-D is a 28 item treatment satisfaction measure with 5 domains assessing Treatment Burden, Daily Life, Diabetes Management, Compliance and Psychological Health. The raw score ranges for each subscale were: treatment burden (6 to 30), daily life (5 to 25), diabetes management (5 to 25), compliance (4 to 20) and psychological health (8 to 40), higher scores indicating better health state. Total raw score was determined by summing the raw scores for each of the subscales and the total score (transformed) was determined as \\[(raw score minus lowest possible raw score)/possible raw score range\\] x100. The possible total (transformed) score range is 0-100, where higher scores indicated better health state. Baseline is the last non-missing value assessed on or before treatment start date. Change from Baseline is the value at specified time point minus the Baseline value.","populationDescription":"ITT Population. Only those participants with value at Baseline and at the specified visit is presented (represented by n=X in category titles)","reportingStatus":"POSTED","paramType":"LEAST_SQUARES_MEAN","dispersionType":"Standard Error","unitOfMeasure":"Scores on a scale","timeFrame":"Baseline and Months 8 and 16","groups":[{"id":"OG000","title":"Placebo","description":"Albiglutide matching placebo was administered once weekly as subcutaneous injection in the abdomen, thigh or upper arm region in addition to the standard of care therapy for diabetes and cardiovascular health."},{"id":"OG001","title":"Albiglutide","description":"Albiglutide was administered once weekly as subcutaneous injection in the abdomen, thigh or upper arm region. Participants were administered albiglutide at a dose of 30 milligrams (mg) or 50 mg once weekly in addition to the standard of care therapy for diabetes and cardiovascular health."}],"denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"4732"},{"groupId":"OG001","value":"4731"}]}],"classes":[{"title":"Month 8, n=3013, 3041","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"3013"},{"groupId":"OG001","value":"3041"}]}],"categories":[{"measurements":[{"groupId":"OG000","value":"4.53","spread":"0.194"},{"groupId":"OG001","value":"6.92","spread":"0.193"}]}]},{"title":"Month 16, n=1738, 1840","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"1738"},{"groupId":"OG001","value":"1840"}]}],"categories":[{"measurements":[{"groupId":"OG000","value":"4.80","spread":"0.247"},{"groupId":"OG001","value":"7.13","spread":"0.241"}]}]}],"analyses":[{"groupIds":["OG000","OG001"],"nonInferiorityType":"OTHER","pValue":"<0.001","pValueComment":"P-value from a two-sided t-test to test whether the difference of least square means (Albiglutide - Placebo) is equal to zero.","statisticalMethod":"t-test, 2 sided","paramType":"Mean Difference (Net)","paramValue":"2.39","ciPctValue":"95","ciNumSides":"TWO_SIDED","ciLowerLimit":"1.85","ciUpperLimit":"2.93","estimateComment":"Based on MMRM model: Change=Baseline Total Score+Treatment+Visit+Treatment-by-Visit Interaction+Baseline Total Score-by-Visit Interaction. Difference of least squares means (Albiglutide-Placebo) is from MMRM model for Month 8"},{"groupIds":["OG000","OG001"],"nonInferiorityType":"OTHER","pValue":"<0.001","pValueComment":"P-value from a two-sided t-test to test whether the difference of least square means (Albiglutide-Placebo) is equal to zero","statisticalMethod":"t-test, 2 sided","paramType":"Mean Difference (Net)","paramValue":"2.33","ciPctValue":"95","ciNumSides":"TWO_SIDED","ciLowerLimit":"1.66","ciUpperLimit":"3.01","estimateComment":"Based on MMRM model: Change=Baseline Total Score+Treatment+Visit+Treatment-by-Visit Interaction+Baseline Total Score-by-Visit Interaction. Difference of least squares means (Albiglutide-Placebo) is from MMRM model for Month 16"}]},{"type":"SECONDARY","title":"Change From Baseline in EuroQol- 5 Dimension (EQ-5D) Visual Analogue Scale (VAS) Score","description":"The EQ-5D is a standardized instrument used to evaluate generic health-related quality of life, comprising 5 domains: mobility, self-care, usual activities, pain/discomfort, and anxiety/depression. It provides a simple descriptive profile and a single index value for health status. The EQ-5D self-reported questionnaire includes a visual analog scale (VAS), which records the respondent's self-rated health status on a graduated (0-100) scale, where 0 represents the worst imaginable health state and 100 represents the best imaginable health state. Baseline is the last non-missing value assessed on or before treatment start date. Change from Baseline is the value at specified time point minus the Baseline value.","populationDescription":"ITT Population. Only those participants with value at Baseline and at the specified visit is presented (represented by n=X in category titles)","reportingStatus":"POSTED","paramType":"LEAST_SQUARES_MEAN","dispersionType":"Standard Error","unitOfMeasure":"Scores on a scale","timeFrame":"Baseline and Months 8 and 16","groups":[{"id":"OG000","title":"Placebo","description":"Albiglutide matching placebo was administered once weekly as subcutaneous injection in the abdomen, thigh or upper arm region in addition to the standard of care therapy for diabetes and cardiovascular health."},{"id":"OG001","title":"Albiglutide","description":"Albiglutide was administered once weekly as subcutaneous injection in the abdomen, thigh or upper arm region. Participants were administered albiglutide at a dose of 30 milligrams (mg) or 50 mg once weekly in addition to the standard of care therapy for diabetes and cardiovascular health."}],"denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"4732"},{"groupId":"OG001","value":"4731"}]}],"classes":[{"title":"Month 8, n=3982, 4014","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"3982"},{"groupId":"OG001","value":"4014"}]}],"categories":[{"measurements":[{"groupId":"OG000","value":"1.36","spread":"0.217"},{"groupId":"OG001","value":"2.83","spread":"0.216"}]}]},{"title":"Month 16, n=2347, 2481","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"2347"},{"groupId":"OG001","value":"2481"}]}],"categories":[{"measurements":[{"groupId":"OG000","value":"1.87","spread":"0.287"},{"groupId":"OG001","value":"2.39","spread":"0.279"}]}]}],"analyses":[{"groupIds":["OG000","OG001"],"nonInferiorityType":"OTHER","pValue":"<0.001","pValueComment":"P-value from a two-sided t-test to test whether the difference of least square means (Albiglutide-Placebo) is equal to zero.","statisticalMethod":"t-test, 2 sided","paramType":"Mean Difference (Net)","paramValue":"1.47","ciPctValue":"95","ciNumSides":"TWO_SIDED","ciLowerLimit":"0.87","ciUpperLimit":"2.07","estimateComment":"Based on MMRM model: Change=Baseline Score+Treatment+Visit+Treatment-by-Visit Interaction+Baseline Score-by-Visit Interaction. Difference of least squares means (Albiglutide-Placebo) is from MMRM model for Month 8."},{"groupIds":["OG000","OG001"],"nonInferiorityType":"OTHER","pValue":"0.192","pValueComment":"P-value from a two-sided t-test to test whether the difference of least square means (Albiglutide - Placebo) is equal to zero","statisticalMethod":"t-test, 2 sided","paramType":"Mean Difference (Net)","paramValue":"0.52","ciPctValue":"95","ciNumSides":"TWO_SIDED","ciLowerLimit":"-0.26","ciUpperLimit":"1.31","estimateComment":"Based on MMRM model: Change=Baseline Score+Treatment+Visit+Treatment-by-Visit Interaction+Baseline Score-by-Visit Interaction. Difference of least squares means (Albiglutide - Placebo) is from MMRM model for Month 16"}]},{"type":"SECONDARY","title":"Time to Death","description":"Time to death was analyzed using a Cox Proportional Hazards regression model with treatment group as the only covariate. The incidence rate per 100 person years (100\\*number of participants who died/endpoint person-years) is presented along with 95% confidence interval. Endpoint person-years=(cumulative total time to event for participants who have the event+cumulative total of censored time for participants without the event)/365.25, based on the Vital Status follow-up time period.","populationDescription":"ITT Population","reportingStatus":"POSTED","paramType":"NUMBER","dispersionType":"95% Confidence Interval","unitOfMeasure":"Events per 100 person years","timeFrame":"Median of 1.73 years for the Vital Status follow-up time period","groups":[{"id":"OG000","title":"Placebo","description":"Albiglutide matching placebo was administered once weekly as subcutaneous injection in the abdomen, thigh or upper arm region in addition to the standard of care therapy for diabetes and cardiovascular health."},{"id":"OG001","title":"Albiglutide","description":"Albiglutide was administered once weekly as subcutaneous injection in the abdomen, thigh or upper arm region. Participants were administered albiglutide at a dose of 30 milligrams (mg) or 50 mg once weekly in addition to the standard of care therapy for diabetes and cardiovascular health."}],"denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"4732"},{"groupId":"OG001","value":"4731"}]}],"classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"2.56","lowerLimit":"2.22","upperLimit":"2.93"},{"groupId":"OG001","value":"2.44","lowerLimit":"2.11","upperLimit":"2.81"}]}]}],"analyses":[{"groupIds":["OG000","OG001"],"nonInferiorityType":"OTHER","pValue":"0.644","pValueComment":"Two-sided p-value based on Wald test of HR=1 versus HR not equal to 1.","statisticalMethod":"Wald test","paramType":"Hazard Ratio (HR)","paramValue":"0.95","ciPctValue":"95","ciNumSides":"TWO_SIDED","ciLowerLimit":"0.79","ciUpperLimit":"1.16","estimateComment":"Hazard ratio is estimated using a Cox proportional hazard regression model with treatment as the only covariate."}]},{"type":"SECONDARY","title":"Number of Participants With Non-fatal Serious Adverse Events (SAEs)","description":"SAE is defined as any untoward medical occurrence that, at any dose: results in death; is life-threatening; requires hospitalization or prolongation of existing hospitalization; results in disability/incapacity; is a congenital anomaly/birth defect; other important medical events that may not be immediately life-threatening or result in death or hospitalization but may jeopardize the participant or may require medical or surgical intervention to prevent one of the other outcomes listed before; is associated with liver injury and impaired liver function. Number of participants with on-therapy non-fatal SAEs are presented. Safety Population comprised of all randomized participants who received at least one dose of study treatment.","populationDescription":"Safety Population","reportingStatus":"POSTED","paramType":"COUNT_OF_PARTICIPANTS","unitOfMeasure":"Participants","timeFrame":"Up to 2.7 years","groups":[{"id":"OG000","title":"Placebo","description":"Albiglutide matching placebo was administered once weekly as subcutaneous injection in the abdomen, thigh or upper arm region in addition to the standard of care therapy for diabetes and cardiovascular health."},{"id":"OG001","title":"Albiglutide","description":"Albiglutide was administered once weekly as subcutaneous injection in the abdomen, thigh or upper arm region. Participants were administered albiglutide at a dose of 30 milligrams (mg) or 50 mg once weekly in addition to the standard of care therapy for diabetes and cardiovascular health."}],"denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"4715"},{"groupId":"OG001","value":"4717"}]}],"classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"974"},{"groupId":"OG001","value":"891"}]}]}]},{"type":"SECONDARY","title":"Number of Participants With Adverse Events (AEs) Leading to Discontinuation of Investigational Product (AELD)","description":"The number of participants with on-therapy AEs leading to discontinuation of investigational product is reported.","populationDescription":"Safety Population","reportingStatus":"POSTED","paramType":"COUNT_OF_PARTICIPANTS","unitOfMeasure":"Participants","timeFrame":"Up to 2.7 years","groups":[{"id":"OG000","title":"Placebo","description":"Albiglutide matching placebo was administered once weekly as subcutaneous injection in the abdomen, thigh or upper arm region in addition to the standard of care therapy for diabetes and cardiovascular health."},{"id":"OG001","title":"Albiglutide","description":"Albiglutide was administered once weekly as subcutaneous injection in the abdomen, thigh or upper arm region. Participants were administered albiglutide at a dose of 30 milligrams (mg) or 50 mg once weekly in addition to the standard of care therapy for diabetes and cardiovascular health."}],"denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"4715"},{"groupId":"OG001","value":"4717"}]}],"classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"334"},{"groupId":"OG001","value":"427"}]}]}]},{"type":"SECONDARY","title":"Number of Participants With AEs of Special Interest","description":"The protocol defined AEs of special interest included: development of thyroid cancer; hematologic malignancy; pancreatic cancer; pancreatitis (investigator reported and pancreatitis positively adjudicated by the Pancreatic Adjudication Committee \\[PAC\\]); investigational product injection site reactions; immunological reactions; severe hypoglycemic events; hepatic events; hepatic enzyme elevations (including gamma glutamyl transferase \\[GGT\\]); serious gastrointestinal (GI) events; appendicitis; atrial fibrillation/flutter; pneumonia; worsening renal function and diabetic retinopathy. The number of participants with on-therapy AEs of special interest is reported.","populationDescription":"Safety Population","reportingStatus":"POSTED","paramType":"COUNT_OF_PARTICIPANTS","unitOfMeasure":"Participants","timeFrame":"Up to 2.7 years","groups":[{"id":"OG000","title":"Placebo","description":"Albiglutide matching placebo was administered once weekly as subcutaneous injection in the abdomen, thigh or upper arm region in addition to the standard of care therapy for diabetes and cardiovascular health."},{"id":"OG001","title":"Albiglutide","description":"Albiglutide was administered once weekly as subcutaneous injection in the abdomen, thigh or upper arm region. Participants were administered albiglutide at a dose of 30 milligrams (mg) or 50 mg once weekly in addition to the standard of care therapy for diabetes and cardiovascular health."}],"denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"4715"},{"groupId":"OG001","value":"4717"}]}],"classes":[{"title":"Thyroid cancer diagnosis","categories":[{"measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"0"}]}]},{"title":"Hematologic malignancy","categories":[{"measurements":[{"groupId":"OG000","value":"5"},{"groupId":"OG001","value":"9"}]}]},{"title":"Pancreatic cancer","categories":[{"measurements":[{"groupId":"OG000","value":"5"},{"groupId":"OG001","value":"6"}]}]},{"title":"Investigational product injection site reaction","categories":[{"measurements":[{"groupId":"OG000","value":"29"},{"groupId":"OG001","value":"86"}]}]},{"title":"Hypersensitivity","categories":[{"measurements":[{"groupId":"OG000","value":"48"},{"groupId":"OG001","value":"45"}]}]},{"title":"Severe hypoglycemic events","categories":[{"measurements":[{"groupId":"OG000","value":"55"},{"groupId":"OG001","value":"31"}]}]},{"title":"Hepatic events","categories":[{"measurements":[{"groupId":"OG000","value":"74"},{"groupId":"OG001","value":"98"}]}]},{"title":"Hepatic enzyme elevations (including GGT)","categories":[{"measurements":[{"groupId":"OG000","value":"34"},{"groupId":"OG001","value":"51"}]}]},{"title":"Serious GI Events","categories":[{"measurements":[{"groupId":"OG000","value":"87"},{"groupId":"OG001","value":"92"}]}]},{"title":"Appendicitis","categories":[{"measurements":[{"groupId":"OG000","value":"8"},{"groupId":"OG001","value":"3"}]}]},{"title":"Atrial fibrillation/atrial flutter","categories":[{"measurements":[{"groupId":"OG000","value":"131"},{"groupId":"OG001","value":"108"}]}]},{"title":"Pneumonia","categories":[{"measurements":[{"groupId":"OG000","value":"138"},{"groupId":"OG001","value":"131"}]}]},{"title":"Renal impairment","categories":[{"measurements":[{"groupId":"OG000","value":"319"},{"groupId":"OG001","value":"279"}]}]},{"title":"Diabetic retinopathy","categories":[{"measurements":[{"groupId":"OG000","value":"89"},{"groupId":"OG001","value":"78"}]}]},{"title":"Investigator-reported pancreatitis","categories":[{"measurements":[{"groupId":"OG000","value":"13"},{"groupId":"OG001","value":"14"}]}]},{"title":"Pancreatitis positively adjudicated by PAC","categories":[{"measurements":[{"groupId":"OG000","value":"7"},{"groupId":"OG001","value":"10"}]}]}]},{"type":"SECONDARY","title":"Change in Estimated Glomerular Filtration Rate (eGFR) Calculated Using Modification of Diet in Renal Disease (MDRD) Formula","description":"Blood samples were collected for the measurement of serum creatinine. Serum creatinine values were used to calculate eGFR using the MDRD formula, eGFR=175 x (serum creatinine)\\^-1.154 x (Age)\\^-0.203 x (0.742 if female) x (1.212 if African American). Baseline is the last non-missing value assessed on or before treatment start date. Change from Baseline is the value at specified time point minus the Baseline value. Change from Baseline in eGFR using Baseline data from Local or Central Laboratory, and post-Baseline Central Laboratory data for the on-treatment time period is presented.","populationDescription":"Safety Population. Only those participants with a value at Baseline and specified visit were analyzed (represented by n=X in category titles)","reportingStatus":"POSTED","paramType":"LEAST_SQUARES_MEAN","dispersionType":"Standard Error","unitOfMeasure":"Milliliter/minute/1.73 meter square","timeFrame":"Baseline and Months 8 and 16","groups":[{"id":"OG000","title":"Placebo","description":"Albiglutide matching placebo was administered once weekly as subcutaneous injection in the abdomen, thigh or upper arm region in addition to the standard of care therapy for diabetes and cardiovascular health."},{"id":"OG001","title":"Albiglutide","description":"Albiglutide was administered once weekly as subcutaneous injection in the abdomen, thigh or upper arm region. Participants were administered albiglutide at a dose of 30 milligrams (mg) or 50 mg once weekly in addition to the standard of care therapy for diabetes and cardiovascular health."}],"denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"4715"},{"groupId":"OG001","value":"4717"}]}],"classes":[{"title":"Month 8; n=3977,4008","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"3977"},{"groupId":"OG001","value":"4008"}]}],"categories":[{"measurements":[{"groupId":"OG000","value":"1.22","spread":"0.264"},{"groupId":"OG001","value":"0.10","spread":"0.262"}]}]},{"title":"Month 16; n=2354,2496","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"2354"},{"groupId":"OG001","value":"2496"}]}],"categories":[{"measurements":[{"groupId":"OG000","value":"-0.90","spread":"0.303"},{"groupId":"OG001","value":"-1.33","spread":"0.296"}]}]}],"analyses":[{"groupIds":["OG000","OG001"],"nonInferiorityType":"OTHER","pValue":"0.003","pValueComment":"P-value from a two-sided t-test to test whether the difference of least square means (Albiglutide-Placebo) is equal to zero.","statisticalMethod":"t-test, 2 sided","paramType":"Mean Difference (Net)","paramValue":"-1.11","ciPctValue":"95","ciNumSides":"TWO_SIDED","ciLowerLimit":"-1.84","ciUpperLimit":"-0.39","estimateComment":"Based on MMRM model: Change=Baseline eGFR+Treatment+Visit+Treatment-by-Visit Interaction+Baseline eGFR-by-Visit Interaction. Difference of least squares means (Albiglutide-Placebo) is from MMRM model for Month 8."},{"groupIds":["OG000","OG001"],"nonInferiorityType":"OTHER","pValue":"0.315","pValueComment":"P-value from a two-sided t-test to test whether the difference of least square means (Albiglutide-Placebo) is equal to zero","statisticalMethod":"t-test, 2 sided","paramType":"Mean Difference (Net)","paramValue":"-0.43","ciPctValue":"95","ciNumSides":"TWO_SIDED","ciLowerLimit":"-1.26","ciUpperLimit":"0.41","estimateComment":"Based on MMRM model: Change=Baseline eGFR+Treatment+Visit+Treatment-by-Visit Interaction+Baseline eGFR-by-Visit Interaction. Difference of least squares means (Albiglutide-Placebo) is from MMRM model for Month 16."}]},{"type":"SECONDARY","title":"Change From Baseline in Blood Pressure","description":"Systolic blood pressure (SBP) and diastolic blood pressure (DBP) were taken with the participant in a semi-recumbent or seated position after at least a 5-minute rest period. Baseline is the last non-missing value assessed on or before treatment start date. Change from Baseline is the value at specified time point minus the Baseline value.","populationDescription":"Safety Population. Only those participants with a value at Baseline and specified visit were analyzed (represented n=X in category titles)","reportingStatus":"POSTED","paramType":"MEAN","dispersionType":"Standard Deviation","unitOfMeasure":"Millimeter of mercury","timeFrame":"Baseline and Months 8,16,24 and end of study (up to 2.7 years)","groups":[{"id":"OG000","title":"Placebo","description":"Albiglutide matching placebo was administered once weekly as subcutaneous injection in the abdomen, thigh or upper arm region in addition to the standard of care therapy for diabetes and cardiovascular health."},{"id":"OG001","title":"Albiglutide","description":"Albiglutide was administered once weekly as subcutaneous injection in the abdomen, thigh or upper arm region. Participants were administered albiglutide at a dose of 30 milligrams (mg) or 50 mg once weekly in addition to the standard of care therapy for diabetes and cardiovascular health."}],"denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"4715"},{"groupId":"OG001","value":"4717"}]}],"classes":[{"title":"SBP, Month 8; n=4241, 4319","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"4241"},{"groupId":"OG001","value":"4319"}]}],"categories":[{"measurements":[{"groupId":"OG000","value":"-0.5","spread":"17.33"},{"groupId":"OG001","value":"-1.0","spread":"16.80"}]}]},{"title":"SBP, Month 16; n=3082, 3187","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"3082"},{"groupId":"OG001","value":"3187"}]}],"categories":[{"measurements":[{"groupId":"OG000","value":"-0.5","spread":"17.45"},{"groupId":"OG001","value":"-0.9","spread":"17.58"}]}]},{"title":"SBP, Month 24; n=1133, 1198","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"1133"},{"groupId":"OG001","value":"1198"}]}],"categories":[{"measurements":[{"groupId":"OG000","value":"-0.9","spread":"18.62"},{"groupId":"OG001","value":"-1.2","spread":"17.51"}]}]},{"title":"SBP, End of study; n=3897, 4015","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"3897"},{"groupId":"OG001","value":"4015"}]}],"categories":[{"measurements":[{"groupId":"OG000","value":"0.0","spread":"17.68"},{"groupId":"OG001","value":"-0.4","spread":"17.58"}]}]},{"title":"DBP, Month 8; n=4241, 4319","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"4241"},{"groupId":"OG001","value":"4319"}]}],"categories":[{"measurements":[{"groupId":"OG000","value":"-0.5","spread":"10.26"},{"groupId":"OG001","value":"-0.4","spread":"10.12"}]}]},{"title":"DBP, Month 16; n=3082, 3187","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"3082"},{"groupId":"OG001","value":"3187"}]}],"categories":[{"measurements":[{"groupId":"OG000","value":"-0.9","spread":"10.74"},{"groupId":"OG001","value":"-0.5","spread":"10.39"}]}]},{"title":"DBP, Month 24; n=1133, 1198","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"1133"},{"groupId":"OG001","value":"1198"}]}],"categories":[{"measurements":[{"groupId":"OG000","value":"-1.1","spread":"10.87"},{"groupId":"OG001","value":"-1.0","spread":"10.29"}]}]},{"title":"DBP, End of study; n=3897, 4015","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"3897"},{"groupId":"OG001","value":"4015"}]}],"categories":[{"measurements":[{"groupId":"OG000","value":"-0.7","spread":"10.66"},{"groupId":"OG001","value":"-0.6","spread":"10.57"}]}]}]},{"type":"SECONDARY","title":"Change From Baseline in Heart Rate","description":"Heart rate was measured with the participant in a semi-recumbent or seated position after at least a 5-minute rest period. Baseline is the last non-missing value assessed on or before treatment start date. Change from Baseline is the value at specified time point minus the Baseline value.","populationDescription":"Safety Population. Only those participants with a value at Baseline and specified visit were analyzed (represented n=X in category titles)","reportingStatus":"POSTED","paramType":"MEAN","dispersionType":"Standard Deviation","unitOfMeasure":"Beats per minute","timeFrame":"Baseline and Months 8, 16, 24 and end of study (up to 2.7 years)","groups":[{"id":"OG000","title":"Placebo","description":"Albiglutide matching placebo was administered once weekly as subcutaneous injection in the abdomen, thigh or upper arm region in addition to the standard of care therapy for diabetes and cardiovascular health."},{"id":"OG001","title":"Albiglutide","description":"Albiglutide was administered once weekly as subcutaneous injection in the abdomen, thigh or upper arm region. Participants were administered albiglutide at a dose of 30 milligrams (mg) or 50 mg once weekly in addition to the standard of care therapy for diabetes and cardiovascular health."}],"denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"4715"},{"groupId":"OG001","value":"4717"}]}],"classes":[{"title":"Month 8; n=4239, 4312","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"4239"},{"groupId":"OG001","value":"4312"}]}],"categories":[{"measurements":[{"groupId":"OG000","value":"0.2","spread":"9.99"},{"groupId":"OG001","value":"1.6","spread":"10.07"}]}]},{"title":"Month 16; n=3078, 3181","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"3078"},{"groupId":"OG001","value":"3181"}]}],"categories":[{"measurements":[{"groupId":"OG000","value":"0.3","spread":"10.19"},{"groupId":"OG001","value":"1.6","spread":"10.16"}]}]},{"title":"Month 24; n=1131, 1195","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"1131"},{"groupId":"OG001","value":"1195"}]}],"categories":[{"measurements":[{"groupId":"OG000","value":"0.6","spread":"10.84"},{"groupId":"OG001","value":"1.7","spread":"10.32"}]}]},{"title":"End of study; n=3892, 4005","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"3892"},{"groupId":"OG001","value":"4005"}]}],"categories":[{"measurements":[{"groupId":"OG000","value":"0.8","spread":"10.64"},{"groupId":"OG001","value":"1.8","spread":"10.50"}]}]}]}]},"adverseEventsModule":{"frequencyThreshold":"5","timeFrame":"On-therapy non-SAEs and SAEs were reported on or after treatment start date and within 56 days after treatment stop date (Up to 2.7 years)","description":"SAEs, non-SAELDs and non-SAEs of pre-specified interest were reported systematically in the Safety Population. Some investigators collected other non-SAEs for some participants (i.e. non-systematically). CV events referred for adjudication as study endpoints were not duplicate reported as AEs. Deaths were reported for ITT Population.","eventGroups":[{"id":"EG000","title":"Albiglutide","description":"Albiglutide was administered once weekly as subcutaneous injection in the abdomen, thigh or upper arm region. Participants were administered albiglutide at a dose of 30 milligrams (mg) or 50 mg once weekly in addition to the standard of care therapy for diabetes and cardiovascular health..","deathsNumAffected":196,"deathsNumAtRisk":4731,"seriousNumAffected":932,"seriousNumAtRisk":4717,"otherNumAffected":0,"otherNumAtRisk":4717},{"id":"EG001","title":"Placebo","description":"Albiglutide matching placebo was administered once weekly as subcutaneous injection in the abdomen, thigh or upper arm region in addition to the standard of care therapy for diabetes and cardiovascular health.","deathsNumAffected":205,"deathsNumAtRisk":4732,"seriousNumAffected":1022,"seriousNumAtRisk":4715,"otherNumAffected":0,"otherNumAtRisk":4715}],"seriousEvents":[{"term":"Pneumonia","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA 21.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":79,"numAffected":74,"numAtRisk":4717},{"groupId":"EG001","numEvents":81,"numAffected":77,"numAtRisk":4715}]},{"term":"Acute kidney injury","organSystem":"Renal and urinary disorders","sourceVocabulary":"MedDRA 21.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":46,"numAffected":42,"numAtRisk":4717},{"groupId":"EG001","numEvents":52,"numAffected":47,"numAtRisk":4715}]},{"term":"Atrial fibrillation","organSystem":"Cardiac disorders","sourceVocabulary":"MedDRA 21.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":48,"numAffected":45,"numAtRisk":4717},{"groupId":"EG001","numEvents":47,"numAffected":41,"numAtRisk":4715}]},{"term":"Peripheral arterial occlusive disease","organSystem":"Vascular disorders","sourceVocabulary":"MedDRA 21.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":37,"numAffected":33,"numAtRisk":4717},{"groupId":"EG001","numEvents":48,"numAffected":41,"numAtRisk":4715}]},{"term":"Angina pectoris","organSystem":"Cardiac disorders","sourceVocabulary":"MedDRA 21.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":38,"numAffected":37,"numAtRisk":4717},{"groupId":"EG001","numEvents":39,"numAffected":36,"numAtRisk":4715}]},{"term":"Coronary artery disease","organSystem":"Cardiac disorders","sourceVocabulary":"MedDRA 21.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":24,"numAffected":24,"numAtRisk":4717},{"groupId":"EG001","numEvents":31,"numAffected":31,"numAtRisk":4715}]},{"term":"Sepsis","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA 21.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":23,"numAffected":23,"numAtRisk":4717},{"groupId":"EG001","numEvents":29,"numAffected":28,"numAtRisk":4715}]},{"term":"Urinary tract infection","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA 21.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":27,"numAffected":26,"numAtRisk":4717},{"groupId":"EG001","numEvents":27,"numAffected":23,"numAtRisk":4715}]},{"term":"Hyperglycaemia","organSystem":"Metabolism and nutrition disorders","sourceVocabulary":"MedDRA 21.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":16,"numAffected":16,"numAtRisk":4717},{"groupId":"EG001","numEvents":42,"numAffected":30,"numAtRisk":4715}]},{"term":"Chronic obstructive pulmonary disease","organSystem":"Respiratory, thoracic and mediastinal disorders","sourceVocabulary":"MedDRA 21.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":30,"numAffected":21,"numAtRisk":4717},{"groupId":"EG001","numEvents":33,"numAffected":21,"numAtRisk":4715}]},{"term":"Hypoglycaemia","organSystem":"Metabolism and nutrition disorders","sourceVocabulary":"MedDRA 21.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":12,"numAffected":12,"numAtRisk":4717},{"groupId":"EG001","numEvents":34,"numAffected":30,"numAtRisk":4715}]},{"term":"Cellulitis","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA 21.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":22,"numAffected":20,"numAtRisk":4717},{"groupId":"EG001","numEvents":20,"numAffected":20,"numAtRisk":4715}]},{"term":"Non-cardiac chest pain","organSystem":"General disorders","sourceVocabulary":"MedDRA 21.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":19,"numAffected":15,"numAtRisk":4717},{"groupId":"EG001","numEvents":23,"numAffected":22,"numAtRisk":4715}]},{"term":"Diabetic foot","organSystem":"Skin and subcutaneous tissue disorders","sourceVocabulary":"MedDRA 21.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":16,"numAffected":14,"numAtRisk":4717},{"groupId":"EG001","numEvents":26,"numAffected":22,"numAtRisk":4715}]},{"term":"Renal impairment","organSystem":"Renal and urinary disorders","sourceVocabulary":"MedDRA 21.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":17,"numAffected":17,"numAtRisk":4717},{"groupId":"EG001","numEvents":13,"numAffected":12,"numAtRisk":4715}]},{"term":"Syncope","organSystem":"Nervous system disorders","sourceVocabulary":"MedDRA 21.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":17,"numAffected":14,"numAtRisk":4717},{"groupId":"EG001","numEvents":15,"numAffected":13,"numAtRisk":4715}]},{"term":"Death","organSystem":"General disorders","sourceVocabulary":"MedDRA 21.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":10,"numAffected":10,"numAtRisk":4717},{"groupId":"EG001","numEvents":14,"numAffected":14,"numAtRisk":4715}]},{"term":"Hypertension","organSystem":"Vascular disorders","sourceVocabulary":"MedDRA 21.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":12,"numAffected":11,"numAtRisk":4717},{"groupId":"EG001","numEvents":12,"numAffected":12,"numAtRisk":4715}]},{"term":"Osteoarthritis","organSystem":"Musculoskeletal and connective tissue disorders","sourceVocabulary":"MedDRA 21.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":9,"numAffected":7,"numAtRisk":4717},{"groupId":"EG001","numEvents":16,"numAffected":16,"numAtRisk":4715}]},{"term":"Acute respiratory failure","organSystem":"Respiratory, thoracic and mediastinal disorders","sourceVocabulary":"MedDRA 21.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":7,"numAffected":7,"numAtRisk":4717},{"groupId":"EG001","numEvents":16,"numAffected":14,"numAtRisk":4715}]},{"term":"Bronchitis","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA 21.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":10,"numAffected":10,"numAtRisk":4717},{"groupId":"EG001","numEvents":12,"numAffected":11,"numAtRisk":4715}]},{"term":"Erysipelas","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA 21.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":9,"numAffected":9,"numAtRisk":4717},{"groupId":"EG001","numEvents":14,"numAffected":12,"numAtRisk":4715}]},{"term":"Atrial flutter","organSystem":"Cardiac disorders","sourceVocabulary":"MedDRA 21.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":6,"numAffected":6,"numAtRisk":4717},{"groupId":"EG001","numEvents":15,"numAffected":14,"numAtRisk":4715}]},{"term":"Osteomyelitis","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA 21.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":6,"numAffected":6,"numAtRisk":4717},{"groupId":"EG001","numEvents":14,"numAffected":14,"numAtRisk":4715}]},{"term":"Peripheral ischaemia","organSystem":"Vascular disorders","sourceVocabulary":"MedDRA 21.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":11,"numAffected":7,"numAtRisk":4717},{"groupId":"EG001","numEvents":13,"numAffected":13,"numAtRisk":4715}]},{"term":"Cholelithiasis","organSystem":"Hepatobiliary disorders","sourceVocabulary":"MedDRA 21.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":12,"numAffected":12,"numAtRisk":4717},{"groupId":"EG001","numEvents":7,"numAffected":7,"numAtRisk":4715}]},{"term":"Gangrene","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA 21.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":6,"numAffected":6,"numAtRisk":4717},{"groupId":"EG001","numEvents":14,"numAffected":13,"numAtRisk":4715}]},{"term":"Hypertensive crisis","organSystem":"Vascular disorders","sourceVocabulary":"MedDRA 21.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":8,"numAffected":8,"numAtRisk":4717},{"groupId":"EG001","numEvents":11,"numAffected":11,"numAtRisk":4715}]},{"term":"Chest pain","organSystem":"General disorders","sourceVocabulary":"MedDRA 21.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":8,"numAffected":8,"numAtRisk":4717},{"groupId":"EG001","numEvents":10,"numAffected":10,"numAtRisk":4715}]},{"term":"Gastrointestinal haemorrhage","organSystem":"Gastrointestinal disorders","sourceVocabulary":"MedDRA 21.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":12,"numAffected":8,"numAtRisk":4717},{"groupId":"EG001","numEvents":10,"numAffected":10,"numAtRisk":4715}]},{"term":"Anaemia","organSystem":"Blood and lymphatic system disorders","sourceVocabulary":"MedDRA 21.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":8,"numAffected":7,"numAtRisk":4717},{"groupId":"EG001","numEvents":10,"numAffected":10,"numAtRisk":4715}]},{"term":"Diabetes mellitus inadequate control","organSystem":"Metabolism and nutrition disorders","sourceVocabulary":"MedDRA 21.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":4,"numAffected":4,"numAtRisk":4717},{"groupId":"EG001","numEvents":13,"numAffected":13,"numAtRisk":4715}]},{"term":"Hypotension","organSystem":"Vascular disorders","sourceVocabulary":"MedDRA 21.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":10,"numAffected":10,"numAtRisk":4717},{"groupId":"EG001","numEvents":7,"numAffected":7,"numAtRisk":4715}]},{"term":"Prostate cancer","organSystem":"Neoplasms benign, malignant and unspecified (incl cysts and polyps)","sourceVocabulary":"MedDRA 21.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":5,"numAffected":5,"numAtRisk":4717},{"groupId":"EG001","numEvents":12,"numAffected":12,"numAtRisk":4715}]},{"term":"Atrioventricular block complete","organSystem":"Cardiac disorders","sourceVocabulary":"MedDRA 21.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":11,"numAffected":11,"numAtRisk":4717},{"groupId":"EG001","numEvents":5,"numAffected":5,"numAtRisk":4715}]},{"term":"Carotid artery stenosis","organSystem":"Nervous system disorders","sourceVocabulary":"MedDRA 21.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":11,"numAffected":9,"numAtRisk":4717},{"groupId":"EG001","numEvents":7,"numAffected":7,"numAtRisk":4715}]},{"term":"Gastroenteritis","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA 21.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":8,"numAffected":8,"numAtRisk":4717},{"groupId":"EG001","numEvents":8,"numAffected":8,"numAtRisk":4715}]},{"term":"Peripheral vascular disorder","organSystem":"Vascular disorders","sourceVocabulary":"MedDRA 21.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":3,"numAffected":3,"numAtRisk":4717},{"groupId":"EG001","numEvents":19,"numAffected":13,"numAtRisk":4715}]},{"term":"Renal failure","organSystem":"Renal and urinary disorders","sourceVocabulary":"MedDRA 21.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":10,"numAffected":9,"numAtRisk":4717},{"groupId":"EG001","numEvents":7,"numAffected":7,"numAtRisk":4715}]},{"term":"Respiratory failure","organSystem":"Respiratory, thoracic and mediastinal disorders","sourceVocabulary":"MedDRA 21.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":10,"numAffected":10,"numAtRisk":4717},{"groupId":"EG001","numEvents":6,"numAffected":6,"numAtRisk":4715}]},{"term":"Skin ulcer","organSystem":"Skin and subcutaneous tissue disorders","sourceVocabulary":"MedDRA 21.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":9,"numAffected":9,"numAtRisk":4717},{"groupId":"EG001","numEvents":7,"numAffected":7,"numAtRisk":4715}]},{"term":"Ventricular tachycardia","organSystem":"Cardiac disorders","sourceVocabulary":"MedDRA 21.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":7,"numAffected":6,"numAtRisk":4717},{"groupId":"EG001","numEvents":10,"numAffected":9,"numAtRisk":4715}]},{"term":"Cardiac failure","organSystem":"Cardiac disorders","sourceVocabulary":"MedDRA 21.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":10,"numAffected":10,"numAtRisk":4717},{"groupId":"EG001","numEvents":4,"numAffected":4,"numAtRisk":4715}]},{"term":"Pleural effusion","organSystem":"Respiratory, thoracic and mediastinal disorders","sourceVocabulary":"MedDRA 21.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":5,"numAffected":4,"numAtRisk":4717},{"groupId":"EG001","numEvents":11,"numAffected":10,"numAtRisk":4715}]},{"term":"Urosepsis","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA 21.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":6,"numAffected":6,"numAtRisk":4717},{"groupId":"EG001","numEvents":8,"numAffected":8,"numAtRisk":4715}]},{"term":"Cardiogenic shock","organSystem":"Cardiac disorders","sourceVocabulary":"MedDRA 21.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":9,"numAffected":9,"numAtRisk":4717},{"groupId":"EG001","numEvents":4,"numAffected":4,"numAtRisk":4715}]},{"term":"Diabetic foot infection","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA 21.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":6,"numAffected":4,"numAtRisk":4717},{"groupId":"EG001","numEvents":9,"numAffected":9,"numAtRisk":4715}]},{"term":"Fall","organSystem":"Injury, poisoning and procedural complications","sourceVocabulary":"MedDRA 21.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":8,"numAffected":7,"numAtRisk":4717},{"groupId":"EG001","numEvents":7,"numAffected":6,"numAtRisk":4715}]},{"term":"Gastritis","organSystem":"Gastrointestinal disorders","sourceVocabulary":"MedDRA 21.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":5,"numAffected":5,"numAtRisk":4717},{"groupId":"EG001","numEvents":8,"numAffected":8,"numAtRisk":4715}]},{"term":"Myocardial ischaemia","organSystem":"Cardiac disorders","sourceVocabulary":"MedDRA 21.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":6,"numAffected":6,"numAtRisk":4717},{"groupId":"EG001","numEvents":7,"numAffected":7,"numAtRisk":4715}]},{"term":"Bradycardia","organSystem":"Cardiac disorders","sourceVocabulary":"MedDRA 21.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":8,"numAffected":8,"numAtRisk":4717},{"groupId":"EG001","numEvents":4,"numAffected":4,"numAtRisk":4715}]},{"term":"Cardiac failure congestive","organSystem":"Cardiac disorders","sourceVocabulary":"MedDRA 21.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":3,"numAffected":3,"numAtRisk":4717},{"groupId":"EG001","numEvents":10,"numAffected":9,"numAtRisk":4715}]},{"term":"Cataract","organSystem":"Eye disorders","sourceVocabulary":"MedDRA 21.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":7,"numAffected":7,"numAtRisk":4717},{"groupId":"EG001","numEvents":6,"numAffected":5,"numAtRisk":4715}]},{"term":"Cholecystitis","organSystem":"Hepatobiliary disorders","sourceVocabulary":"MedDRA 21.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":7,"numAffected":7,"numAtRisk":4717},{"groupId":"EG001","numEvents":5,"numAffected":5,"numAtRisk":4715}]},{"term":"Chronic kidney disease","organSystem":"Renal and urinary disorders","sourceVocabulary":"MedDRA 21.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":5,"numAffected":5,"numAtRisk":4717},{"groupId":"EG001","numEvents":7,"numAffected":7,"numAtRisk":4715}]},{"term":"Dehydration","organSystem":"Metabolism and nutrition disorders","sourceVocabulary":"MedDRA 21.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":3,"numAffected":3,"numAtRisk":4717},{"groupId":"EG001","numEvents":9,"numAffected":9,"numAtRisk":4715}]},{"term":"Extremity necrosis","organSystem":"Vascular disorders","sourceVocabulary":"MedDRA 21.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":7,"numAffected":7,"numAtRisk":4717},{"groupId":"EG001","numEvents":6,"numAffected":5,"numAtRisk":4715}]},{"term":"Multiple organ dysfunction syndrome","organSystem":"General disorders","sourceVocabulary":"MedDRA 21.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":6,"numAffected":6,"numAtRisk":4717},{"groupId":"EG001","numEvents":6,"numAffected":6,"numAtRisk":4715}]},{"term":"Pulmonary oedema","organSystem":"Respiratory, thoracic and mediastinal disorders","sourceVocabulary":"MedDRA 21.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":5,"numAffected":5,"numAtRisk":4717},{"groupId":"EG001","numEvents":9,"numAffected":7,"numAtRisk":4715}]},{"term":"Cholecystitis acute","organSystem":"Hepatobiliary disorders","sourceVocabulary":"MedDRA 21.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":7,"numAffected":7,"numAtRisk":4717},{"groupId":"EG001","numEvents":4,"numAffected":4,"numAtRisk":4715}]},{"term":"Deep vein thrombosis","organSystem":"Vascular disorders","sourceVocabulary":"MedDRA 21.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":9,"numAffected":9,"numAtRisk":4717},{"groupId":"EG001","numEvents":2,"numAffected":2,"numAtRisk":4715}]},{"term":"Diabetic ketoacidosis","organSystem":"Metabolism and nutrition disorders","sourceVocabulary":"MedDRA 21.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":5,"numAffected":5,"numAtRisk":4717},{"groupId":"EG001","numEvents":6,"numAffected":6,"numAtRisk":4715}]},{"term":"Lung neoplasm malignant","organSystem":"Neoplasms benign, malignant and unspecified (incl cysts and polyps)","sourceVocabulary":"MedDRA 21.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":9,"numAffected":9,"numAtRisk":4717},{"groupId":"EG001","numEvents":2,"numAffected":2,"numAtRisk":4715}]},{"term":"Septic shock","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA 21.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":4,"numAffected":4,"numAtRisk":4717},{"groupId":"EG001","numEvents":7,"numAffected":7,"numAtRisk":4715}]},{"term":"Cardio-respiratory arrest","organSystem":"Cardiac disorders","sourceVocabulary":"MedDRA 21.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":5,"numAffected":5,"numAtRisk":4717},{"groupId":"EG001","numEvents":6,"numAffected":5,"numAtRisk":4715}]},{"term":"Diabetic metabolic decompensation","organSystem":"Metabolism and nutrition disorders","sourceVocabulary":"MedDRA 21.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":2,"numAffected":2,"numAtRisk":4717},{"groupId":"EG001","numEvents":9,"numAffected":8,"numAtRisk":4715}]},{"term":"Hyperkalaemia","organSystem":"Metabolism and nutrition disorders","sourceVocabulary":"MedDRA 21.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":5,"numAffected":5,"numAtRisk":4717},{"groupId":"EG001","numEvents":5,"numAffected":5,"numAtRisk":4715}]},{"term":"Musculoskeletal chest pain","organSystem":"Musculoskeletal and connective tissue disorders","sourceVocabulary":"MedDRA 21.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":6,"numAffected":4,"numAtRisk":4717},{"groupId":"EG001","numEvents":6,"numAffected":6,"numAtRisk":4715}]},{"term":"Orthostatic hypotension","organSystem":"Vascular disorders","sourceVocabulary":"MedDRA 21.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":5,"numAffected":4,"numAtRisk":4717},{"groupId":"EG001","numEvents":6,"numAffected":6,"numAtRisk":4715}]},{"term":"Postoperative wound infection","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA 21.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":6,"numAffected":6,"numAtRisk":4717},{"groupId":"EG001","numEvents":4,"numAffected":4,"numAtRisk":4715}]},{"term":"Pulmonary embolism","organSystem":"Respiratory, thoracic and mediastinal disorders","sourceVocabulary":"MedDRA 21.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":6,"numAffected":6,"numAtRisk":4717},{"groupId":"EG001","numEvents":4,"numAffected":4,"numAtRisk":4715}]},{"term":"Respiratory tract infection","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA 21.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":5,"numAffected":5,"numAtRisk":4717},{"groupId":"EG001","numEvents":5,"numAffected":5,"numAtRisk":4715}]},{"term":"Small intestinal obstruction","organSystem":"Gastrointestinal disorders","sourceVocabulary":"MedDRA 21.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":5,"numAffected":5,"numAtRisk":4717},{"groupId":"EG001","numEvents":6,"numAffected":5,"numAtRisk":4715}]},{"term":"Type 2 diabetes mellitus","organSystem":"Metabolism and nutrition disorders","sourceVocabulary":"MedDRA 21.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":4,"numAffected":4,"numAtRisk":4717},{"groupId":"EG001","numEvents":6,"numAffected":6,"numAtRisk":4715}]},{"term":"Appendicitis","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA 21.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":2,"numAffected":2,"numAtRisk":4717},{"groupId":"EG001","numEvents":7,"numAffected":7,"numAtRisk":4715}]},{"term":"Arteriosclerosis coronary artery","organSystem":"Cardiac disorders","sourceVocabulary":"MedDRA 21.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":4,"numAffected":4,"numAtRisk":4717},{"groupId":"EG001","numEvents":5,"numAffected":5,"numAtRisk":4715}]},{"term":"Benign prostatic hyperplasia","organSystem":"Reproductive system and breast disorders","sourceVocabulary":"MedDRA 21.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":3,"numAffected":3,"numAtRisk":4717},{"groupId":"EG001","numEvents":6,"numAffected":6,"numAtRisk":4715}]},{"term":"Breast cancer","organSystem":"Neoplasms benign, malignant and unspecified (incl cysts and polyps)","sourceVocabulary":"MedDRA 21.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":4,"numAffected":4,"numAtRisk":4717},{"groupId":"EG001","numEvents":5,"numAffected":5,"numAtRisk":4715}]},{"term":"Cardiac arrest","organSystem":"Cardiac disorders","sourceVocabulary":"MedDRA 21.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":4,"numAffected":4,"numAtRisk":4717},{"groupId":"EG001","numEvents":5,"numAffected":5,"numAtRisk":4715}]},{"term":"Coronary artery stenosis","organSystem":"Cardiac disorders","sourceVocabulary":"MedDRA 21.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":3,"numAffected":3,"numAtRisk":4717},{"groupId":"EG001","numEvents":6,"numAffected":6,"numAtRisk":4715}]},{"term":"Dyspnoea","organSystem":"Respiratory, thoracic and mediastinal disorders","sourceVocabulary":"MedDRA 21.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":5,"numAffected":5,"numAtRisk":4717},{"groupId":"EG001","numEvents":4,"numAffected":4,"numAtRisk":4715}]},{"term":"Pancreatitis acute","organSystem":"Gastrointestinal disorders","sourceVocabulary":"MedDRA 21.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":7,"numAffected":6,"numAtRisk":4717},{"groupId":"EG001","numEvents":3,"numAffected":3,"numAtRisk":4715}]},{"term":"Peripheral artery stenosis","organSystem":"Vascular disorders","sourceVocabulary":"MedDRA 21.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":6,"numAffected":4,"numAtRisk":4717},{"groupId":"EG001","numEvents":6,"numAffected":5,"numAtRisk":4715}]},{"term":"Acute pulmonary oedema","organSystem":"Respiratory, thoracic and mediastinal disorders","sourceVocabulary":"MedDRA 21.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":4,"numAffected":3,"numAtRisk":4717},{"groupId":"EG001","numEvents":5,"numAffected":5,"numAtRisk":4715}]},{"term":"Aortic stenosis","organSystem":"Vascular disorders","sourceVocabulary":"MedDRA 21.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":4,"numAffected":4,"numAtRisk":4717},{"groupId":"EG001","numEvents":4,"numAffected":4,"numAtRisk":4715}]},{"term":"Asthenia","organSystem":"General disorders","sourceVocabulary":"MedDRA 21.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":4,"numAffected":4,"numAtRisk":4717},{"groupId":"EG001","numEvents":4,"numAffected":4,"numAtRisk":4715}]},{"term":"Bladder cancer","organSystem":"Neoplasms benign, malignant and unspecified (incl cysts and polyps)","sourceVocabulary":"MedDRA 21.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":4717},{"groupId":"EG001","numEvents":7,"numAffected":7,"numAtRisk":4715}]},{"term":"Diabetes mellitus","organSystem":"Metabolism and nutrition disorders","sourceVocabulary":"MedDRA 21.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":2,"numAffected":2,"numAtRisk":4717},{"groupId":"EG001","numEvents":6,"numAffected":6,"numAtRisk":4715}]},{"term":"Haematuria","organSystem":"Renal and urinary disorders","sourceVocabulary":"MedDRA 21.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":5,"numAffected":5,"numAtRisk":4717},{"groupId":"EG001","numEvents":3,"numAffected":3,"numAtRisk":4715}]},{"term":"Hip fracture","organSystem":"Injury, poisoning and procedural complications","sourceVocabulary":"MedDRA 21.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":6,"numAffected":6,"numAtRisk":4717},{"groupId":"EG001","numEvents":2,"numAffected":2,"numAtRisk":4715}]},{"term":"Influenza","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA 21.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":3,"numAffected":3,"numAtRisk":4717},{"groupId":"EG001","numEvents":5,"numAffected":5,"numAtRisk":4715}]},{"term":"Inguinal hernia","organSystem":"Gastrointestinal disorders","sourceVocabulary":"MedDRA 21.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":6,"numAffected":6,"numAtRisk":4717},{"groupId":"EG001","numEvents":2,"numAffected":2,"numAtRisk":4715}]},{"term":"Iron deficiency anaemia","organSystem":"Blood and lymphatic system disorders","sourceVocabulary":"MedDRA 21.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":5,"numAffected":5,"numAtRisk":4717},{"groupId":"EG001","numEvents":3,"numAffected":3,"numAtRisk":4715}]},{"term":"Lumbar spinal stenosis","organSystem":"Musculoskeletal and connective tissue disorders","sourceVocabulary":"MedDRA 21.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":4,"numAffected":4,"numAtRisk":4717},{"groupId":"EG001","numEvents":4,"numAffected":4,"numAtRisk":4715}]},{"term":"Nephrolithiasis","organSystem":"Renal and urinary disorders","sourceVocabulary":"MedDRA 21.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":2,"numAffected":2,"numAtRisk":4717},{"groupId":"EG001","numEvents":6,"numAffected":6,"numAtRisk":4715}]},{"term":"Peripheral artery occlusion","organSystem":"Vascular disorders","sourceVocabulary":"MedDRA 21.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":2,"numAffected":2,"numAtRisk":4717},{"groupId":"EG001","numEvents":6,"numAffected":6,"numAtRisk":4715}]},{"term":"Presyncope","organSystem":"Nervous system disorders","sourceVocabulary":"MedDRA 21.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":5,"numAffected":5,"numAtRisk":4717},{"groupId":"EG001","numEvents":3,"numAffected":3,"numAtRisk":4715}]},{"term":"Rotator cuff syndrome","organSystem":"Musculoskeletal and connective tissue disorders","sourceVocabulary":"MedDRA 21.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":6,"numAffected":6,"numAtRisk":4717},{"groupId":"EG001","numEvents":2,"numAffected":2,"numAtRisk":4715}]},{"term":"Sinus node dysfunction","organSystem":"Cardiac disorders","sourceVocabulary":"MedDRA 21.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":2,"numAffected":2,"numAtRisk":4717},{"groupId":"EG001","numEvents":6,"numAffected":6,"numAtRisk":4715}]},{"term":"Adenocarcinoma of colon","organSystem":"Neoplasms benign, malignant and unspecified (incl cysts and polyps)","sourceVocabulary":"MedDRA 21.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":2,"numAffected":2,"numAtRisk":4717},{"groupId":"EG001","numEvents":5,"numAffected":5,"numAtRisk":4715}]},{"term":"Aortic aneurysm","organSystem":"Vascular disorders","sourceVocabulary":"MedDRA 21.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":4,"numAffected":4,"numAtRisk":4717},{"groupId":"EG001","numEvents":3,"numAffected":3,"numAtRisk":4715}]},{"term":"Asthma","organSystem":"Respiratory, thoracic and mediastinal disorders","sourceVocabulary":"MedDRA 21.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":2,"numAffected":2,"numAtRisk":4717},{"groupId":"EG001","numEvents":6,"numAffected":5,"numAtRisk":4715}]},{"term":"Atrioventricular block second degree","organSystem":"Cardiac disorders","sourceVocabulary":"MedDRA 21.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":3,"numAffected":3,"numAtRisk":4717},{"groupId":"EG001","numEvents":4,"numAffected":4,"numAtRisk":4715}]},{"term":"Back pain","organSystem":"Musculoskeletal and connective tissue disorders","sourceVocabulary":"MedDRA 21.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":4,"numAffected":4,"numAtRisk":4717},{"groupId":"EG001","numEvents":4,"numAffected":3,"numAtRisk":4715}]},{"term":"Colitis","organSystem":"Gastrointestinal disorders","sourceVocabulary":"MedDRA 21.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":3,"numAffected":3,"numAtRisk":4717},{"groupId":"EG001","numEvents":4,"numAffected":4,"numAtRisk":4715}]},{"term":"Glaucoma","organSystem":"Eye disorders","sourceVocabulary":"MedDRA 21.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":4717},{"groupId":"EG001","numEvents":6,"numAffected":6,"numAtRisk":4715}]},{"term":"Localised infection","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA 21.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":3,"numAffected":3,"numAtRisk":4717},{"groupId":"EG001","numEvents":4,"numAffected":4,"numAtRisk":4715}]},{"term":"Pneumonia aspiration","organSystem":"Respiratory, thoracic and mediastinal disorders","sourceVocabulary":"MedDRA 21.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":4,"numAffected":4,"numAtRisk":4717},{"groupId":"EG001","numEvents":3,"numAffected":3,"numAtRisk":4715}]},{"term":"Road traffic accident","organSystem":"Injury, poisoning and procedural complications","sourceVocabulary":"MedDRA 21.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":3,"numAffected":3,"numAtRisk":4717},{"groupId":"EG001","numEvents":4,"numAffected":4,"numAtRisk":4715}]},{"term":"Upper gastrointestinal haemorrhage","organSystem":"Gastrointestinal disorders","sourceVocabulary":"MedDRA 21.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":4,"numAffected":4,"numAtRisk":4717},{"groupId":"EG001","numEvents":4,"numAffected":3,"numAtRisk":4715}]},{"term":"Upper limb fracture","organSystem":"Injury, poisoning and procedural complications","sourceVocabulary":"MedDRA 21.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":4,"numAffected":4,"numAtRisk":4717},{"groupId":"EG001","numEvents":3,"numAffected":3,"numAtRisk":4715}]},{"term":"Ureterolithiasis","organSystem":"Renal and urinary disorders","sourceVocabulary":"MedDRA 21.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":3,"numAffected":3,"numAtRisk":4717},{"groupId":"EG001","numEvents":4,"numAffected":4,"numAtRisk":4715}]},{"term":"Ventricular fibrillation","organSystem":"Cardiac disorders","sourceVocabulary":"MedDRA 21.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":4,"numAffected":4,"numAtRisk":4717},{"groupId":"EG001","numEvents":3,"numAffected":3,"numAtRisk":4715}]},{"term":"Vertigo","organSystem":"Ear and labyrinth disorders","sourceVocabulary":"MedDRA 21.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":2,"numAffected":2,"numAtRisk":4717},{"groupId":"EG001","numEvents":6,"numAffected":5,"numAtRisk":4715}]},{"term":"Vitreous haemorrhage","organSystem":"Eye disorders","sourceVocabulary":"MedDRA 21.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":5,"numAffected":5,"numAtRisk":4717},{"groupId":"EG001","numEvents":2,"numAffected":2,"numAtRisk":4715}]},{"term":"Abdominal pain","organSystem":"Gastrointestinal disorders","sourceVocabulary":"MedDRA 21.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":2,"numAffected":2,"numAtRisk":4717},{"groupId":"EG001","numEvents":4,"numAffected":4,"numAtRisk":4715}]},{"term":"Abdominal pain upper","organSystem":"Gastrointestinal disorders","sourceVocabulary":"MedDRA 21.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":3,"numAffected":3,"numAtRisk":4717},{"groupId":"EG001","numEvents":4,"numAffected":3,"numAtRisk":4715}]},{"term":"Aortic valve stenosis","organSystem":"Cardiac disorders","sourceVocabulary":"MedDRA 21.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":3,"numAffected":3,"numAtRisk":4717},{"groupId":"EG001","numEvents":3,"numAffected":3,"numAtRisk":4715}]},{"term":"Diarrhoea","organSystem":"Gastrointestinal disorders","sourceVocabulary":"MedDRA 21.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":4,"numAffected":4,"numAtRisk":4717},{"groupId":"EG001","numEvents":2,"numAffected":2,"numAtRisk":4715}]},{"term":"Embolism arterial","organSystem":"Vascular disorders","sourceVocabulary":"MedDRA 21.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":5,"numAffected":5,"numAtRisk":4717},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":4715}]},{"term":"Endocarditis","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA 21.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":4717},{"groupId":"EG001","numEvents":5,"numAffected":5,"numAtRisk":4715}]},{"term":"Haematoma","organSystem":"Vascular disorders","sourceVocabulary":"MedDRA 21.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":5,"numAffected":5,"numAtRisk":4717},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":4715}]},{"term":"Haemorrhagic anaemia","organSystem":"Blood and lymphatic system disorders","sourceVocabulary":"MedDRA 21.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":5,"numAffected":5,"numAtRisk":4717},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":4715}]},{"term":"Infected skin ulcer","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA 21.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":5,"numAffected":5,"numAtRisk":4717},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":4715}]},{"term":"Intervertebral disc protrusion","organSystem":"Musculoskeletal and connective tissue disorders","sourceVocabulary":"MedDRA 21.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":4,"numAffected":4,"numAtRisk":4717},{"groupId":"EG001","numEvents":2,"numAffected":2,"numAtRisk":4715}]},{"term":"Metabolic encephalopathy","organSystem":"Nervous system disorders","sourceVocabulary":"MedDRA 21.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":5,"numAffected":5,"numAtRisk":4717},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":4715}]},{"term":"Pancreatic carcinoma metastatic","organSystem":"Neoplasms benign, malignant and unspecified (incl cysts and polyps)","sourceVocabulary":"MedDRA 21.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":4,"numAffected":4,"numAtRisk":4717},{"groupId":"EG001","numEvents":2,"numAffected":2,"numAtRisk":4715}]},{"term":"Pulmonary hypertension","organSystem":"Respiratory, thoracic and mediastinal disorders","sourceVocabulary":"MedDRA 21.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":5,"numAffected":5,"numAtRisk":4717},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":4715}]},{"term":"Pyelonephritis","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA 21.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":2,"numAffected":2,"numAtRisk":4717},{"groupId":"EG001","numEvents":4,"numAffected":4,"numAtRisk":4715}]},{"term":"Rib fracture","organSystem":"Injury, poisoning and procedural complications","sourceVocabulary":"MedDRA 21.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":2,"numAffected":2,"numAtRisk":4717},{"groupId":"EG001","numEvents":4,"numAffected":4,"numAtRisk":4715}]},{"term":"Staphylococcal infection","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA 21.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":2,"numAffected":2,"numAtRisk":4717},{"groupId":"EG001","numEvents":4,"numAffected":4,"numAtRisk":4715}]},{"term":"Subcutaneous abscess","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA 21.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":2,"numAffected":2,"numAtRisk":4717},{"groupId":"EG001","numEvents":4,"numAffected":4,"numAtRisk":4715}]},{"term":"Upper respiratory tract infection","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA 21.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":2,"numAffected":2,"numAtRisk":4717},{"groupId":"EG001","numEvents":4,"numAffected":4,"numAtRisk":4715}]},{"term":"Vomiting","organSystem":"Gastrointestinal disorders","sourceVocabulary":"MedDRA 21.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":5,"numAffected":5,"numAtRisk":4717},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":4715}]},{"term":"Abscess limb","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA 21.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":2,"numAffected":2,"numAtRisk":4717},{"groupId":"EG001","numEvents":3,"numAffected":3,"numAtRisk":4715}]},{"term":"Acute coronary syndrome","organSystem":"Cardiac disorders","sourceVocabulary":"MedDRA 21.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":4,"numAffected":4,"numAtRisk":4717},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":4715}]},{"term":"Anal abscess","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA 21.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":4717},{"groupId":"EG001","numEvents":5,"numAffected":5,"numAtRisk":4715}]},{"term":"Ankle fracture","organSystem":"Injury, poisoning and procedural complications","sourceVocabulary":"MedDRA 21.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":2,"numAffected":2,"numAtRisk":4717},{"groupId":"EG001","numEvents":3,"numAffected":3,"numAtRisk":4715}]},{"term":"Bacteraemia","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA 21.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":4,"numAffected":3,"numAtRisk":4717},{"groupId":"EG001","numEvents":2,"numAffected":2,"numAtRisk":4715}]},{"term":"Carotid artery occlusion","organSystem":"Nervous system disorders","sourceVocabulary":"MedDRA 21.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":3,"numAffected":3,"numAtRisk":4717},{"groupId":"EG001","numEvents":2,"numAffected":2,"numAtRisk":4715}]},{"term":"Contusion","organSystem":"Injury, poisoning and procedural complications","sourceVocabulary":"MedDRA 21.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":2,"numAffected":2,"numAtRisk":4717},{"groupId":"EG001","numEvents":4,"numAffected":3,"numAtRisk":4715}]},{"term":"Cystitis","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA 21.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":3,"numAffected":3,"numAtRisk":4717},{"groupId":"EG001","numEvents":2,"numAffected":2,"numAtRisk":4715}]},{"term":"Depression","organSystem":"Psychiatric disorders","sourceVocabulary":"MedDRA 21.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":2,"numAffected":2,"numAtRisk":4717},{"groupId":"EG001","numEvents":3,"numAffected":3,"numAtRisk":4715}]},{"term":"Diabetic neuropathy","organSystem":"Nervous system disorders","sourceVocabulary":"MedDRA 21.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":2,"numAffected":2,"numAtRisk":4717},{"groupId":"EG001","numEvents":3,"numAffected":3,"numAtRisk":4715}]},{"term":"Dizziness","organSystem":"Nervous system disorders","sourceVocabulary":"MedDRA 21.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":2,"numAffected":2,"numAtRisk":4717},{"groupId":"EG001","numEvents":3,"numAffected":3,"numAtRisk":4715}]},{"term":"Duodenal ulcer","organSystem":"Gastrointestinal disorders","sourceVocabulary":"MedDRA 21.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":4717},{"groupId":"EG001","numEvents":4,"numAffected":4,"numAtRisk":4715}]},{"term":"Gastric ulcer","organSystem":"Gastrointestinal disorders","sourceVocabulary":"MedDRA 21.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":3,"numAffected":3,"numAtRisk":4717},{"groupId":"EG001","numEvents":2,"numAffected":2,"numAtRisk":4715}]},{"term":"Humerus fracture","organSystem":"Injury, poisoning and procedural complications","sourceVocabulary":"MedDRA 21.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":3,"numAffected":3,"numAtRisk":4717},{"groupId":"EG001","numEvents":2,"numAffected":2,"numAtRisk":4715}]},{"term":"Hypokalaemia","organSystem":"Metabolism and nutrition disorders","sourceVocabulary":"MedDRA 21.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":4717},{"groupId":"EG001","numEvents":4,"numAffected":4,"numAtRisk":4715}]},{"term":"Infective exacerbation of chronic obstructive airways disease","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA 21.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":2,"numAffected":2,"numAtRisk":4717},{"groupId":"EG001","numEvents":3,"numAffected":3,"numAtRisk":4715}]},{"term":"Joint dislocation","organSystem":"Injury, poisoning and procedural complications","sourceVocabulary":"MedDRA 21.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":2,"numAffected":2,"numAtRisk":4717},{"groupId":"EG001","numEvents":3,"numAffected":3,"numAtRisk":4715}]},{"term":"Large intestine polyp","organSystem":"Gastrointestinal disorders","sourceVocabulary":"MedDRA 21.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":2,"numAffected":2,"numAtRisk":4717},{"groupId":"EG001","numEvents":3,"numAffected":3,"numAtRisk":4715}]},{"term":"Lower respiratory tract infection","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA 21.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":4717},{"groupId":"EG001","numEvents":5,"numAffected":4,"numAtRisk":4715}]},{"term":"Lung cancer metastatic","organSystem":"Neoplasms benign, malignant and unspecified (incl cysts and polyps)","sourceVocabulary":"MedDRA 21.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":3,"numAffected":3,"numAtRisk":4717},{"groupId":"EG001","numEvents":2,"numAffected":2,"numAtRisk":4715}]},{"term":"Mental status changes","organSystem":"Psychiatric disorders","sourceVocabulary":"MedDRA 21.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":4717},{"groupId":"EG001","numEvents":5,"numAffected":5,"numAtRisk":4715}]},{"term":"Metabolic acidosis","organSystem":"Metabolism and nutrition disorders","sourceVocabulary":"MedDRA 21.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":4717},{"groupId":"EG001","numEvents":4,"numAffected":4,"numAtRisk":4715}]},{"term":"Metastases to liver","organSystem":"Neoplasms benign, malignant and unspecified (incl cysts and polyps)","sourceVocabulary":"MedDRA 21.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":2,"numAffected":2,"numAtRisk":4717},{"groupId":"EG001","numEvents":3,"numAffected":3,"numAtRisk":4715}]},{"term":"Obesity","organSystem":"Metabolism and nutrition disorders","sourceVocabulary":"MedDRA 21.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":2,"numAffected":2,"numAtRisk":4717},{"groupId":"EG001","numEvents":3,"numAffected":3,"numAtRisk":4715}]},{"term":"Pancreatic carcinoma","organSystem":"Neoplasms benign, malignant and unspecified (incl cysts and polyps)","sourceVocabulary":"MedDRA 21.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":2,"numAffected":2,"numAtRisk":4717},{"groupId":"EG001","numEvents":3,"numAffected":3,"numAtRisk":4715}]},{"term":"Pericarditis","organSystem":"Cardiac disorders","sourceVocabulary":"MedDRA 21.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":4717},{"groupId":"EG001","numEvents":5,"numAffected":4,"numAtRisk":4715}]},{"term":"Prostatitis","organSystem":"Reproductive system and breast disorders","sourceVocabulary":"MedDRA 21.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":3,"numAffected":3,"numAtRisk":4717},{"groupId":"EG001","numEvents":2,"numAffected":2,"numAtRisk":4715}]},{"term":"Seizure","organSystem":"Nervous system disorders","sourceVocabulary":"MedDRA 21.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":4717},{"groupId":"EG001","numEvents":4,"numAffected":4,"numAtRisk":4715}]},{"term":"Sudden death","organSystem":"General disorders","sourceVocabulary":"MedDRA 21.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":2,"numAffected":2,"numAtRisk":4717},{"groupId":"EG001","numEvents":3,"numAffected":3,"numAtRisk":4715}]},{"term":"Supraventricular tachycardia","organSystem":"Cardiac disorders","sourceVocabulary":"MedDRA 21.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":3,"numAffected":3,"numAtRisk":4717},{"groupId":"EG001","numEvents":2,"numAffected":2,"numAtRisk":4715}]},{"term":"Tibia fracture","organSystem":"Injury, poisoning and procedural complications","sourceVocabulary":"MedDRA 21.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":3,"numAffected":3,"numAtRisk":4717},{"groupId":"EG001","numEvents":2,"numAffected":2,"numAtRisk":4715}]},{"term":"Vascular stent stenosis","organSystem":"General disorders","sourceVocabulary":"MedDRA 21.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":3,"numAffected":3,"numAtRisk":4717},{"groupId":"EG001","numEvents":2,"numAffected":2,"numAtRisk":4715}]},{"term":"Abdominal hernia","organSystem":"Gastrointestinal disorders","sourceVocabulary":"MedDRA 21.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":3,"numAffected":3,"numAtRisk":4717},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":4715}]},{"term":"Angina unstable","organSystem":"Cardiac disorders","sourceVocabulary":"MedDRA 21.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":2,"numAffected":2,"numAtRisk":4717},{"groupId":"EG001","numEvents":2,"numAffected":2,"numAtRisk":4715}]},{"term":"Arteriosclerosis","organSystem":"Vascular disorders","sourceVocabulary":"MedDRA 21.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":4717},{"groupId":"EG001","numEvents":4,"numAffected":4,"numAtRisk":4715}]},{"term":"Atrioventricular block","organSystem":"Cardiac disorders","sourceVocabulary":"MedDRA 21.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":4717},{"groupId":"EG001","numEvents":3,"numAffected":3,"numAtRisk":4715}]},{"term":"Breast cancer metastatic","organSystem":"Neoplasms benign, malignant and unspecified (incl cysts and polyps)","sourceVocabulary":"MedDRA 21.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":4717},{"groupId":"EG001","numEvents":3,"numAffected":3,"numAtRisk":4715}]},{"term":"Colon cancer","organSystem":"Neoplasms benign, malignant and unspecified (incl cysts and polyps)","sourceVocabulary":"MedDRA 21.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":4717},{"groupId":"EG001","numEvents":3,"numAffected":3,"numAtRisk":4715}]},{"term":"Constipation","organSystem":"Gastrointestinal disorders","sourceVocabulary":"MedDRA 21.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":3,"numAffected":3,"numAtRisk":4717},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":4715}]},{"term":"Craniocerebral injury","organSystem":"Injury, poisoning and procedural complications","sourceVocabulary":"MedDRA 21.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":4,"numAffected":4,"numAtRisk":4717},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":4715}]},{"term":"Device malfunction","organSystem":"Product Issues","sourceVocabulary":"MedDRA 21.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":4717},{"groupId":"EG001","numEvents":3,"numAffected":3,"numAtRisk":4715}]},{"term":"Diabetic retinopathy","organSystem":"Eye disorders","sourceVocabulary":"MedDRA 21.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":4717},{"groupId":"EG001","numEvents":3,"numAffected":3,"numAtRisk":4715}]},{"term":"Dyspepsia","organSystem":"Gastrointestinal disorders","sourceVocabulary":"MedDRA 21.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":2,"numAffected":2,"numAtRisk":4717},{"groupId":"EG001","numEvents":2,"numAffected":2,"numAtRisk":4715}]},{"term":"Electrocardiogram QT prolonged","organSystem":"Investigations","sourceVocabulary":"MedDRA 21.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":4,"numAffected":4,"numAtRisk":4717},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":4715}]},{"term":"Escherichia urinary tract infection","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA 21.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":3,"numAffected":3,"numAtRisk":4717},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":4715}]},{"term":"Femur fracture","organSystem":"Injury, poisoning and procedural complications","sourceVocabulary":"MedDRA 21.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":4717},{"groupId":"EG001","numEvents":3,"numAffected":3,"numAtRisk":4715}]},{"term":"Gastroenteritis viral","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA 21.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":3,"numAffected":3,"numAtRisk":4717},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":4715}]},{"term":"Headache","organSystem":"Nervous system disorders","sourceVocabulary":"MedDRA 21.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":2,"numAffected":2,"numAtRisk":4717},{"groupId":"EG001","numEvents":2,"numAffected":2,"numAtRisk":4715}]},{"term":"Hyperglycaemic hyperosmolar nonketotic syndrome","organSystem":"Metabolism and nutrition disorders","sourceVocabulary":"MedDRA 21.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":2,"numAffected":2,"numAtRisk":4717},{"groupId":"EG001","numEvents":3,"numAffected":2,"numAtRisk":4715}]},{"term":"Hypoxia","organSystem":"Respiratory, thoracic and mediastinal disorders","sourceVocabulary":"MedDRA 21.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":2,"numAffected":1,"numAtRisk":4717},{"groupId":"EG001","numEvents":4,"numAffected":3,"numAtRisk":4715}]},{"term":"Impaired gastric emptying","organSystem":"Gastrointestinal disorders","sourceVocabulary":"MedDRA 21.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":4717},{"groupId":"EG001","numEvents":3,"numAffected":3,"numAtRisk":4715}]},{"term":"Impaired healing","organSystem":"General disorders","sourceVocabulary":"MedDRA 21.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":4717},{"groupId":"EG001","numEvents":4,"numAffected":3,"numAtRisk":4715}]},{"term":"Intermittent claudication","organSystem":"Vascular disorders","sourceVocabulary":"MedDRA 21.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":3,"numAffected":2,"numAtRisk":4717},{"groupId":"EG001","numEvents":2,"numAffected":2,"numAtRisk":4715}]},{"term":"Meniscus injury","organSystem":"Injury, poisoning and procedural complications","sourceVocabulary":"MedDRA 21.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":2,"numAffected":2,"numAtRisk":4717},{"groupId":"EG001","numEvents":2,"numAffected":2,"numAtRisk":4715}]},{"term":"Metastases to central nervous system","organSystem":"Neoplasms benign, malignant and unspecified (incl cysts and polyps)","sourceVocabulary":"MedDRA 21.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":2,"numAffected":2,"numAtRisk":4717},{"groupId":"EG001","numEvents":2,"numAffected":2,"numAtRisk":4715}]},{"term":"Osteomyelitis acute","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA 21.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":2,"numAffected":2,"numAtRisk":4717},{"groupId":"EG001","numEvents":2,"numAffected":2,"numAtRisk":4715}]},{"term":"Peripheral artery restenosis","organSystem":"Injury, poisoning and procedural complications","sourceVocabulary":"MedDRA 21.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":4717},{"groupId":"EG001","numEvents":4,"numAffected":4,"numAtRisk":4715}]},{"term":"Peripheral artery thrombosis","organSystem":"Vascular disorders","sourceVocabulary":"MedDRA 21.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":3,"numAffected":3,"numAtRisk":4717},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":4715}]},{"term":"Respiratory distress","organSystem":"Respiratory, thoracic and mediastinal disorders","sourceVocabulary":"MedDRA 21.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":4717},{"groupId":"EG001","numEvents":4,"numAffected":4,"numAtRisk":4715}]},{"term":"Sleep apnoea syndrome","organSystem":"Respiratory, thoracic and mediastinal disorders","sourceVocabulary":"MedDRA 21.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":4,"numAffected":3,"numAtRisk":4717},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":4715}]},{"term":"Spinal column stenosis","organSystem":"Musculoskeletal and connective tissue disorders","sourceVocabulary":"MedDRA 21.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":4717},{"groupId":"EG001","numEvents":3,"numAffected":3,"numAtRisk":4715}]},{"term":"Tendon rupture","organSystem":"Injury, poisoning and procedural complications","sourceVocabulary":"MedDRA 21.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":2,"numAffected":2,"numAtRisk":4717},{"groupId":"EG001","numEvents":2,"numAffected":2,"numAtRisk":4715}]},{"term":"Urticaria","organSystem":"Skin and subcutaneous tissue disorders","sourceVocabulary":"MedDRA 21.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":4717},{"groupId":"EG001","numEvents":3,"numAffected":3,"numAtRisk":4715}]},{"term":"Ventricular arrhythmia","organSystem":"Cardiac disorders","sourceVocabulary":"MedDRA 21.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":4717},{"groupId":"EG001","numEvents":3,"numAffected":3,"numAtRisk":4715}]},{"term":"Wound infection","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA 21.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":4717},{"groupId":"EG001","numEvents":3,"numAffected":3,"numAtRisk":4715}]},{"term":"Adenocarcinoma","organSystem":"Neoplasms benign, malignant and unspecified (incl cysts and polyps)","sourceVocabulary":"MedDRA 21.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":4717},{"groupId":"EG001","numEvents":3,"numAffected":3,"numAtRisk":4715}]},{"term":"Aortic dissection","organSystem":"Vascular disorders","sourceVocabulary":"MedDRA 21.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":3,"numAffected":3,"numAtRisk":4717},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":4715}]},{"term":"Arrhythmia","organSystem":"Cardiac disorders","sourceVocabulary":"MedDRA 21.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":4717},{"groupId":"EG001","numEvents":2,"numAffected":2,"numAtRisk":4715}]},{"term":"Arterial disorder","organSystem":"Vascular disorders","sourceVocabulary":"MedDRA 21.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":4717},{"groupId":"EG001","numEvents":3,"numAffected":3,"numAtRisk":4715}]},{"term":"Arthritis bacterial","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA 21.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":3,"numAffected":3,"numAtRisk":4717},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":4715}]},{"term":"Atelectasis","organSystem":"Respiratory, thoracic and mediastinal disorders","sourceVocabulary":"MedDRA 21.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":4717},{"groupId":"EG001","numEvents":2,"numAffected":2,"numAtRisk":4715}]},{"term":"Basal cell carcinoma","organSystem":"Neoplasms benign, malignant and unspecified (incl cysts and polyps)","sourceVocabulary":"MedDRA 21.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":2,"numAffected":2,"numAtRisk":4717},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":4715}]},{"term":"Bile duct stone","organSystem":"Hepatobiliary disorders","sourceVocabulary":"MedDRA 21.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":2,"numAffected":2,"numAtRisk":4717},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":4715}]},{"term":"Blood creatinine increased","organSystem":"Investigations","sourceVocabulary":"MedDRA 21.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":4717},{"groupId":"EG001","numEvents":2,"numAffected":2,"numAtRisk":4715}]},{"term":"Brain injury","organSystem":"Nervous system disorders","sourceVocabulary":"MedDRA 21.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":3,"numAffected":3,"numAtRisk":4717},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":4715}]},{"term":"Bronchial carcinoma","organSystem":"Neoplasms benign, malignant and unspecified (incl cysts and polyps)","sourceVocabulary":"MedDRA 21.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":2,"numAffected":2,"numAtRisk":4717},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":4715}]},{"term":"Bundle branch block left","organSystem":"Cardiac disorders","sourceVocabulary":"MedDRA 21.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":4717},{"groupId":"EG001","numEvents":2,"numAffected":2,"numAtRisk":4715}]},{"term":"Cardiopulmonary failure","organSystem":"Cardiac disorders","sourceVocabulary":"MedDRA 21.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":4717},{"groupId":"EG001","numEvents":2,"numAffected":2,"numAtRisk":4715}]},{"term":"Colon cancer metastatic","organSystem":"Neoplasms benign, malignant and unspecified (incl cysts and polyps)","sourceVocabulary":"MedDRA 21.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":4717},{"groupId":"EG001","numEvents":3,"numAffected":3,"numAtRisk":4715}]},{"term":"Coronary artery restenosis","organSystem":"Injury, poisoning and procedural complications","sourceVocabulary":"MedDRA 21.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":4717},{"groupId":"EG001","numEvents":4,"numAffected":3,"numAtRisk":4715}]},{"term":"Dementia","organSystem":"Nervous system disorders","sourceVocabulary":"MedDRA 21.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":4717},{"groupId":"EG001","numEvents":3,"numAffected":3,"numAtRisk":4715}]},{"term":"Device failure","organSystem":"Product Issues","sourceVocabulary":"MedDRA 21.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":2,"numAffected":2,"numAtRisk":4717},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":4715}]},{"term":"Diabetic gangrene","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA 21.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":4717},{"groupId":"EG001","numEvents":2,"numAffected":2,"numAtRisk":4715}]},{"term":"Diverticulitis","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA 21.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":2,"numAffected":1,"numAtRisk":4717},{"groupId":"EG001","numEvents":3,"numAffected":2,"numAtRisk":4715}]},{"term":"Dyspnoea exertional","organSystem":"Respiratory, thoracic and mediastinal disorders","sourceVocabulary":"MedDRA 21.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":4717},{"groupId":"EG001","numEvents":2,"numAffected":2,"numAtRisk":4715}]},{"term":"Encephalopathy","organSystem":"Nervous system disorders","sourceVocabulary":"MedDRA 21.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":4717},{"groupId":"EG001","numEvents":2,"numAffected":2,"numAtRisk":4715}]},{"term":"Endometrial hyperplasia","organSystem":"Reproductive system and breast disorders","sourceVocabulary":"MedDRA 21.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":4717},{"groupId":"EG001","numEvents":3,"numAffected":3,"numAtRisk":4715}]},{"term":"Epididymitis","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA 21.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":4717},{"groupId":"EG001","numEvents":2,"numAffected":2,"numAtRisk":4715}]},{"term":"Facial paralysis","organSystem":"Nervous system disorders","sourceVocabulary":"MedDRA 21.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":4717},{"groupId":"EG001","numEvents":2,"numAffected":2,"numAtRisk":4715}]},{"term":"Fibula fracture","organSystem":"Injury, poisoning and procedural complications","sourceVocabulary":"MedDRA 21.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":4717},{"groupId":"EG001","numEvents":2,"numAffected":2,"numAtRisk":4715}]},{"term":"Gastric ulcer haemorrhage","organSystem":"Gastrointestinal disorders","sourceVocabulary":"MedDRA 21.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":4717},{"groupId":"EG001","numEvents":2,"numAffected":2,"numAtRisk":4715}]},{"term":"Gastritis erosive","organSystem":"Gastrointestinal disorders","sourceVocabulary":"MedDRA 21.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":2,"numAffected":2,"numAtRisk":4717},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":4715}]},{"term":"Gastrooesophageal reflux disease","organSystem":"Gastrointestinal disorders","sourceVocabulary":"MedDRA 21.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":2,"numAffected":2,"numAtRisk":4717},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":4715}]},{"term":"Groin abscess","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA 21.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":2,"numAffected":2,"numAtRisk":4717},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":4715}]},{"term":"Hepatic cirrhosis","organSystem":"Hepatobiliary disorders","sourceVocabulary":"MedDRA 21.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":4717},{"groupId":"EG001","numEvents":2,"numAffected":2,"numAtRisk":4715}]},{"term":"Hepatic enzyme increased","organSystem":"Investigations","sourceVocabulary":"MedDRA 21.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":3,"numAffected":3,"numAtRisk":4717},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":4715}]},{"term":"Hepatic failure","organSystem":"Hepatobiliary disorders","sourceVocabulary":"MedDRA 21.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":4717},{"groupId":"EG001","numEvents":3,"numAffected":3,"numAtRisk":4715}]},{"term":"Hepatocellular carcinoma","organSystem":"Neoplasms benign, malignant and unspecified (incl cysts and polyps)","sourceVocabulary":"MedDRA 21.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":4717},{"groupId":"EG001","numEvents":2,"numAffected":2,"numAtRisk":4715}]},{"term":"Hydronephrosis","organSystem":"Renal and urinary disorders","sourceVocabulary":"MedDRA 21.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":4717},{"groupId":"EG001","numEvents":2,"numAffected":2,"numAtRisk":4715}]},{"term":"Hypertensive emergency","organSystem":"Vascular disorders","sourceVocabulary":"MedDRA 21.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":3,"numAffected":3,"numAtRisk":4717},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":4715}]},{"term":"Hypovolaemic shock","organSystem":"Vascular disorders","sourceVocabulary":"MedDRA 21.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":4717},{"groupId":"EG001","numEvents":3,"numAffected":3,"numAtRisk":4715}]},{"term":"Incisional hernia","organSystem":"Injury, poisoning and procedural complications","sourceVocabulary":"MedDRA 21.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":3,"numAffected":3,"numAtRisk":4717},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":4715}]},{"term":"Ischaemic cardiomyopathy","organSystem":"Cardiac disorders","sourceVocabulary":"MedDRA 21.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":4717},{"groupId":"EG001","numEvents":3,"numAffected":3,"numAtRisk":4715}]},{"term":"Lactic acidosis","organSystem":"Metabolism and nutrition disorders","sourceVocabulary":"MedDRA 21.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":4717},{"groupId":"EG001","numEvents":3,"numAffected":3,"numAtRisk":4715}]},{"term":"Limb injury","organSystem":"Injury, poisoning and procedural complications","sourceVocabulary":"MedDRA 21.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":4717},{"groupId":"EG001","numEvents":2,"numAffected":2,"numAtRisk":4715}]},{"term":"Liver function test increased","organSystem":"Investigations","sourceVocabulary":"MedDRA 21.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":2,"numAffected":2,"numAtRisk":4717},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":4715}]},{"term":"Lower gastrointestinal haemorrhage","organSystem":"Gastrointestinal disorders","sourceVocabulary":"MedDRA 21.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":5,"numAffected":2,"numAtRisk":4717},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":4715}]},{"term":"Malignant melanoma","organSystem":"Neoplasms benign, malignant and unspecified (incl cysts and polyps)","sourceVocabulary":"MedDRA 21.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":2,"numAffected":2,"numAtRisk":4717},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":4715}]},{"term":"Migraine","organSystem":"Nervous system disorders","sourceVocabulary":"MedDRA 21.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":3,"numAffected":3,"numAtRisk":4717},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":4715}]},{"term":"Muscle haemorrhage","organSystem":"Musculoskeletal and connective tissue disorders","sourceVocabulary":"MedDRA 21.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":2,"numAffected":2,"numAtRisk":4717},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":4715}]},{"term":"Muscular weakness","organSystem":"Musculoskeletal and connective tissue disorders","sourceVocabulary":"MedDRA 21.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":4717},{"groupId":"EG001","numEvents":4,"numAffected":3,"numAtRisk":4715}]},{"term":"Musculoskeletal pain","organSystem":"Musculoskeletal and connective tissue disorders","sourceVocabulary":"MedDRA 21.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":2,"numAffected":2,"numAtRisk":4717},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":4715}]},{"term":"Oesophagitis","organSystem":"Gastrointestinal disorders","sourceVocabulary":"MedDRA 21.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":4717},{"groupId":"EG001","numEvents":2,"numAffected":2,"numAtRisk":4715}]},{"term":"Pancreatitis","organSystem":"Gastrointestinal disorders","sourceVocabulary":"MedDRA 21.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":4717},{"groupId":"EG001","numEvents":2,"numAffected":2,"numAtRisk":4715}]},{"term":"Post procedural haematoma","organSystem":"Injury, poisoning and procedural complications","sourceVocabulary":"MedDRA 21.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":4717},{"groupId":"EG001","numEvents":2,"numAffected":2,"numAtRisk":4715}]},{"term":"Post procedural haemorrhage","organSystem":"Injury, poisoning and procedural complications","sourceVocabulary":"MedDRA 21.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":4717},{"groupId":"EG001","numEvents":3,"numAffected":2,"numAtRisk":4715}]},{"term":"Renal artery stenosis","organSystem":"Renal and urinary disorders","sourceVocabulary":"MedDRA 21.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":2,"numAffected":2,"numAtRisk":4717},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":4715}]},{"term":"Renal colic","organSystem":"Renal and urinary disorders","sourceVocabulary":"MedDRA 21.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":4717},{"groupId":"EG001","numEvents":2,"numAffected":2,"numAtRisk":4715}]},{"term":"Renal neoplasm","organSystem":"Neoplasms benign, malignant and unspecified (incl cysts and polyps)","sourceVocabulary":"MedDRA 21.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":2,"numAffected":2,"numAtRisk":4717},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":4715}]},{"term":"Renal tubular necrosis","organSystem":"Renal and urinary disorders","sourceVocabulary":"MedDRA 21.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":2,"numAffected":2,"numAtRisk":4717},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":4715}]},{"term":"Salivary gland neoplasm","organSystem":"Neoplasms benign, malignant and unspecified (incl cysts and polyps)","sourceVocabulary":"MedDRA 21.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":2,"numAffected":2,"numAtRisk":4717},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":4715}]},{"term":"Spinal fracture","organSystem":"Injury, poisoning and procedural complications","sourceVocabulary":"MedDRA 21.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":4717},{"groupId":"EG001","numEvents":2,"numAffected":2,"numAtRisk":4715}]},{"term":"Squamous cell carcinoma","organSystem":"Neoplasms benign, malignant and unspecified (incl cysts and polyps)","sourceVocabulary":"MedDRA 21.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":2,"numAffected":2,"numAtRisk":4717},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":4715}]},{"term":"Staphylococcal sepsis","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA 21.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":4717},{"groupId":"EG001","numEvents":3,"numAffected":3,"numAtRisk":4715}]},{"term":"Subclavian artery stenosis","organSystem":"Vascular disorders","sourceVocabulary":"MedDRA 21.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":4717},{"groupId":"EG001","numEvents":2,"numAffected":2,"numAtRisk":4715}]},{"term":"Suicide attempt","organSystem":"Psychiatric disorders","sourceVocabulary":"MedDRA 21.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":4717},{"groupId":"EG001","numEvents":2,"numAffected":2,"numAtRisk":4715}]},{"term":"Uterine cancer","organSystem":"Neoplasms benign, malignant and unspecified (incl cysts and polyps)","sourceVocabulary":"MedDRA 21.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":4717},{"groupId":"EG001","numEvents":3,"numAffected":3,"numAtRisk":4715}]},{"term":"Uterine leiomyoma","organSystem":"Neoplasms benign, malignant and unspecified (incl cysts and polyps)","sourceVocabulary":"MedDRA 21.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":2,"numAffected":2,"numAtRisk":4717},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":4715}]},{"term":"Vertebrobasilar insufficiency","organSystem":"Nervous system disorders","sourceVocabulary":"MedDRA 21.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":2,"numAffected":2,"numAtRisk":4717},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":4715}]},{"term":"Viral infection","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA 21.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":2,"numAffected":2,"numAtRisk":4717},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":4715}]},{"term":"Wound dehiscence","organSystem":"Injury, poisoning and procedural complications","sourceVocabulary":"MedDRA 21.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":4717},{"groupId":"EG001","numEvents":3,"numAffected":3,"numAtRisk":4715}]},{"term":"Abscess soft tissue","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA 21.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":2,"numAffected":2,"numAtRisk":4717},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":4715}]},{"term":"Acute myeloid leukaemia","organSystem":"Neoplasms benign, malignant and unspecified (incl cysts and polyps)","sourceVocabulary":"MedDRA 21.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":2,"numAffected":2,"numAtRisk":4717},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":4715}]},{"term":"Acute sinusitis","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA 21.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":4717},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":4715}]},{"term":"Adenocarcinoma gastric","organSystem":"Neoplasms benign, malignant and unspecified (incl cysts and polyps)","sourceVocabulary":"MedDRA 21.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":2,"numAffected":2,"numAtRisk":4717},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":4715}]},{"term":"Anaphylactic reaction","organSystem":"Immune system disorders","sourceVocabulary":"MedDRA 21.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":2,"numAffected":2,"numAtRisk":4717},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":4715}]},{"term":"Angioedema","organSystem":"Skin and subcutaneous tissue disorders","sourceVocabulary":"MedDRA 21.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":4717},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":4715}]},{"term":"Aortic valve disease","organSystem":"Cardiac disorders","sourceVocabulary":"MedDRA 21.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":4717},{"groupId":"EG001","numEvents":2,"numAffected":2,"numAtRisk":4715}]},{"term":"Aortic valve incompetence","organSystem":"Cardiac disorders","sourceVocabulary":"MedDRA 21.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":4717},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":4715}]},{"term":"Arrhythmia supraventricular","organSystem":"Cardiac disorders","sourceVocabulary":"MedDRA 21.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":4717},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":4715}]},{"term":"Arthralgia","organSystem":"Musculoskeletal and connective tissue disorders","sourceVocabulary":"MedDRA 21.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":2,"numAffected":2,"numAtRisk":4717},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":4715}]},{"term":"B-cell lymphoma","organSystem":"Neoplasms benign, malignant and unspecified (incl cysts and polyps)","sourceVocabulary":"MedDRA 21.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":4717},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":4715}]},{"term":"Biliary colic","organSystem":"Hepatobiliary disorders","sourceVocabulary":"MedDRA 21.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":2,"numAffected":2,"numAtRisk":4717},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":4715}]},{"term":"Bladder neoplasm","organSystem":"Neoplasms benign, malignant and unspecified (incl cysts and polyps)","sourceVocabulary":"MedDRA 21.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":4717},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":4715}]},{"term":"Bronchitis bacterial","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA 21.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":4717},{"groupId":"EG001","numEvents":2,"numAffected":2,"numAtRisk":4715}]},{"term":"Cardiac asthma","organSystem":"Cardiac disorders","sourceVocabulary":"MedDRA 21.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":4717},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":4715}]},{"term":"Cardiac failure chronic","organSystem":"Cardiac disorders","sourceVocabulary":"MedDRA 21.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":2,"numAffected":2,"numAtRisk":4717},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":4715}]},{"term":"Cardiac procedure complication","organSystem":"Injury, poisoning and procedural complications","sourceVocabulary":"MedDRA 21.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":4717},{"groupId":"EG001","numEvents":2,"numAffected":2,"numAtRisk":4715}]},{"term":"Cardiomegaly","organSystem":"Cardiac disorders","sourceVocabulary":"MedDRA 21.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":4717},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":4715}]},{"term":"Cardiomyopathy","organSystem":"Cardiac disorders","sourceVocabulary":"MedDRA 21.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":4717},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":4715}]},{"term":"Cardiovascular disorder","organSystem":"Cardiac disorders","sourceVocabulary":"MedDRA 21.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":4717},{"groupId":"EG001","numEvents":2,"numAffected":2,"numAtRisk":4715}]},{"term":"Carotid arteriosclerosis","organSystem":"Nervous system disorders","sourceVocabulary":"MedDRA 21.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":4717},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":4715}]},{"term":"Carpal tunnel syndrome","organSystem":"Nervous system disorders","sourceVocabulary":"MedDRA 21.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":4717},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":4715}]},{"term":"Catheter site haemorrhage","organSystem":"General disorders","sourceVocabulary":"MedDRA 21.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":4717},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":4715}]},{"term":"Cerebral arteriosclerosis","organSystem":"Nervous system disorders","sourceVocabulary":"MedDRA 21.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":4717},{"groupId":"EG001","numEvents":2,"numAffected":2,"numAtRisk":4715}]},{"term":"Cerebral haemorrhage","organSystem":"Nervous system disorders","sourceVocabulary":"MedDRA 21.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":4717},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":4715}]},{"term":"Cervicobrachial syndrome","organSystem":"Nervous system disorders","sourceVocabulary":"MedDRA 21.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":4717},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":4715}]},{"term":"Cholangiocarcinoma","organSystem":"Neoplasms benign, malignant and unspecified (incl cysts and polyps)","sourceVocabulary":"MedDRA 21.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":4717},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":4715}]},{"term":"Cholecystitis chronic","organSystem":"Hepatobiliary disorders","sourceVocabulary":"MedDRA 21.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":4717},{"groupId":"EG001","numEvents":2,"numAffected":2,"numAtRisk":4715}]},{"term":"Chronic gastritis","organSystem":"Gastrointestinal disorders","sourceVocabulary":"MedDRA 21.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":4717},{"groupId":"EG001","numEvents":2,"numAffected":2,"numAtRisk":4715}]},{"term":"Clostridium difficile infection","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA 21.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":4717},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":4715}]},{"term":"Concussion","organSystem":"Injury, poisoning and procedural complications","sourceVocabulary":"MedDRA 21.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":4717},{"groupId":"EG001","numEvents":2,"numAffected":2,"numAtRisk":4715}]},{"term":"Coronary artery occlusion","organSystem":"Cardiac disorders","sourceVocabulary":"MedDRA 21.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":4717},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":4715}]},{"term":"Cough","organSystem":"Respiratory, thoracic and mediastinal disorders","sourceVocabulary":"MedDRA 21.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":4717},{"groupId":"EG001","numEvents":2,"numAffected":2,"numAtRisk":4715}]},{"term":"Delirium","organSystem":"Psychiatric disorders","sourceVocabulary":"MedDRA 21.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":4717},{"groupId":"EG001","numEvents":2,"numAffected":2,"numAtRisk":4715}]},{"term":"Device related infection","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA 21.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":4717},{"groupId":"EG001","numEvents":2,"numAffected":2,"numAtRisk":4715}]},{"term":"Diabetic vascular disorder","organSystem":"Vascular disorders","sourceVocabulary":"MedDRA 21.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":2,"numAffected":2,"numAtRisk":4717},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":4715}]},{"term":"Diverticulum intestinal","organSystem":"Gastrointestinal disorders","sourceVocabulary":"MedDRA 21.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":2,"numAffected":2,"numAtRisk":4717},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":4715}]},{"term":"Dizziness postural","organSystem":"Nervous system disorders","sourceVocabulary":"MedDRA 21.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":4717},{"groupId":"EG001","numEvents":2,"numAffected":2,"numAtRisk":4715}]},{"term":"Duodenal ulcer haemorrhage","organSystem":"Gastrointestinal disorders","sourceVocabulary":"MedDRA 21.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":4717},{"groupId":"EG001","numEvents":2,"numAffected":2,"numAtRisk":4715}]},{"term":"Enteritis","organSystem":"Gastrointestinal disorders","sourceVocabulary":"MedDRA 21.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":4717},{"groupId":"EG001","numEvents":2,"numAffected":2,"numAtRisk":4715}]},{"term":"Epilepsy","organSystem":"Nervous system disorders","sourceVocabulary":"MedDRA 21.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":4717},{"groupId":"EG001","numEvents":2,"numAffected":2,"numAtRisk":4715}]},{"term":"Epistaxis","organSystem":"Respiratory, thoracic and mediastinal disorders","sourceVocabulary":"MedDRA 21.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":4717},{"groupId":"EG001","numEvents":2,"numAffected":2,"numAtRisk":4715}]},{"term":"Essential hypertension","organSystem":"Vascular disorders","sourceVocabulary":"MedDRA 21.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":4717},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":4715}]},{"term":"Eyelid ptosis","organSystem":"Eye disorders","sourceVocabulary":"MedDRA 21.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":4717},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":4715}]},{"term":"Facial paresis","organSystem":"Nervous system disorders","sourceVocabulary":"MedDRA 21.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":4717},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":4715}]},{"term":"Femoral neck fracture","organSystem":"Injury, poisoning and procedural complications","sourceVocabulary":"MedDRA 21.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":4717},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":4715}]},{"term":"Gastric cancer","organSystem":"Neoplasms benign, malignant and unspecified (incl cysts and polyps)","sourceVocabulary":"MedDRA 21.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":2,"numAffected":2,"numAtRisk":4717},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":4715}]},{"term":"Generalised oedema","organSystem":"General disorders","sourceVocabulary":"MedDRA 21.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":4717},{"groupId":"EG001","numEvents":2,"numAffected":2,"numAtRisk":4715}]},{"term":"Glomerular filtration rate decreased","organSystem":"Investigations","sourceVocabulary":"MedDRA 21.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":4717},{"groupId":"EG001","numEvents":2,"numAffected":2,"numAtRisk":4715}]},{"term":"Graft infection","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA 21.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":4717},{"groupId":"EG001","numEvents":2,"numAffected":2,"numAtRisk":4715}]},{"term":"Haemorrhoidal haemorrhage","organSystem":"Gastrointestinal disorders","sourceVocabulary":"MedDRA 21.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":4717},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":4715}]},{"term":"Haemothorax","organSystem":"Respiratory, thoracic and mediastinal disorders","sourceVocabulary":"MedDRA 21.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":2,"numAffected":2,"numAtRisk":4717},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":4715}]},{"term":"Hand fracture","organSystem":"Injury, poisoning and procedural complications","sourceVocabulary":"MedDRA 21.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":4717},{"groupId":"EG001","numEvents":2,"numAffected":2,"numAtRisk":4715}]},{"term":"Head injury","organSystem":"Injury, poisoning and procedural complications","sourceVocabulary":"MedDRA 21.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":4717},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":4715}]},{"term":"Hepatic cancer","organSystem":"Neoplasms benign, malignant and unspecified (incl cysts and polyps)","sourceVocabulary":"MedDRA 21.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":2,"numAffected":2,"numAtRisk":4717},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":4715}]},{"term":"Hepatitis C","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA 21.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":4717},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":4715}]},{"term":"Hepatitis acute","organSystem":"Hepatobiliary disorders","sourceVocabulary":"MedDRA 21.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":4717},{"groupId":"EG001","numEvents":2,"numAffected":2,"numAtRisk":4715}]},{"term":"Hiatus hernia","organSystem":"Gastrointestinal disorders","sourceVocabulary":"MedDRA 21.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":4717},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":4715}]},{"term":"Hypocalcaemia","organSystem":"Metabolism and nutrition disorders","sourceVocabulary":"MedDRA 21.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":4717},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":4715}]},{"term":"Hypomagnesaemia","organSystem":"Metabolism and nutrition disorders","sourceVocabulary":"MedDRA 21.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":4717},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":4715}]},{"term":"IIIrd nerve paresis","organSystem":"Nervous system disorders","sourceVocabulary":"MedDRA 21.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":2,"numAffected":2,"numAtRisk":4717},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":4715}]},{"term":"Infection","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA 21.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":4717},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":4715}]},{"term":"Intervertebral disc degeneration","organSystem":"Musculoskeletal and connective tissue disorders","sourceVocabulary":"MedDRA 21.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":4717},{"groupId":"EG001","numEvents":2,"numAffected":2,"numAtRisk":4715}]},{"term":"Intervertebral discitis","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA 21.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":4717},{"groupId":"EG001","numEvents":2,"numAffected":2,"numAtRisk":4715}]},{"term":"Intestinal obstruction","organSystem":"Gastrointestinal disorders","sourceVocabulary":"MedDRA 21.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":2,"numAffected":2,"numAtRisk":4717},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":4715}]},{"term":"Intraductal proliferative breast lesion","organSystem":"Neoplasms benign, malignant and unspecified (incl cysts and polyps)","sourceVocabulary":"MedDRA 21.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":4717},{"groupId":"EG001","numEvents":2,"numAffected":2,"numAtRisk":4715}]},{"term":"Ischaemic hepatitis","organSystem":"Hepatobiliary disorders","sourceVocabulary":"MedDRA 21.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":4717},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":4715}]},{"term":"Laryngeal cancer","organSystem":"Neoplasms benign, malignant and unspecified (incl cysts and polyps)","sourceVocabulary":"MedDRA 21.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":4717},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":4715}]},{"term":"Laryngeal papilloma","organSystem":"Neoplasms benign, malignant and unspecified (incl cysts and polyps)","sourceVocabulary":"MedDRA 21.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":4717},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":4715}]},{"term":"Left ventricular failure","organSystem":"Cardiac disorders","sourceVocabulary":"MedDRA 21.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":2,"numAffected":2,"numAtRisk":4717},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":4715}]},{"term":"Leriche syndrome","organSystem":"Vascular disorders","sourceVocabulary":"MedDRA 21.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":4717},{"groupId":"EG001","numEvents":2,"numAffected":2,"numAtRisk":4715}]},{"term":"Liver abscess","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA 21.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":2,"numAffected":2,"numAtRisk":4717},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":4715}]},{"term":"Loss of consciousness","organSystem":"Nervous system disorders","sourceVocabulary":"MedDRA 21.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":4717},{"groupId":"EG001","numEvents":2,"numAffected":2,"numAtRisk":4715}]},{"term":"Lower limb fracture","organSystem":"Injury, poisoning and procedural complications","sourceVocabulary":"MedDRA 21.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":4717},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":4715}]},{"term":"Lumbar vertebral fracture","organSystem":"Injury, poisoning and procedural complications","sourceVocabulary":"MedDRA 21.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":4717},{"groupId":"EG001","numEvents":2,"numAffected":2,"numAtRisk":4715}]},{"term":"Lung adenocarcinoma","organSystem":"Neoplasms benign, malignant and unspecified (incl cysts and polyps)","sourceVocabulary":"MedDRA 21.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":4717},{"groupId":"EG001","numEvents":2,"numAffected":2,"numAtRisk":4715}]},{"term":"Lung neoplasm","organSystem":"Neoplasms benign, malignant and unspecified (incl cysts and polyps)","sourceVocabulary":"MedDRA 21.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":4717},{"groupId":"EG001","numEvents":2,"numAffected":2,"numAtRisk":4715}]},{"term":"Lymphadenopathy mediastinal","organSystem":"Blood and lymphatic system disorders","sourceVocabulary":"MedDRA 21.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":2,"numAffected":2,"numAtRisk":4717},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":4715}]},{"term":"Lymphoproliferative disorder","organSystem":"Neoplasms benign, malignant and unspecified (incl cysts and polyps)","sourceVocabulary":"MedDRA 21.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":2,"numAffected":2,"numAtRisk":4717},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":4715}]},{"term":"Macular degeneration","organSystem":"Eye disorders","sourceVocabulary":"MedDRA 21.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":4717},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":4715}]},{"term":"Malignant neoplasm of unknown primary site","organSystem":"Neoplasms benign, malignant and unspecified (incl cysts and polyps)","sourceVocabulary":"MedDRA 21.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":2,"numAffected":2,"numAtRisk":4717},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":4715}]},{"term":"Melaena","organSystem":"Gastrointestinal disorders","sourceVocabulary":"MedDRA 21.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":4717},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":4715}]},{"term":"Meningioma","organSystem":"Neoplasms benign, malignant and unspecified (incl cysts and polyps)","sourceVocabulary":"MedDRA 21.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":4717},{"groupId":"EG001","numEvents":2,"numAffected":2,"numAtRisk":4715}]},{"term":"Metastases to bone","organSystem":"Neoplasms benign, malignant and unspecified (incl cysts and polyps)","sourceVocabulary":"MedDRA 21.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":4717},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":4715}]},{"term":"Metastatic gastric cancer","organSystem":"Neoplasms benign, malignant and unspecified (incl cysts and polyps)","sourceVocabulary":"MedDRA 21.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":4717},{"groupId":"EG001","numEvents":2,"numAffected":2,"numAtRisk":4715}]},{"term":"Microcytic anaemia","organSystem":"Blood and lymphatic system disorders","sourceVocabulary":"MedDRA 21.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":4717},{"groupId":"EG001","numEvents":2,"numAffected":2,"numAtRisk":4715}]},{"term":"Myelopathy","organSystem":"Nervous system disorders","sourceVocabulary":"MedDRA 21.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":4717},{"groupId":"EG001","numEvents":2,"numAffected":2,"numAtRisk":4715}]},{"term":"Myocardial fibrosis","organSystem":"Cardiac disorders","sourceVocabulary":"MedDRA 21.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":4717},{"groupId":"EG001","numEvents":2,"numAffected":2,"numAtRisk":4715}]},{"term":"Nausea","organSystem":"Gastrointestinal disorders","sourceVocabulary":"MedDRA 21.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":2,"numAffected":2,"numAtRisk":4717},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":4715}]},{"term":"Neuropathy peripheral","organSystem":"Nervous system disorders","sourceVocabulary":"MedDRA 21.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":4717},{"groupId":"EG001","numEvents":2,"numAffected":2,"numAtRisk":4715}]},{"term":"Oesophageal varices haemorrhage","organSystem":"Gastrointestinal disorders","sourceVocabulary":"MedDRA 21.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":4717},{"groupId":"EG001","numEvents":2,"numAffected":2,"numAtRisk":4715}]},{"term":"Osteitis","organSystem":"Musculoskeletal and connective tissue disorders","sourceVocabulary":"MedDRA 21.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":2,"numAffected":2,"numAtRisk":4717},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":4715}]},{"term":"Osteonecrosis","organSystem":"Musculoskeletal and connective tissue disorders","sourceVocabulary":"MedDRA 21.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":4717},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":4715}]},{"term":"Pain in extremity","organSystem":"Musculoskeletal and connective tissue disorders","sourceVocabulary":"MedDRA 21.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":4717},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":4715}]},{"term":"Pancreatitis chronic","organSystem":"Gastrointestinal disorders","sourceVocabulary":"MedDRA 21.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":4717},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":4715}]},{"term":"Peptic ulcer","organSystem":"Gastrointestinal disorders","sourceVocabulary":"MedDRA 21.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":2,"numAffected":2,"numAtRisk":4717},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":4715}]},{"term":"Peripheral sensory neuropathy","organSystem":"Nervous system disorders","sourceVocabulary":"MedDRA 21.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":4717},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":4715}]},{"term":"Perirectal abscess","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA 21.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":3,"numAffected":2,"numAtRisk":4717},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":4715}]},{"term":"Pneumonia viral","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA 21.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":2,"numAffected":2,"numAtRisk":4717},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":4715}]},{"term":"Post procedural sepsis","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA 21.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":4717},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":4715}]},{"term":"Postoperative thoracic procedure complication","organSystem":"Injury, poisoning and procedural complications","sourceVocabulary":"MedDRA 21.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":2,"numAffected":2,"numAtRisk":4717},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":4715}]},{"term":"Postoperative wound complication","organSystem":"Injury, poisoning and procedural complications","sourceVocabulary":"MedDRA 21.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":2,"numAffected":1,"numAtRisk":4717},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":4715}]},{"term":"Prostatic adenoma","organSystem":"Neoplasms benign, malignant and unspecified (incl cysts and polyps)","sourceVocabulary":"MedDRA 21.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":4717},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":4715}]},{"term":"Pulmonary sepsis","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA 21.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":2,"numAffected":2,"numAtRisk":4717},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":4715}]},{"term":"Pyrexia","organSystem":"General disorders","sourceVocabulary":"MedDRA 21.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":2,"numAffected":2,"numAtRisk":4717},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":4715}]},{"term":"Rectal cancer","organSystem":"Neoplasms benign, malignant and unspecified (incl cysts and polyps)","sourceVocabulary":"MedDRA 21.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":2,"numAffected":2,"numAtRisk":4717},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":4715}]},{"term":"Rectal haemorrhage","organSystem":"Gastrointestinal disorders","sourceVocabulary":"MedDRA 21.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":4717},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":4715}]},{"term":"Respiratory arrest","organSystem":"Respiratory, thoracic and mediastinal disorders","sourceVocabulary":"MedDRA 21.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":2,"numAffected":2,"numAtRisk":4717},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":4715}]},{"term":"Rheumatoid arthritis","organSystem":"Musculoskeletal and connective tissue disorders","sourceVocabulary":"MedDRA 21.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":4717},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":4715}]},{"term":"Sinus tachycardia","organSystem":"Cardiac disorders","sourceVocabulary":"MedDRA 21.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":2,"numAffected":2,"numAtRisk":4717},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":4715}]},{"term":"Sinusitis","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA 21.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":2,"numAffected":2,"numAtRisk":4717},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":4715}]},{"term":"Spinal compression fracture","organSystem":"Injury, poisoning and procedural complications","sourceVocabulary":"MedDRA 21.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":2,"numAffected":2,"numAtRisk":4717},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":4715}]},{"term":"Spinal osteoarthritis","organSystem":"Musculoskeletal and connective tissue disorders","sourceVocabulary":"MedDRA 21.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":4717},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":4715}]},{"term":"Spinal pain","organSystem":"Musculoskeletal and connective tissue disorders","sourceVocabulary":"MedDRA 21.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":4717},{"groupId":"EG001","numEvents":2,"numAffected":2,"numAtRisk":4715}]},{"term":"Squamous cell carcinoma of lung","organSystem":"Neoplasms benign, malignant and unspecified (incl cysts and polyps)","sourceVocabulary":"MedDRA 21.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":4717},{"groupId":"EG001","numEvents":2,"numAffected":2,"numAtRisk":4715}]},{"term":"Squamous cell carcinoma of skin","organSystem":"Neoplasms benign, malignant and unspecified (incl cysts and polyps)","sourceVocabulary":"MedDRA 21.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":4717},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":4715}]},{"term":"Squamous cell carcinoma of the oral cavity","organSystem":"Neoplasms benign, malignant and unspecified (incl cysts and polyps)","sourceVocabulary":"MedDRA 21.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":4717},{"groupId":"EG001","numEvents":2,"numAffected":2,"numAtRisk":4715}]},{"term":"Staphylococcal bacteraemia","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA 21.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":4717},{"groupId":"EG001","numEvents":2,"numAffected":2,"numAtRisk":4715}]},{"term":"Strangulated umbilical hernia","organSystem":"Gastrointestinal disorders","sourceVocabulary":"MedDRA 21.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":4717},{"groupId":"EG001","numEvents":2,"numAffected":2,"numAtRisk":4715}]},{"term":"Subdural haematoma","organSystem":"Injury, poisoning and procedural complications","sourceVocabulary":"MedDRA 21.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":2,"numAffected":2,"numAtRisk":4717},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":4715}]},{"term":"Sudden cardiac death","organSystem":"General disorders","sourceVocabulary":"MedDRA 21.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":2,"numAffected":2,"numAtRisk":4717},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":4715}]},{"term":"Suicidal ideation","organSystem":"Psychiatric disorders","sourceVocabulary":"MedDRA 21.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":4,"numAffected":1,"numAtRisk":4717},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":4715}]},{"term":"Systemic inflammatory response syndrome","organSystem":"General disorders","sourceVocabulary":"MedDRA 21.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":4717},{"groupId":"EG001","numEvents":2,"numAffected":2,"numAtRisk":4715}]},{"term":"Troponin increased","organSystem":"Investigations","sourceVocabulary":"MedDRA 21.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":4717},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":4715}]},{"term":"Urinary tract obstruction","organSystem":"Renal and urinary disorders","sourceVocabulary":"MedDRA 21.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":4717},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":4715}]},{"term":"Vascular pseudoaneurysm","organSystem":"Injury, poisoning and procedural complications","sourceVocabulary":"MedDRA 21.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":2,"numAffected":2,"numAtRisk":4717},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":4715}]},{"term":"Venous thrombosis","organSystem":"Vascular disorders","sourceVocabulary":"MedDRA 21.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":2,"numAffected":2,"numAtRisk":4717},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":4715}]},{"term":"Wound sepsis","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA 21.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":4717},{"groupId":"EG001","numEvents":2,"numAffected":2,"numAtRisk":4715}]},{"term":"Abdominal abscess","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA 21.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":4717},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":4715}]},{"term":"Abdominal discomfort","organSystem":"Gastrointestinal disorders","sourceVocabulary":"MedDRA 21.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":4717},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":4715}]},{"term":"Abdominal sepsis","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA 21.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":4717},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":4715}]},{"term":"Abdominal wall abscess","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA 21.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":4717},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":4715}]},{"term":"Abscess neck","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA 21.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":4717},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":4715}]},{"term":"Abscess oral","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA 21.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":4717},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":4715}]},{"term":"Accelerated hypertension","organSystem":"Vascular disorders","sourceVocabulary":"MedDRA 21.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":4717},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":4715}]},{"term":"Accidental death","organSystem":"General disorders","sourceVocabulary":"MedDRA 21.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":4717},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":4715}]},{"term":"Accidental overdose","organSystem":"Injury, poisoning and procedural complications","sourceVocabulary":"MedDRA 21.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":4717},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":4715}]},{"term":"Acoustic neuritis","organSystem":"Nervous system disorders","sourceVocabulary":"MedDRA 21.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":4717},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":4715}]},{"term":"Actinic keratosis","organSystem":"Skin and subcutaneous tissue disorders","sourceVocabulary":"MedDRA 21.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":4717},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":4715}]},{"term":"Acute hepatic failure","organSystem":"Hepatobiliary disorders","sourceVocabulary":"MedDRA 21.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":4717},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":4715}]},{"term":"Acute left ventricular failure","organSystem":"Cardiac disorders","sourceVocabulary":"MedDRA 21.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":4717},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":4715}]},{"term":"Acute myocardial infarction","organSystem":"Cardiac disorders","sourceVocabulary":"MedDRA 21.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":4717},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":4715}]},{"term":"Adenomatous polyposis coli","organSystem":"Congenital, familial and genetic disorders","sourceVocabulary":"MedDRA 21.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":4717},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":4715}]},{"term":"Adjacent segment degeneration","organSystem":"Injury, poisoning and procedural complications","sourceVocabulary":"MedDRA 21.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":4717},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":4715}]},{"term":"Adjustment disorder","organSystem":"Psychiatric disorders","sourceVocabulary":"MedDRA 21.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":4717},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":4715}]},{"term":"Adrenal adenoma","organSystem":"Neoplasms benign, malignant and unspecified (incl cysts and polyps)","sourceVocabulary":"MedDRA 21.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":4717},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":4715}]},{"term":"Adrenal mass","organSystem":"Endocrine disorders","sourceVocabulary":"MedDRA 21.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":4717},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":4715}]},{"term":"Affective disorder","organSystem":"Psychiatric disorders","sourceVocabulary":"MedDRA 21.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":4717},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":4715}]},{"term":"Alanine aminotransferase increased","organSystem":"Investigations","sourceVocabulary":"MedDRA 21.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":4717},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":4715}]},{"term":"Alcoholic pancreatitis","organSystem":"Gastrointestinal disorders","sourceVocabulary":"MedDRA 21.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":4717},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":4715}]},{"term":"Alcoholism","organSystem":"Psychiatric disorders","sourceVocabulary":"MedDRA 21.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":4717},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":4715}]},{"term":"Anaemia of chronic disease","organSystem":"Blood and lymphatic system disorders","sourceVocabulary":"MedDRA 21.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":4717},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":4715}]},{"term":"Anal fistula","organSystem":"Gastrointestinal disorders","sourceVocabulary":"MedDRA 21.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":4717},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":4715}]},{"term":"Anastomotic stenosis","organSystem":"Injury, poisoning and procedural complications","sourceVocabulary":"MedDRA 21.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":4717},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":4715}]},{"term":"Animal bite","organSystem":"Injury, poisoning and procedural complications","sourceVocabulary":"MedDRA 21.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":4717},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":4715}]},{"term":"Anticoagulation drug level above therapeutic","organSystem":"Investigations","sourceVocabulary":"MedDRA 21.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":4717},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":4715}]},{"term":"Anxiety disorder","organSystem":"Psychiatric disorders","sourceVocabulary":"MedDRA 21.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":4717},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":4715}]},{"term":"Aortoenteric fistula","organSystem":"Gastrointestinal disorders","sourceVocabulary":"MedDRA 21.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":4717},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":4715}]},{"term":"Aphasia","organSystem":"Nervous system disorders","sourceVocabulary":"MedDRA 21.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":4717},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":4715}]},{"term":"Arterial haemorrhage","organSystem":"Vascular disorders","sourceVocabulary":"MedDRA 21.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":4717},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":4715}]},{"term":"Arterial restenosis","organSystem":"Injury, poisoning and procedural complications","sourceVocabulary":"MedDRA 21.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":4717},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":4715}]},{"term":"Arthritis","organSystem":"Musculoskeletal and connective tissue disorders","sourceVocabulary":"MedDRA 21.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":4717},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":4715}]},{"term":"Arthritis infective","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA 21.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":4717},{"groupId":"EG001","numEvents":2,"numAffected":1,"numAtRisk":4715}]},{"term":"Arthropathy","organSystem":"Musculoskeletal and connective tissue disorders","sourceVocabulary":"MedDRA 21.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":4717},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":4715}]},{"term":"Articular calcification","organSystem":"Musculoskeletal and connective tissue disorders","sourceVocabulary":"MedDRA 21.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":4717},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":4715}]},{"term":"Ascites","organSystem":"Gastrointestinal disorders","sourceVocabulary":"MedDRA 21.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":4717},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":4715}]},{"term":"Aspiration bronchial","organSystem":"Investigations","sourceVocabulary":"MedDRA 21.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":4717},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":4715}]},{"term":"Atrial thrombosis","organSystem":"Cardiac disorders","sourceVocabulary":"MedDRA 21.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":4717},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":4715}]},{"term":"Autonomic neuropathy","organSystem":"Nervous system disorders","sourceVocabulary":"MedDRA 21.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":4717},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":4715}]},{"term":"Basilar artery aneurysm","organSystem":"Nervous system disorders","sourceVocabulary":"MedDRA 21.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":4717},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":4715}]},{"term":"Benign gastric neoplasm","organSystem":"Neoplasms benign, malignant and unspecified (incl cysts and polyps)","sourceVocabulary":"MedDRA 21.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":4717},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":4715}]},{"term":"Benign neoplasm of bladder","organSystem":"Neoplasms benign, malignant and unspecified (incl cysts and polyps)","sourceVocabulary":"MedDRA 21.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":4717},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":4715}]},{"term":"Benign salivary gland neoplasm","organSystem":"Neoplasms benign, malignant and unspecified (incl cysts and polyps)","sourceVocabulary":"MedDRA 21.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":4717},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":4715}]},{"term":"Beta haemolytic streptococcal infection","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA 21.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":4717},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":4715}]},{"term":"Biliary ascites","organSystem":"Gastrointestinal disorders","sourceVocabulary":"MedDRA 21.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":4717},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":4715}]},{"term":"Bipolar disorder","organSystem":"Psychiatric disorders","sourceVocabulary":"MedDRA 21.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":4717},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":4715}]},{"term":"Bladder cancer recurrent","organSystem":"Neoplasms benign, malignant and unspecified (incl cysts and polyps)","sourceVocabulary":"MedDRA 21.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":4717},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":4715}]},{"term":"Bladder cancer stage 0, with cancer in situ","organSystem":"Neoplasms benign, malignant and unspecified (incl cysts and polyps)","sourceVocabulary":"MedDRA 21.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":4717},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":4715}]},{"term":"Bladder cancer stage III","organSystem":"Neoplasms benign, malignant and unspecified (incl cysts and polyps)","sourceVocabulary":"MedDRA 21.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":4717},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":4715}]},{"term":"Bladder neck obstruction","organSystem":"Renal and urinary disorders","sourceVocabulary":"MedDRA 21.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":4717},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":4715}]},{"term":"Bleeding varicose vein","organSystem":"Vascular disorders","sourceVocabulary":"MedDRA 21.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":4717},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":4715}]},{"term":"Blindness","organSystem":"Eye disorders","sourceVocabulary":"MedDRA 21.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":4717},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":4715}]},{"term":"Blood alkaline phosphatase increased","organSystem":"Investigations","sourceVocabulary":"MedDRA 21.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":4717},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":4715}]},{"term":"Blood glucose abnormal","organSystem":"Investigations","sourceVocabulary":"MedDRA 21.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":4717},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":4715}]},{"term":"Blood ketone body increased","organSystem":"Investigations","sourceVocabulary":"MedDRA 21.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":4717},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":4715}]},{"term":"Blood pressure inadequately controlled","organSystem":"Vascular disorders","sourceVocabulary":"MedDRA 21.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":4717},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":4715}]},{"term":"Bone cancer","organSystem":"Neoplasms benign, malignant and unspecified (incl cysts and polyps)","sourceVocabulary":"MedDRA 21.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":4717},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":4715}]},{"term":"Brain abscess","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA 21.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":4717},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":4715}]},{"term":"Brain neoplasm malignant","organSystem":"Neoplasms benign, malignant and unspecified (incl cysts and polyps)","sourceVocabulary":"MedDRA 21.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":4717},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":4715}]},{"term":"Breast cancer stage II","organSystem":"Neoplasms benign, malignant and unspecified (incl cysts and polyps)","sourceVocabulary":"MedDRA 21.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":4717},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":4715}]},{"term":"Breast fibroma","organSystem":"Neoplasms benign, malignant and unspecified (incl cysts and polyps)","sourceVocabulary":"MedDRA 21.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":4717},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":4715}]},{"term":"Breast haematoma","organSystem":"Reproductive system and breast disorders","sourceVocabulary":"MedDRA 21.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":4717},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":4715}]},{"term":"Breast neoplasm","organSystem":"Neoplasms benign, malignant and unspecified (incl cysts and polyps)","sourceVocabulary":"MedDRA 21.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":4717},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":4715}]},{"term":"Breathing-related sleep disorder","organSystem":"Psychiatric disorders","sourceVocabulary":"MedDRA 21.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":4717},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":4715}]},{"term":"Bronchial neoplasm","organSystem":"Neoplasms benign, malignant and unspecified (incl cysts and polyps)","sourceVocabulary":"MedDRA 21.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":4717},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":4715}]},{"term":"Bronchiectasis","organSystem":"Respiratory, thoracic and mediastinal disorders","sourceVocabulary":"MedDRA 21.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":4717},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":4715}]},{"term":"Brugada syndrome","organSystem":"Cardiac disorders","sourceVocabulary":"MedDRA 21.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":2,"numAffected":1,"numAtRisk":4717},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":4715}]},{"term":"Bursitis","organSystem":"Musculoskeletal and connective tissue disorders","sourceVocabulary":"MedDRA 21.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":4717},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":4715}]},{"term":"Calculus urinary","organSystem":"Renal and urinary disorders","sourceVocabulary":"MedDRA 21.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":4717},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":4715}]},{"term":"Campylobacter gastroenteritis","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA 21.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":4717},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":4715}]},{"term":"Candiduria","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA 21.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":4717},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":4715}]},{"term":"Carbon monoxide poisoning","organSystem":"Injury, poisoning and procedural complications","sourceVocabulary":"MedDRA 21.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":4717},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":4715}]},{"term":"Cardiac complication associated with device","organSystem":"General disorders","sourceVocabulary":"MedDRA 21.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":4717},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":4715}]},{"term":"Cardiac myxoma","organSystem":"Neoplasms benign, malignant and unspecified (incl cysts and polyps)","sourceVocabulary":"MedDRA 21.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":4717},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":4715}]},{"term":"Cardiorenal syndrome","organSystem":"Cardiac disorders","sourceVocabulary":"MedDRA 21.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":4717},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":4715}]},{"term":"Carotid artery disease","organSystem":"Nervous system disorders","sourceVocabulary":"MedDRA 21.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":4717},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":4715}]},{"term":"Cartilage injury","organSystem":"Injury, poisoning and procedural complications","sourceVocabulary":"MedDRA 21.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":4717},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":4715}]},{"term":"Cauda equina syndrome","organSystem":"Nervous system disorders","sourceVocabulary":"MedDRA 21.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":4717},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":4715}]},{"term":"Cellulitis gangrenous","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA 21.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":4717},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":4715}]},{"term":"Cellulitis of male external genital organ","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA 21.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":4717},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":4715}]},{"term":"Cerebral infarction","organSystem":"Nervous system disorders","sourceVocabulary":"MedDRA 21.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":4717},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":4715}]},{"term":"Cerebral ischaemia","organSystem":"Nervous system disorders","sourceVocabulary":"MedDRA 21.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":4717},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":4715}]},{"term":"Cerebrovascular accident","organSystem":"Nervous system disorders","sourceVocabulary":"MedDRA 21.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":4717},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":4715}]},{"term":"Cervical dysplasia","organSystem":"Reproductive system and breast disorders","sourceVocabulary":"MedDRA 21.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":4717},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":4715}]},{"term":"Cervical spinal stenosis","organSystem":"Musculoskeletal and connective tissue disorders","sourceVocabulary":"MedDRA 21.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":4717},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":4715}]},{"term":"Chest injury","organSystem":"Injury, poisoning and procedural complications","sourceVocabulary":"MedDRA 21.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":4717},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":4715}]},{"term":"Cholecystitis infective","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA 21.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":4717},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":4715}]},{"term":"Choroidal detachment","organSystem":"Eye disorders","sourceVocabulary":"MedDRA 21.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":4717},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":4715}]},{"term":"Chromophobe renal cell carcinoma","organSystem":"Neoplasms benign, malignant and unspecified (incl cysts and polyps)","sourceVocabulary":"MedDRA 21.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":4717},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":4715}]},{"term":"Chronic lymphocytic leukaemia","organSystem":"Neoplasms benign, malignant and unspecified (incl cysts and polyps)","sourceVocabulary":"MedDRA 21.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":4717},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":4715}]},{"term":"Chronic myeloid leukaemia","organSystem":"Neoplasms benign, malignant and unspecified (incl cysts and polyps)","sourceVocabulary":"MedDRA 21.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":4717},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":4715}]},{"term":"Chronic respiratory failure","organSystem":"Respiratory, thoracic and mediastinal disorders","sourceVocabulary":"MedDRA 21.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":4717},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":4715}]},{"term":"Chronic sinusitis","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA 21.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":4717},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":4715}]},{"term":"Circulatory collapse","organSystem":"Vascular disorders","sourceVocabulary":"MedDRA 21.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":4717},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":4715}]},{"term":"Citrobacter infection","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA 21.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":4717},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":4715}]},{"term":"Citrobacter sepsis","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA 21.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":4717},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":4715}]},{"term":"Clostridial infection","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA 21.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":4717},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":4715}]},{"term":"Clostridium difficile colitis","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA 21.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":4717},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":4715}]},{"term":"Coagulopathy","organSystem":"Blood and lymphatic system disorders","sourceVocabulary":"MedDRA 21.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":4717},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":4715}]},{"term":"Cognitive disorder","organSystem":"Nervous system disorders","sourceVocabulary":"MedDRA 21.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":4717},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":4715}]},{"term":"Colitis ischaemic","organSystem":"Gastrointestinal disorders","sourceVocabulary":"MedDRA 21.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":4717},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":4715}]},{"term":"Colitis ulcerative","organSystem":"Gastrointestinal disorders","sourceVocabulary":"MedDRA 21.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":4717},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":4715}]},{"term":"Colon cancer stage 0","organSystem":"Neoplasms benign, malignant and unspecified (incl cysts and polyps)","sourceVocabulary":"MedDRA 21.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":4717},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":4715}]},{"term":"Colon cancer stage IV","organSystem":"Neoplasms benign, malignant and unspecified (incl cysts and polyps)","sourceVocabulary":"MedDRA 21.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":4717},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":4715}]},{"term":"Colorectal adenocarcinoma","organSystem":"Neoplasms benign, malignant and unspecified (incl cysts and polyps)","sourceVocabulary":"MedDRA 21.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":4717},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":4715}]},{"term":"Completed suicide","organSystem":"Psychiatric disorders","sourceVocabulary":"MedDRA 21.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":4717},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":4715}]},{"term":"Complication associated with device","organSystem":"General disorders","sourceVocabulary":"MedDRA 21.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":4717},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":4715}]},{"term":"Condition aggravated","organSystem":"General disorders","sourceVocabulary":"MedDRA 21.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":4717},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":4715}]},{"term":"Contrast media reaction","organSystem":"Immune system disorders","sourceVocabulary":"MedDRA 21.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":4717},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":4715}]},{"term":"Corneoconjunctival intraepithelial neoplasia","organSystem":"Neoplasms benign, malignant and unspecified (incl cysts and polyps)","sourceVocabulary":"MedDRA 21.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":4717},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":4715}]},{"term":"Coronary artery dissection","organSystem":"Cardiac disorders","sourceVocabulary":"MedDRA 21.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":4717},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":4715}]},{"term":"Coronary no-reflow phenomenon","organSystem":"Cardiac disorders","sourceVocabulary":"MedDRA 21.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":4717},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":4715}]},{"term":"Coronary ostial stenosis","organSystem":"Cardiac disorders","sourceVocabulary":"MedDRA 21.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":4717},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":4715}]},{"term":"Costochondritis","organSystem":"Musculoskeletal and connective tissue disorders","sourceVocabulary":"MedDRA 21.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":4717},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":4715}]},{"term":"Crohn's disease","organSystem":"Gastrointestinal disorders","sourceVocabulary":"MedDRA 21.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":4717},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":4715}]},{"term":"Cystitis klebsiella","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA 21.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":4717},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":4715}]},{"term":"Cystocele","organSystem":"Reproductive system and breast disorders","sourceVocabulary":"MedDRA 21.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":4717},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":4715}]},{"term":"Dacryocystitis","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA 21.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":4717},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":4715}]},{"term":"Deafness","organSystem":"Ear and labyrinth disorders","sourceVocabulary":"MedDRA 21.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":4717},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":4715}]},{"term":"Deafness unilateral","organSystem":"Ear and labyrinth disorders","sourceVocabulary":"MedDRA 21.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":4717},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":4715}]},{"term":"Decreased appetite","organSystem":"Metabolism and nutrition disorders","sourceVocabulary":"MedDRA 21.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":4717},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":4715}]},{"term":"Dementia Alzheimer's type","organSystem":"Nervous system disorders","sourceVocabulary":"MedDRA 21.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":4717},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":4715}]},{"term":"Dengue fever","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA 21.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":4717},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":4715}]},{"term":"Dengue haemorrhagic fever","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA 21.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":4717},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":4715}]},{"term":"Depressed level of consciousness","organSystem":"Nervous system disorders","sourceVocabulary":"MedDRA 21.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":4717},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":4715}]},{"term":"Dermatitis allergic","organSystem":"Skin and subcutaneous tissue disorders","sourceVocabulary":"MedDRA 21.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":4717},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":4715}]},{"term":"Dermatofibrosarcoma protuberans","organSystem":"Neoplasms benign, malignant and unspecified (incl cysts and polyps)","sourceVocabulary":"MedDRA 21.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":4717},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":4715}]},{"term":"Device extrusion","organSystem":"Product Issues","sourceVocabulary":"MedDRA 21.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":4717},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":4715}]},{"term":"Device issue","organSystem":"Product Issues","sourceVocabulary":"MedDRA 21.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":4717},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":4715}]},{"term":"Diabetic gastroparesis","organSystem":"Gastrointestinal disorders","sourceVocabulary":"MedDRA 21.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":4717},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":4715}]},{"term":"Diabetic microangiopathy","organSystem":"Vascular disorders","sourceVocabulary":"MedDRA 21.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":4717},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":4715}]},{"term":"Diabetic mononeuropathy","organSystem":"Nervous system disorders","sourceVocabulary":"MedDRA 21.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":4717},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":4715}]},{"term":"Diabetic nephropathy","organSystem":"Renal and urinary disorders","sourceVocabulary":"MedDRA 21.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":4717},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":4715}]},{"term":"Diabetic neuropathic ulcer","organSystem":"Skin and subcutaneous tissue disorders","sourceVocabulary":"MedDRA 21.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":4717},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":4715}]},{"term":"Diffuse large B-cell lymphoma","organSystem":"Neoplasms benign, malignant and unspecified (incl cysts and polyps)","sourceVocabulary":"MedDRA 21.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":4717},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":4715}]},{"term":"Diplopia","organSystem":"Eye disorders","sourceVocabulary":"MedDRA 21.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":4717},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":4715}]},{"term":"Discomfort","organSystem":"General disorders","sourceVocabulary":"MedDRA 21.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":4717},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":4715}]},{"term":"Drug hypersensitivity","organSystem":"Immune system disorders","sourceVocabulary":"MedDRA 21.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":4717},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":4715}]},{"term":"Drug withdrawal syndrome","organSystem":"General disorders","sourceVocabulary":"MedDRA 21.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":4717},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":4715}]},{"term":"Drug-induced liver injury","organSystem":"Hepatobiliary disorders","sourceVocabulary":"MedDRA 21.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":4717},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":4715}]},{"term":"Dry gangrene","organSystem":"Vascular disorders","sourceVocabulary":"MedDRA 21.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":4717},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":4715}]},{"term":"Duodenal ulcer perforation","organSystem":"Gastrointestinal disorders","sourceVocabulary":"MedDRA 21.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":4717},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":4715}]},{"term":"Duodenitis","organSystem":"Gastrointestinal disorders","sourceVocabulary":"MedDRA 21.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":4717},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":4715}]},{"term":"Dysarthria","organSystem":"Nervous system disorders","sourceVocabulary":"MedDRA 21.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":4717},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":4715}]},{"term":"Dysfunctional uterine bleeding","organSystem":"Reproductive system and breast disorders","sourceVocabulary":"MedDRA 21.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":4717},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":4715}]},{"term":"Dysphagia","organSystem":"Gastrointestinal disorders","sourceVocabulary":"MedDRA 21.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":4717},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":4715}]},{"term":"Emphysematous pyelonephritis","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA 21.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":4717},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":4715}]},{"term":"Empyema","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA 21.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":4717},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":4715}]},{"term":"Endometrial adenocarcinoma","organSystem":"Neoplasms benign, malignant and unspecified (incl cysts and polyps)","sourceVocabulary":"MedDRA 21.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":4717},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":4715}]},{"term":"Enterobacter sepsis","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA 21.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":4717},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":4715}]},{"term":"Enterococcal bacteraemia","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA 21.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":4717},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":4715}]},{"term":"Enterocolitis infectious","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA 21.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":4717},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":4715}]},{"term":"Epiglottic cyst","organSystem":"Respiratory, thoracic and mediastinal disorders","sourceVocabulary":"MedDRA 21.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":4717},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":4715}]},{"term":"Epiploic appendagitis","organSystem":"Gastrointestinal disorders","sourceVocabulary":"MedDRA 21.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":4717},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":4715}]},{"term":"Erosive oesophagitis","organSystem":"Gastrointestinal disorders","sourceVocabulary":"MedDRA 21.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":4717},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":4715}]},{"term":"Extradural abscess","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA 21.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":4717},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":4715}]},{"term":"Eye pain","organSystem":"Eye disorders","sourceVocabulary":"MedDRA 21.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":4717},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":4715}]},{"term":"Facial nerve disorder","organSystem":"Nervous system disorders","sourceVocabulary":"MedDRA 21.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":4717},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":4715}]},{"term":"Faecaloma","organSystem":"Gastrointestinal disorders","sourceVocabulary":"MedDRA 21.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":4717},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":4715}]},{"term":"Failure to thrive","organSystem":"Metabolism and nutrition disorders","sourceVocabulary":"MedDRA 21.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":4717},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":4715}]},{"term":"Fatigue","organSystem":"General disorders","sourceVocabulary":"MedDRA 21.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":4717},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":4715}]},{"term":"Femoral artery embolism","organSystem":"Vascular disorders","sourceVocabulary":"MedDRA 21.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":4717},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":4715}]},{"term":"Fibromyalgia","organSystem":"Musculoskeletal and connective tissue disorders","sourceVocabulary":"MedDRA 21.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":4717},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":4715}]},{"term":"Finger amputation","organSystem":"Surgical and medical procedures","sourceVocabulary":"MedDRA 21.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":4717},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":4715}]},{"term":"Fluid overload","organSystem":"Metabolism and nutrition disorders","sourceVocabulary":"MedDRA 21.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":4717},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":4715}]},{"term":"Food intolerance","organSystem":"Metabolism and nutrition disorders","sourceVocabulary":"MedDRA 21.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":4717},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":4715}]},{"term":"Fracture nonunion","organSystem":"Musculoskeletal and connective tissue disorders","sourceVocabulary":"MedDRA 21.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":4717},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":4715}]},{"term":"Fractured coccyx","organSystem":"Injury, poisoning and procedural complications","sourceVocabulary":"MedDRA 21.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":4717},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":4715}]},{"term":"Fractured sacrum","organSystem":"Injury, poisoning and procedural complications","sourceVocabulary":"MedDRA 21.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":4717},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":4715}]},{"term":"Gamma-glutamyltransferase increased","organSystem":"Investigations","sourceVocabulary":"MedDRA 21.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":4717},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":4715}]},{"term":"Gas gangrene","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA 21.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":4717},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":4715}]},{"term":"Gastric antral vascular ectasia","organSystem":"Gastrointestinal disorders","sourceVocabulary":"MedDRA 21.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":4717},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":4715}]},{"term":"Gastric haemorrhage","organSystem":"Gastrointestinal disorders","sourceVocabulary":"MedDRA 21.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":4717},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":4715}]},{"term":"Gastroenteritis eosinophilic","organSystem":"Gastrointestinal disorders","sourceVocabulary":"MedDRA 21.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":4717},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":4715}]},{"term":"Gastroenteritis salmonella","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA 21.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":4717},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":4715}]},{"term":"Gastrointestinal disorder","organSystem":"Gastrointestinal disorders","sourceVocabulary":"MedDRA 21.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":4717},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":4715}]},{"term":"Gastrointestinal disorder postoperative","organSystem":"Injury, poisoning and procedural complications","sourceVocabulary":"MedDRA 21.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":4717},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":4715}]},{"term":"Gastrointestinal necrosis","organSystem":"Gastrointestinal disorders","sourceVocabulary":"MedDRA 21.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":4717},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":4715}]},{"term":"Glioblastoma","organSystem":"Neoplasms benign, malignant and unspecified (incl cysts and polyps)","sourceVocabulary":"MedDRA 21.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":4717},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":4715}]},{"term":"Glomerulonephritis acute","organSystem":"Renal and urinary disorders","sourceVocabulary":"MedDRA 21.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":4717},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":4715}]},{"term":"Goitre","organSystem":"Endocrine disorders","sourceVocabulary":"MedDRA 21.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":4717},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":4715}]},{"term":"Gout","organSystem":"Metabolism and nutrition disorders","sourceVocabulary":"MedDRA 21.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":4717},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":4715}]},{"term":"Graft thrombosis","organSystem":"Injury, poisoning and procedural complications","sourceVocabulary":"MedDRA 21.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":4717},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":4715}]},{"term":"Granulomatosis with polyangiitis","organSystem":"Vascular disorders","sourceVocabulary":"MedDRA 21.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":4717},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":4715}]},{"term":"Gun shot wound","organSystem":"Injury, poisoning and procedural complications","sourceVocabulary":"MedDRA 21.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":4717},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":4715}]},{"term":"H1N1 influenza","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA 21.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":4717},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":4715}]},{"term":"Haematemesis","organSystem":"Gastrointestinal disorders","sourceVocabulary":"MedDRA 21.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":4717},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":4715}]},{"term":"Haematoma infection","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA 21.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":4717},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":4715}]},{"term":"Haemolysis","organSystem":"Blood and lymphatic system disorders","sourceVocabulary":"MedDRA 21.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":4717},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":4715}]},{"term":"Haemorrhage","organSystem":"Vascular disorders","sourceVocabulary":"MedDRA 21.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":4717},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":4715}]},{"term":"Haemorrhagic arteriovenous malformation","organSystem":"Congenital, familial and genetic disorders","sourceVocabulary":"MedDRA 21.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":4717},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":4715}]},{"term":"Haemorrhoids","organSystem":"Gastrointestinal disorders","sourceVocabulary":"MedDRA 21.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":4717},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":4715}]},{"term":"Hallucination","organSystem":"Psychiatric disorders","sourceVocabulary":"MedDRA 21.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":4717},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":4715}]},{"term":"Helicobacter gastritis","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA 21.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":4717},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":4715}]},{"term":"Helicobacter infection","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA 21.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":4717},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":4715}]},{"term":"Hemiparesis","organSystem":"Nervous system disorders","sourceVocabulary":"MedDRA 21.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":4717},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":4715}]},{"term":"Hepatic steatosis","organSystem":"Hepatobiliary disorders","sourceVocabulary":"MedDRA 21.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":4717},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":4715}]},{"term":"Hepatitis E","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA 21.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":4717},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":4715}]},{"term":"Hepatotoxicity","organSystem":"Hepatobiliary disorders","sourceVocabulary":"MedDRA 21.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":4717},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":4715}]},{"term":"Herpes zoster","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA 21.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":4717},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":4715}]},{"term":"Herpes zoster infection neurological","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA 21.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":4717},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":4715}]},{"term":"Hidradenitis","organSystem":"Skin and subcutaneous tissue disorders","sourceVocabulary":"MedDRA 21.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":4717},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":4715}]},{"term":"Hydrocephalus","organSystem":"Nervous system disorders","sourceVocabulary":"MedDRA 21.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":4717},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":4715}]},{"term":"Hydrothorax","organSystem":"Respiratory, thoracic and mediastinal disorders","sourceVocabulary":"MedDRA 21.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":4717},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":4715}]},{"term":"Hypercalcaemia","organSystem":"Metabolism and nutrition disorders","sourceVocabulary":"MedDRA 21.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":4717},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":4715}]},{"term":"Hypercapnia","organSystem":"Respiratory, thoracic and mediastinal disorders","sourceVocabulary":"MedDRA 21.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":4717},{"groupId":"EG001","numEvents":2,"numAffected":1,"numAtRisk":4715}]},{"term":"Hyperhidrosis","organSystem":"Skin and subcutaneous tissue disorders","sourceVocabulary":"MedDRA 21.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":4717},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":4715}]},{"term":"Hyperosmolar state","organSystem":"Metabolism and nutrition disorders","sourceVocabulary":"MedDRA 21.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":4717},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":4715}]},{"term":"Hyperparathyroidism","organSystem":"Endocrine disorders","sourceVocabulary":"MedDRA 21.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":4717},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":4715}]},{"term":"Hypersensitivity","organSystem":"Immune system disorders","sourceVocabulary":"MedDRA 21.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":4717},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":4715}]},{"term":"Hypertensive heart disease","organSystem":"Cardiac disorders","sourceVocabulary":"MedDRA 21.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":4717},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":4715}]},{"term":"Hypertonic bladder","organSystem":"Renal and urinary disorders","sourceVocabulary":"MedDRA 21.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":4717},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":4715}]},{"term":"Hypertrophic cardiomyopathy","organSystem":"Congenital, familial and genetic disorders","sourceVocabulary":"MedDRA 21.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":4717},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":4715}]},{"term":"Hyperventilation","organSystem":"Respiratory, thoracic and mediastinal disorders","sourceVocabulary":"MedDRA 21.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":4717},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":4715}]},{"term":"Hypoaesthesia","organSystem":"Nervous system disorders","sourceVocabulary":"MedDRA 21.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":4717},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":4715}]},{"term":"Hypoaesthesia oral","organSystem":"Gastrointestinal disorders","sourceVocabulary":"MedDRA 21.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":4717},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":4715}]},{"term":"Hypoalbuminaemia","organSystem":"Metabolism and nutrition disorders","sourceVocabulary":"MedDRA 21.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":4717},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":4715}]},{"term":"Hypoglycaemic coma","organSystem":"Nervous system disorders","sourceVocabulary":"MedDRA 21.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":4717},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":4715}]},{"term":"Hypoglycaemic unconsciousness","organSystem":"Nervous system disorders","sourceVocabulary":"MedDRA 21.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":4717},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":4715}]},{"term":"Hyponatraemia","organSystem":"Metabolism and nutrition disorders","sourceVocabulary":"MedDRA 21.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":4717},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":4715}]},{"term":"Hypopharyngeal cancer","organSystem":"Neoplasms benign, malignant and unspecified (incl cysts and polyps)","sourceVocabulary":"MedDRA 21.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":4717},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":4715}]},{"term":"Hypotony of eye","organSystem":"Eye disorders","sourceVocabulary":"MedDRA 21.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":4717},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":4715}]},{"term":"Hypovolaemia","organSystem":"Metabolism and nutrition disorders","sourceVocabulary":"MedDRA 21.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":4717},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":4715}]},{"term":"IIIrd nerve disorder","organSystem":"Nervous system disorders","sourceVocabulary":"MedDRA 21.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":4717},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":4715}]},{"term":"Idiopathic pulmonary fibrosis","organSystem":"Respiratory, thoracic and mediastinal disorders","sourceVocabulary":"MedDRA 21.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":4717},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":4715}]},{"term":"Ileus","organSystem":"Gastrointestinal disorders","sourceVocabulary":"MedDRA 21.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":4717},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":4715}]},{"term":"Iliac artery occlusion","organSystem":"Vascular disorders","sourceVocabulary":"MedDRA 21.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":4717},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":4715}]},{"term":"Impulse-control disorder","organSystem":"Psychiatric disorders","sourceVocabulary":"MedDRA 21.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":4717},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":4715}]},{"term":"Incarcerated hernia","organSystem":"General disorders","sourceVocabulary":"MedDRA 21.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":4717},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":4715}]},{"term":"Infected bite","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA 21.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":4717},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":4715}]},{"term":"Infectious pleural effusion","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA 21.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":4717},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":4715}]},{"term":"Inflammation","organSystem":"General disorders","sourceVocabulary":"MedDRA 21.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":4717},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":4715}]},{"term":"Insulin-requiring type 2 diabetes mellitus","organSystem":"Metabolism and nutrition disorders","sourceVocabulary":"MedDRA 21.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":4717},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":4715}]},{"term":"Intensive care unit acquired weakness","organSystem":"Nervous system disorders","sourceVocabulary":"MedDRA 21.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":4717},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":4715}]},{"term":"Intentional overdose","organSystem":"Injury, poisoning and procedural complications","sourceVocabulary":"MedDRA 21.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":4717},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":4715}]},{"term":"Intervertebral disc disorder","organSystem":"Musculoskeletal and connective tissue disorders","sourceVocabulary":"MedDRA 21.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":4717},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":4715}]},{"term":"Intestinal adenocarcinoma","organSystem":"Neoplasms benign, malignant and unspecified (incl cysts and polyps)","sourceVocabulary":"MedDRA 21.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":4717},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":4715}]},{"term":"Intestinal metastasis","organSystem":"Neoplasms benign, malignant and unspecified (incl cysts and polyps)","sourceVocabulary":"MedDRA 21.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":4717},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":4715}]},{"term":"Intestinal perforation","organSystem":"Gastrointestinal disorders","sourceVocabulary":"MedDRA 21.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":4717},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":4715}]},{"term":"Intestinal polyp","organSystem":"Gastrointestinal disorders","sourceVocabulary":"MedDRA 21.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":4717},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":4715}]},{"term":"Intracardiac thrombus","organSystem":"Cardiac disorders","sourceVocabulary":"MedDRA 21.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":4717},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":4715}]},{"term":"Intracranial aneurysm","organSystem":"Nervous system disorders","sourceVocabulary":"MedDRA 21.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":4717},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":4715}]},{"term":"Invasive ductal breast carcinoma","organSystem":"Neoplasms benign, malignant and unspecified (incl cysts and polyps)","sourceVocabulary":"MedDRA 21.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":4717},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":4715}]},{"term":"Iron deficiency","organSystem":"Metabolism and nutrition disorders","sourceVocabulary":"MedDRA 21.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":4717},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":4715}]},{"term":"Irritable bowel syndrome","organSystem":"Gastrointestinal disorders","sourceVocabulary":"MedDRA 21.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":4717},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":4715}]},{"term":"Jaundice cholestatic","organSystem":"Hepatobiliary disorders","sourceVocabulary":"MedDRA 21.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":4717},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":4715}]},{"term":"Joint injury","organSystem":"Injury, poisoning and procedural complications","sourceVocabulary":"MedDRA 21.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":4717},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":4715}]},{"term":"Ketoacidosis","organSystem":"Metabolism and nutrition disorders","sourceVocabulary":"MedDRA 21.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":4717},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":4715}]},{"term":"Ketosis","organSystem":"Metabolism and nutrition disorders","sourceVocabulary":"MedDRA 21.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":4717},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":4715}]},{"term":"Kidney contusion","organSystem":"Injury, poisoning and procedural complications","sourceVocabulary":"MedDRA 21.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":4717},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":4715}]},{"term":"Lacunar infarction","organSystem":"Nervous system disorders","sourceVocabulary":"MedDRA 21.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":4717},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":4715}]},{"term":"Laryngeal squamous cell carcinoma","organSystem":"Neoplasms benign, malignant and unspecified (incl cysts and polyps)","sourceVocabulary":"MedDRA 21.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":4717},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":4715}]},{"term":"Ligament injury","organSystem":"Injury, poisoning and procedural complications","sourceVocabulary":"MedDRA 21.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":4717},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":4715}]},{"term":"Ligament sprain","organSystem":"Injury, poisoning and procedural complications","sourceVocabulary":"MedDRA 21.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":4717},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":4715}]},{"term":"Limb traumatic amputation","organSystem":"Injury, poisoning and procedural complications","sourceVocabulary":"MedDRA 21.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":4717},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":4715}]},{"term":"Lip injury","organSystem":"Injury, poisoning and procedural complications","sourceVocabulary":"MedDRA 21.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":4717},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":4715}]},{"term":"Lip oedema","organSystem":"Gastrointestinal disorders","sourceVocabulary":"MedDRA 21.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":4717},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":4715}]},{"term":"Lip squamous cell carcinoma","organSystem":"Neoplasms benign, malignant and unspecified (incl cysts and polyps)","sourceVocabulary":"MedDRA 21.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":4717},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":4715}]},{"term":"Liver disorder","organSystem":"Hepatobiliary disorders","sourceVocabulary":"MedDRA 21.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":4717},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":4715}]},{"term":"Liver injury","organSystem":"Hepatobiliary disorders","sourceVocabulary":"MedDRA 21.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":4717},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":4715}]},{"term":"Lower respiratory tract congestion","organSystem":"Respiratory, thoracic and mediastinal disorders","sourceVocabulary":"MedDRA 21.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":4717},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":4715}]},{"term":"Lower respiratory tract infection bacterial","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA 21.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":4717},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":4715}]},{"term":"Lower urinary tract symptoms","organSystem":"Renal and urinary disorders","sourceVocabulary":"MedDRA 21.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":4717},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":4715}]},{"term":"Lumbosacral radiculopathy","organSystem":"Nervous system disorders","sourceVocabulary":"MedDRA 21.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":4717},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":4715}]},{"term":"Lymph node fibrosis","organSystem":"Blood and lymphatic system disorders","sourceVocabulary":"MedDRA 21.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":4717},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":4715}]},{"term":"Lymphocytic leukaemia","organSystem":"Neoplasms benign, malignant and unspecified (incl cysts and polyps)","sourceVocabulary":"MedDRA 21.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":4717},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":4715}]},{"term":"Lymphorrhoea","organSystem":"Vascular disorders","sourceVocabulary":"MedDRA 21.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":4717},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":4715}]},{"term":"Lymphostasis","organSystem":"Vascular disorders","sourceVocabulary":"MedDRA 21.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":4717},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":4715}]},{"term":"Malignant hypertension","organSystem":"Vascular disorders","sourceVocabulary":"MedDRA 21.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":4717},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":4715}]},{"term":"Malignant melanoma in situ","organSystem":"Neoplasms benign, malignant and unspecified (incl cysts and polyps)","sourceVocabulary":"MedDRA 21.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":4717},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":4715}]},{"term":"Mass","organSystem":"General disorders","sourceVocabulary":"MedDRA 21.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":4717},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":4715}]},{"term":"Medical device site infection","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA 21.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":4717},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":4715}]},{"term":"Memory impairment","organSystem":"Nervous system disorders","sourceVocabulary":"MedDRA 21.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":4717},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":4715}]},{"term":"Meningitis pneumococcal","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA 21.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":4717},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":4715}]},{"term":"Meningitis viral","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA 21.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":4717},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":4715}]},{"term":"Metastases to adrenals","organSystem":"Neoplasms benign, malignant and unspecified (incl cysts and polyps)","sourceVocabulary":"MedDRA 21.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":4717},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":4715}]},{"term":"Metastases to lung","organSystem":"Neoplasms benign, malignant and unspecified (incl cysts and polyps)","sourceVocabulary":"MedDRA 21.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":4717},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":4715}]},{"term":"Metastases to peritoneum","organSystem":"Neoplasms benign, malignant and unspecified (incl cysts and polyps)","sourceVocabulary":"MedDRA 21.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":4717},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":4715}]},{"term":"Metastatic bronchial carcinoma","organSystem":"Neoplasms benign, malignant and unspecified (incl cysts and polyps)","sourceVocabulary":"MedDRA 21.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":4717},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":4715}]},{"term":"Metastatic neoplasm","organSystem":"Neoplasms benign, malignant and unspecified (incl cysts and polyps)","sourceVocabulary":"MedDRA 21.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":4717},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":4715}]},{"term":"Mitral valve incompetence","organSystem":"Cardiac disorders","sourceVocabulary":"MedDRA 21.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":4717},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":4715}]},{"term":"Mixed dementia","organSystem":"Nervous system disorders","sourceVocabulary":"MedDRA 21.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":4717},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":4715}]},{"term":"Mononeuritis","organSystem":"Nervous system disorders","sourceVocabulary":"MedDRA 21.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":4717},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":4715}]},{"term":"Mononeuropathy multiplex","organSystem":"Nervous system disorders","sourceVocabulary":"MedDRA 21.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":4717},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":4715}]},{"term":"Multiple injuries","organSystem":"Injury, poisoning and procedural complications","sourceVocabulary":"MedDRA 21.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":4717},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":4715}]},{"term":"Multiple system atrophy","organSystem":"Nervous system disorders","sourceVocabulary":"MedDRA 21.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":4717},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":4715}]},{"term":"Muscle rupture","organSystem":"Injury, poisoning and procedural complications","sourceVocabulary":"MedDRA 21.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":4717},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":4715}]},{"term":"Myalgia","organSystem":"Musculoskeletal and connective tissue disorders","sourceVocabulary":"MedDRA 21.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":4717},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":4715}]},{"term":"Myasthenia gravis","organSystem":"Nervous system disorders","sourceVocabulary":"MedDRA 21.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":4717},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":4715}]},{"term":"Myocardial necrosis marker increased","organSystem":"Investigations","sourceVocabulary":"MedDRA 21.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":4717},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":4715}]},{"term":"Myocarditis","organSystem":"Cardiac disorders","sourceVocabulary":"MedDRA 21.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":4717},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":4715}]},{"term":"Nasal septum deviation","organSystem":"Respiratory, thoracic and mediastinal disorders","sourceVocabulary":"MedDRA 21.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":4717},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":4715}]},{"term":"Nasal ulcer","organSystem":"Respiratory, thoracic and mediastinal disorders","sourceVocabulary":"MedDRA 21.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":4717},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":4715}]},{"term":"Nasopharyngitis","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA 21.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":4717},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":4715}]},{"term":"Necrobiosis","organSystem":"General disorders","sourceVocabulary":"MedDRA 21.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":4717},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":4715}]},{"term":"Necrosis","organSystem":"General disorders","sourceVocabulary":"MedDRA 21.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":4717},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":4715}]},{"term":"Nephropathy","organSystem":"Renal and urinary disorders","sourceVocabulary":"MedDRA 21.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":4717},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":4715}]},{"term":"Nephropathy toxic","organSystem":"Renal and urinary disorders","sourceVocabulary":"MedDRA 21.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":4717},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":4715}]},{"term":"Nephrotic syndrome","organSystem":"Renal and urinary disorders","sourceVocabulary":"MedDRA 21.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":4717},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":4715}]},{"term":"Nerve degeneration","organSystem":"Nervous system disorders","sourceVocabulary":"MedDRA 21.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":4717},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":4715}]},{"term":"Nervous system neoplasm benign","organSystem":"Neoplasms benign, malignant and unspecified (incl cysts and polyps)","sourceVocabulary":"MedDRA 21.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":4717},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":4715}]},{"term":"Neuroendocrine carcinoma","organSystem":"Neoplasms benign, malignant and unspecified (incl cysts and polyps)","sourceVocabulary":"MedDRA 21.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":4717},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":4715}]},{"term":"Neuroendocrine carcinoma metastatic","organSystem":"Neoplasms benign, malignant and unspecified (incl cysts and polyps)","sourceVocabulary":"MedDRA 21.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":4717},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":4715}]},{"term":"Neuromyopathy","organSystem":"Nervous system disorders","sourceVocabulary":"MedDRA 21.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":4717},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":4715}]},{"term":"Neuropathic arthropathy","organSystem":"Musculoskeletal and connective tissue disorders","sourceVocabulary":"MedDRA 21.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":2,"numAffected":1,"numAtRisk":4717},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":4715}]},{"term":"Non-alcoholic steatohepatitis","organSystem":"Hepatobiliary disorders","sourceVocabulary":"MedDRA 21.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":4717},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":4715}]},{"term":"Non-small cell lung cancer metastatic","organSystem":"Neoplasms benign, malignant and unspecified (incl cysts and polyps)","sourceVocabulary":"MedDRA 21.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":4717},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":4715}]},{"term":"Non-small cell lung cancer stage II","organSystem":"Neoplasms benign, malignant and unspecified (incl cysts and polyps)","sourceVocabulary":"MedDRA 21.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":4717},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":4715}]},{"term":"Normal pressure hydrocephalus","organSystem":"Nervous system disorders","sourceVocabulary":"MedDRA 21.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":4717},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":4715}]},{"term":"Normochromic anaemia","organSystem":"Blood and lymphatic system disorders","sourceVocabulary":"MedDRA 21.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":4717},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":4715}]},{"term":"Normocytic anaemia","organSystem":"Blood and lymphatic system disorders","sourceVocabulary":"MedDRA 21.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":4717},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":4715}]},{"term":"Obstructive airways disorder","organSystem":"Respiratory, thoracic and mediastinal disorders","sourceVocabulary":"MedDRA 21.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":4717},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":4715}]},{"term":"Oesophageal cancer metastatic","organSystem":"Neoplasms benign, malignant and unspecified (incl cysts and polyps)","sourceVocabulary":"MedDRA 21.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":4717},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":4715}]},{"term":"Oesophageal candidiasis","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA 21.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":4717},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":4715}]},{"term":"Oesophageal carcinoma","organSystem":"Neoplasms benign, malignant and unspecified (incl cysts and polyps)","sourceVocabulary":"MedDRA 21.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":4717},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":4715}]},{"term":"Oesophageal squamous cell carcinoma","organSystem":"Neoplasms benign, malignant and unspecified (incl cysts and polyps)","sourceVocabulary":"MedDRA 21.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":4717},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":4715}]},{"term":"Oesophageal stenosis","organSystem":"Gastrointestinal disorders","sourceVocabulary":"MedDRA 21.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":4717},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":4715}]},{"term":"Oesophageal ulcer","organSystem":"Gastrointestinal disorders","sourceVocabulary":"MedDRA 21.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":4717},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":4715}]},{"term":"Open globe injury","organSystem":"Injury, poisoning and procedural complications","sourceVocabulary":"MedDRA 21.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":4717},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":4715}]},{"term":"Oral candidiasis","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA 21.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":4717},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":4715}]},{"term":"Oral papilloma","organSystem":"Neoplasms benign, malignant and unspecified (incl cysts and polyps)","sourceVocabulary":"MedDRA 21.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":4717},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":4715}]},{"term":"Orthostatic intolerance","organSystem":"Nervous system disorders","sourceVocabulary":"MedDRA 21.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":4717},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":4715}]},{"term":"Osteochondrosis","organSystem":"Musculoskeletal and connective tissue disorders","sourceVocabulary":"MedDRA 21.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":4717},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":4715}]},{"term":"Osteolysis","organSystem":"Musculoskeletal and connective tissue disorders","sourceVocabulary":"MedDRA 21.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":4717},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":4715}]},{"term":"Osteoma","organSystem":"Neoplasms benign, malignant and unspecified (incl cysts and polyps)","sourceVocabulary":"MedDRA 21.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":4717},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":4715}]},{"term":"Osteomyelitis chronic","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA 21.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":4717},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":4715}]},{"term":"Osteoporosis","organSystem":"Musculoskeletal and connective tissue disorders","sourceVocabulary":"MedDRA 21.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":4717},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":4715}]},{"term":"Osteoporotic fracture","organSystem":"Musculoskeletal and connective tissue disorders","sourceVocabulary":"MedDRA 21.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":4717},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":4715}]},{"term":"Osteosarcoma metastatic","organSystem":"Neoplasms benign, malignant and unspecified (incl cysts and polyps)","sourceVocabulary":"MedDRA 21.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":4717},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":4715}]},{"term":"Otitis externa","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA 21.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":4717},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":4715}]},{"term":"Otitis media","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA 21.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":4717},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":4715}]},{"term":"Ovarian adenoma","organSystem":"Neoplasms benign, malignant and unspecified (incl cysts and polyps)","sourceVocabulary":"MedDRA 21.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":4717},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":4715}]},{"term":"Ovarian cancer stage I","organSystem":"Neoplasms benign, malignant and unspecified (incl cysts and polyps)","sourceVocabulary":"MedDRA 21.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":4717},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":4715}]},{"term":"Ovarian cyst","organSystem":"Reproductive system and breast disorders","sourceVocabulary":"MedDRA 21.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":4717},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":4715}]},{"term":"Overdose","organSystem":"Injury, poisoning and procedural complications","sourceVocabulary":"MedDRA 21.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":4717},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":4715}]},{"term":"Pain","organSystem":"General disorders","sourceVocabulary":"MedDRA 21.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":4717},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":4715}]},{"term":"Palatal ulcer","organSystem":"Gastrointestinal disorders","sourceVocabulary":"MedDRA 21.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":4717},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":4715}]},{"term":"Palpitations","organSystem":"Cardiac disorders","sourceVocabulary":"MedDRA 21.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":4717},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":4715}]},{"term":"Pancreatic duct stenosis","organSystem":"Gastrointestinal disorders","sourceVocabulary":"MedDRA 21.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":4717},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":4715}]},{"term":"Pancytopenia","organSystem":"Blood and lymphatic system disorders","sourceVocabulary":"MedDRA 21.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":4717},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":4715}]},{"term":"Panniculitis","organSystem":"Skin and subcutaneous tissue disorders","sourceVocabulary":"MedDRA 21.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":4717},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":4715}]},{"term":"Papillary cystadenoma lymphomatosum","organSystem":"Neoplasms benign, malignant and unspecified (incl cysts and polyps)","sourceVocabulary":"MedDRA 21.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":4717},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":4715}]},{"term":"Parotitis","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA 21.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":4717},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":4715}]},{"term":"Partial seizures","organSystem":"Nervous system disorders","sourceVocabulary":"MedDRA 21.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":4717},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":4715}]},{"term":"Patella fracture","organSystem":"Injury, poisoning and procedural complications","sourceVocabulary":"MedDRA 21.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":4717},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":4715}]},{"term":"Peptic ulcer perforation","organSystem":"Gastrointestinal disorders","sourceVocabulary":"MedDRA 21.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":4717},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":4715}]},{"term":"Pericardial effusion","organSystem":"Cardiac disorders","sourceVocabulary":"MedDRA 21.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":4717},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":4715}]},{"term":"Peripheral venous disease","organSystem":"Vascular disorders","sourceVocabulary":"MedDRA 21.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":4717},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":4715}]},{"term":"Perirenal haematoma","organSystem":"Injury, poisoning and procedural complications","sourceVocabulary":"MedDRA 21.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":4717},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":4715}]},{"term":"Pharyngeal abscess","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA 21.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":4717},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":4715}]},{"term":"Pharyngeal cyst","organSystem":"Respiratory, thoracic and mediastinal disorders","sourceVocabulary":"MedDRA 21.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":4717},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":4715}]},{"term":"Phimosis","organSystem":"Congenital, familial and genetic disorders","sourceVocabulary":"MedDRA 21.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":4717},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":4715}]},{"term":"Plasma cell myeloma","organSystem":"Neoplasms benign, malignant and unspecified (incl cysts and polyps)","sourceVocabulary":"MedDRA 21.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":4717},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":4715}]},{"term":"Pleuritic pain","organSystem":"Respiratory, thoracic and mediastinal disorders","sourceVocabulary":"MedDRA 21.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":4717},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":4715}]},{"term":"Pneumonia bacterial","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA 21.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":4717},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":4715}]},{"term":"Pneumonia haemophilus","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA 21.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":4717},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":4715}]},{"term":"Pneumonia influenzal","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA 21.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":4717},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":4715}]},{"term":"Pneumonia moraxella","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA 21.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":4717},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":4715}]},{"term":"Pneumothorax","organSystem":"Respiratory, thoracic and mediastinal disorders","sourceVocabulary":"MedDRA 21.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":4717},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":4715}]},{"term":"Polycythaemia vera","organSystem":"Neoplasms benign, malignant and unspecified (incl cysts and polyps)","sourceVocabulary":"MedDRA 21.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":4717},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":4715}]},{"term":"Post procedural cellulitis","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA 21.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":4717},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":4715}]},{"term":"Post procedural haematuria","organSystem":"Injury, poisoning and procedural complications","sourceVocabulary":"MedDRA 21.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":4717},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":4715}]},{"term":"Post procedural infection","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA 21.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":4717},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":4715}]},{"term":"Post stroke seizure","organSystem":"Nervous system disorders","sourceVocabulary":"MedDRA 21.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":4717},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":4715}]},{"term":"Post-traumatic pain","organSystem":"Injury, poisoning and procedural complications","sourceVocabulary":"MedDRA 21.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":4717},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":4715}]},{"term":"Posterior capsule rupture","organSystem":"Eye disorders","sourceVocabulary":"MedDRA 21.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":4717},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":4715}]},{"term":"Postoperative delirium","organSystem":"Injury, poisoning and procedural complications","sourceVocabulary":"MedDRA 21.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":4717},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":4715}]},{"term":"Procedural pneumothorax","organSystem":"Injury, poisoning and procedural complications","sourceVocabulary":"MedDRA 21.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":4717},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":4715}]},{"term":"Proctalgia","organSystem":"Gastrointestinal disorders","sourceVocabulary":"MedDRA 21.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":4717},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":4715}]},{"term":"Prostate cancer metastatic","organSystem":"Neoplasms benign, malignant and unspecified (incl cysts and polyps)","sourceVocabulary":"MedDRA 21.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":4717},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":4715}]},{"term":"Prostate cancer recurrent","organSystem":"Neoplasms benign, malignant and unspecified (incl cysts and polyps)","sourceVocabulary":"MedDRA 21.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":4717},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":4715}]},{"term":"Prostatic abscess","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA 21.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":4717},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":4715}]},{"term":"Prostatic varices","organSystem":"Reproductive system and breast disorders","sourceVocabulary":"MedDRA 21.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":4717},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":4715}]},{"term":"Psoas abscess","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA 21.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":4717},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":4715}]},{"term":"Psoriasis","organSystem":"Skin and subcutaneous tissue disorders","sourceVocabulary":"MedDRA 21.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":4717},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":4715}]},{"term":"Psychotic disorder","organSystem":"Psychiatric disorders","sourceVocabulary":"MedDRA 21.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":4717},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":4715}]},{"term":"Pulmonary arterial hypertension","organSystem":"Respiratory, thoracic and mediastinal disorders","sourceVocabulary":"MedDRA 21.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":4717},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":4715}]},{"term":"Pulmonary congestion","organSystem":"Respiratory, thoracic and mediastinal disorders","sourceVocabulary":"MedDRA 21.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":4717},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":4715}]},{"term":"Pulmonary fibrosis","organSystem":"Respiratory, thoracic and mediastinal disorders","sourceVocabulary":"MedDRA 21.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":4717},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":4715}]},{"term":"Pulmonary mass","organSystem":"Respiratory, thoracic and mediastinal disorders","sourceVocabulary":"MedDRA 21.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":4717},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":4715}]},{"term":"Pustular psoriasis","organSystem":"Skin and subcutaneous tissue disorders","sourceVocabulary":"MedDRA 21.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":4717},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":4715}]},{"term":"Pyelonephritis acute","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA 21.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":4717},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":4715}]},{"term":"Pyonephrosis","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA 21.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":2,"numAffected":1,"numAtRisk":4717},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":4715}]},{"term":"Radial nerve compression","organSystem":"Nervous system disorders","sourceVocabulary":"MedDRA 21.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":4717},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":4715}]},{"term":"Radius fracture","organSystem":"Injury, poisoning and procedural complications","sourceVocabulary":"MedDRA 21.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":4717},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":4715}]},{"term":"Rash papular","organSystem":"Skin and subcutaneous tissue disorders","sourceVocabulary":"MedDRA 21.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":4717},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":4715}]},{"term":"Rectal adenocarcinoma","organSystem":"Neoplasms benign, malignant and unspecified (incl cysts and polyps)","sourceVocabulary":"MedDRA 21.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":4717},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":4715}]},{"term":"Rectal polyp","organSystem":"Gastrointestinal disorders","sourceVocabulary":"MedDRA 21.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":4717},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":4715}]},{"term":"Rectosigmoid cancer stage II","organSystem":"Neoplasms benign, malignant and unspecified (incl cysts and polyps)","sourceVocabulary":"MedDRA 21.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":4717},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":4715}]},{"term":"Renal abscess","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA 21.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":4717},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":4715}]},{"term":"Renal adenoma","organSystem":"Neoplasms benign, malignant and unspecified (incl cysts and polyps)","sourceVocabulary":"MedDRA 21.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":4717},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":4715}]},{"term":"Renal cancer","organSystem":"Neoplasms benign, malignant and unspecified (incl cysts and polyps)","sourceVocabulary":"MedDRA 21.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":4717},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":4715}]},{"term":"Renal cancer metastatic","organSystem":"Neoplasms benign, malignant and unspecified (incl cysts and polyps)","sourceVocabulary":"MedDRA 21.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":4717},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":4715}]},{"term":"Renal cell carcinoma","organSystem":"Neoplasms benign, malignant and unspecified (incl cysts and polyps)","sourceVocabulary":"MedDRA 21.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":4717},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":4715}]},{"term":"Renal cyst","organSystem":"Renal and urinary disorders","sourceVocabulary":"MedDRA 21.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":4717},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":4715}]},{"term":"Renal disorder","organSystem":"Renal and urinary disorders","sourceVocabulary":"MedDRA 21.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":4717},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":4715}]},{"term":"Renal haematoma","organSystem":"Renal and urinary disorders","sourceVocabulary":"MedDRA 21.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":4717},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":4715}]},{"term":"Renal injury","organSystem":"Renal and urinary disorders","sourceVocabulary":"MedDRA 21.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":4717},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":4715}]},{"term":"Renal mass","organSystem":"Renal and urinary disorders","sourceVocabulary":"MedDRA 21.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":4717},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":4715}]},{"term":"Respiratory depression","organSystem":"Respiratory, thoracic and mediastinal disorders","sourceVocabulary":"MedDRA 21.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":4717},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":4715}]},{"term":"Respiratory syncytial virus infection","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA 21.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":4717},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":4715}]},{"term":"Retinal artery occlusion","organSystem":"Eye disorders","sourceVocabulary":"MedDRA 21.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":4717},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":4715}]},{"term":"Retinal detachment","organSystem":"Eye disorders","sourceVocabulary":"MedDRA 21.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":4717},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":4715}]},{"term":"Retinopathy","organSystem":"Eye disorders","sourceVocabulary":"MedDRA 21.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":4717},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":4715}]},{"term":"Retinopathy proliferative","organSystem":"Eye disorders","sourceVocabulary":"MedDRA 21.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":4717},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":4715}]},{"term":"Retroperitoneal abscess","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA 21.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":4717},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":4715}]},{"term":"Retroperitoneal haematoma","organSystem":"Gastrointestinal disorders","sourceVocabulary":"MedDRA 21.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":4717},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":4715}]},{"term":"Retroperitoneal neoplasm","organSystem":"Neoplasms benign, malignant and unspecified (incl cysts and polyps)","sourceVocabulary":"MedDRA 21.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":4717},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":4715}]},{"term":"Rhabdomyolysis","organSystem":"Musculoskeletal and connective tissue disorders","sourceVocabulary":"MedDRA 21.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":4717},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":4715}]},{"term":"Rhinitis hypertrophic","organSystem":"Respiratory, thoracic and mediastinal disorders","sourceVocabulary":"MedDRA 21.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":4717},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":4715}]},{"term":"Right ventricular failure","organSystem":"Cardiac disorders","sourceVocabulary":"MedDRA 21.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":4717},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":4715}]},{"term":"Sciatica","organSystem":"Nervous system disorders","sourceVocabulary":"MedDRA 21.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":4717},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":4715}]},{"term":"Septic embolus","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA 21.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":4717},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":4715}]},{"term":"Shunt stenosis","organSystem":"Injury, poisoning and procedural complications","sourceVocabulary":"MedDRA 21.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":4717},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":4715}]},{"term":"Sinoatrial block","organSystem":"Cardiac disorders","sourceVocabulary":"MedDRA 21.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":4717},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":4715}]},{"term":"Sinus arrest","organSystem":"Cardiac disorders","sourceVocabulary":"MedDRA 21.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":4717},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":4715}]},{"term":"Sinus bradycardia","organSystem":"Cardiac disorders","sourceVocabulary":"MedDRA 21.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":4717},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":4715}]},{"term":"Sinus headache","organSystem":"Nervous system disorders","sourceVocabulary":"MedDRA 21.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":4717},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":4715}]},{"term":"Sjogren's syndrome","organSystem":"Musculoskeletal and connective tissue disorders","sourceVocabulary":"MedDRA 21.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":2,"numAffected":1,"numAtRisk":4717},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":4715}]},{"term":"Skin necrosis","organSystem":"Skin and subcutaneous tissue disorders","sourceVocabulary":"MedDRA 21.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":4717},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":4715}]},{"term":"Small cell lung cancer","organSystem":"Neoplasms benign, malignant and unspecified (incl cysts and polyps)","sourceVocabulary":"MedDRA 21.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":4717},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":4715}]},{"term":"Small intestine carcinoma","organSystem":"Neoplasms benign, malignant and unspecified (incl cysts and polyps)","sourceVocabulary":"MedDRA 21.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":4717},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":4715}]},{"term":"Soft tissue infection","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA 21.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":4717},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":4715}]},{"term":"Soft tissue inflammation","organSystem":"General disorders","sourceVocabulary":"MedDRA 21.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":4717},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":4715}]},{"term":"Spinal cord compression","organSystem":"Nervous system disorders","sourceVocabulary":"MedDRA 21.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":4717},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":4715}]},{"term":"Spinal cord herniation","organSystem":"Nervous system disorders","sourceVocabulary":"MedDRA 21.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":4717},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":4715}]},{"term":"Spinal cord ischaemia","organSystem":"Nervous system disorders","sourceVocabulary":"MedDRA 21.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":4717},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":4715}]},{"term":"Spondylolisthesis","organSystem":"Musculoskeletal and connective tissue disorders","sourceVocabulary":"MedDRA 21.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":4717},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":4715}]},{"term":"Squamous cell carcinoma of the tongue","organSystem":"Neoplasms benign, malignant and unspecified (incl cysts and polyps)","sourceVocabulary":"MedDRA 21.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":4717},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":4715}]},{"term":"Squamous cell carcinoma of the vulva","organSystem":"Neoplasms benign, malignant and unspecified (incl cysts and polyps)","sourceVocabulary":"MedDRA 21.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":4717},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":4715}]},{"term":"Sternal fracture","organSystem":"Injury, poisoning and procedural complications","sourceVocabulary":"MedDRA 21.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":4717},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":4715}]},{"term":"Sternitis","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA 21.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":4717},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":4715}]},{"term":"Streptococcal bacteraemia","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA 21.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":4717},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":4715}]},{"term":"Streptococcal endocarditis","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA 21.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":4717},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":4715}]},{"term":"Streptococcal sepsis","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA 21.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":4717},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":4715}]},{"term":"Subarachnoid haemorrhage","organSystem":"Injury, poisoning and procedural complications","sourceVocabulary":"MedDRA 21.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":4717},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":4715}]},{"term":"Subclavian artery occlusion","organSystem":"Vascular disorders","sourceVocabulary":"MedDRA 21.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":4717},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":4715}]},{"term":"Suture related complication","organSystem":"Injury, poisoning and procedural complications","sourceVocabulary":"MedDRA 21.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":4717},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":4715}]},{"term":"Suture rupture","organSystem":"Injury, poisoning and procedural complications","sourceVocabulary":"MedDRA 21.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":4717},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":4715}]},{"term":"Systemic candida","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA 21.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":4717},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":4715}]},{"term":"Systemic infection","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA 21.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":4717},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":4715}]},{"term":"Tachycardia","organSystem":"Cardiac disorders","sourceVocabulary":"MedDRA 21.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":4717},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":4715}]},{"term":"Tendonitis","organSystem":"Musculoskeletal and connective tissue disorders","sourceVocabulary":"MedDRA 21.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":4717},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":4715}]},{"term":"Testicular neoplasm","organSystem":"Neoplasms benign, malignant and unspecified (incl cysts and polyps)","sourceVocabulary":"MedDRA 21.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":4717},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":4715}]},{"term":"Thoracic vertebral fracture","organSystem":"Injury, poisoning and procedural complications","sourceVocabulary":"MedDRA 21.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":4717},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":4715}]},{"term":"Thrombocytopenia","organSystem":"Blood and lymphatic system disorders","sourceVocabulary":"MedDRA 21.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":4717},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":4715}]},{"term":"Thyroid function test normal","organSystem":"Investigations","sourceVocabulary":"MedDRA 21.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":4717},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":4715}]},{"term":"Tongue abscess","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA 21.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":4717},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":4715}]},{"term":"Tonsillitis","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA 21.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":4717},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":4715}]},{"term":"Torsade de pointes","organSystem":"Cardiac disorders","sourceVocabulary":"MedDRA 21.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":4717},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":4715}]},{"term":"Toxic encephalopathy","organSystem":"Nervous system disorders","sourceVocabulary":"MedDRA 21.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":4717},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":4715}]},{"term":"Transient ischaemic attack","organSystem":"Nervous system disorders","sourceVocabulary":"MedDRA 21.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":4717},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":4715}]},{"term":"Traumatic haematoma","organSystem":"Injury, poisoning and procedural complications","sourceVocabulary":"MedDRA 21.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":4717},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":4715}]},{"term":"Traumatic intracranial haemorrhage","organSystem":"Injury, poisoning and procedural complications","sourceVocabulary":"MedDRA 21.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":4717},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":4715}]},{"term":"Treatment noncompliance","organSystem":"General disorders","sourceVocabulary":"MedDRA 21.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":4717},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":4715}]},{"term":"Tremor","organSystem":"Nervous system disorders","sourceVocabulary":"MedDRA 21.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":4717},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":4715}]},{"term":"Tuberculosis","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA 21.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":4717},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":4715}]},{"term":"Ulnar nerve injury","organSystem":"Injury, poisoning and procedural complications","sourceVocabulary":"MedDRA 21.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":4717},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":4715}]},{"term":"Umbilical discharge","organSystem":"Skin and subcutaneous tissue disorders","sourceVocabulary":"MedDRA 21.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":4717},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":4715}]},{"term":"Umbilical hernia","organSystem":"Gastrointestinal disorders","sourceVocabulary":"MedDRA 21.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":4717},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":4715}]},{"term":"Urethral obstruction","organSystem":"Renal and urinary disorders","sourceVocabulary":"MedDRA 21.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":4717},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":4715}]},{"term":"Urethral stenosis","organSystem":"Renal and urinary disorders","sourceVocabulary":"MedDRA 21.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":4717},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":4715}]},{"term":"Urinary incontinence","organSystem":"Renal and urinary disorders","sourceVocabulary":"MedDRA 21.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":4717},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":4715}]},{"term":"Urinary retention","organSystem":"Renal and urinary disorders","sourceVocabulary":"MedDRA 21.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":4717},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":4715}]},{"term":"Uterine polyp","organSystem":"Reproductive system and breast disorders","sourceVocabulary":"MedDRA 21.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":4717},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":4715}]},{"term":"Uterine prolapse","organSystem":"Reproductive system and breast disorders","sourceVocabulary":"MedDRA 21.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":4717},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":4715}]},{"term":"Uvulitis","organSystem":"Gastrointestinal disorders","sourceVocabulary":"MedDRA 21.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":4717},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":4715}]},{"term":"Varices oesophageal","organSystem":"Gastrointestinal disorders","sourceVocabulary":"MedDRA 21.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":4717},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":4715}]},{"term":"Varicose vein","organSystem":"Vascular disorders","sourceVocabulary":"MedDRA 21.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":4717},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":4715}]},{"term":"Vascular graft occlusion","organSystem":"Injury, poisoning and procedural complications","sourceVocabulary":"MedDRA 21.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":4717},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":4715}]},{"term":"Vascular graft thrombosis","organSystem":"Injury, poisoning and procedural complications","sourceVocabulary":"MedDRA 21.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":4717},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":4715}]},{"term":"Vascular stent occlusion","organSystem":"General disorders","sourceVocabulary":"MedDRA 21.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":4717},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":4715}]},{"term":"Vascular stent thrombosis","organSystem":"General disorders","sourceVocabulary":"MedDRA 21.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":4717},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":4715}]},{"term":"Venous occlusion","organSystem":"Vascular disorders","sourceVocabulary":"MedDRA 21.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":4717},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":4715}]},{"term":"Ventricular extrasystoles","organSystem":"Cardiac disorders","sourceVocabulary":"MedDRA 21.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":4717},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":4715}]},{"term":"Vertebral artery dissection","organSystem":"Nervous system disorders","sourceVocabulary":"MedDRA 21.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":4717},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":4715}]},{"term":"Vertebral artery stenosis","organSystem":"Nervous system disorders","sourceVocabulary":"MedDRA 21.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":4717},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":4715}]},{"term":"Vertigo positional","organSystem":"Ear and labyrinth disorders","sourceVocabulary":"MedDRA 21.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":4717},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":4715}]},{"term":"Viral diarrhoea","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA 21.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":4717},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":4715}]},{"term":"Viral upper respiratory tract infection","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA 21.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":4717},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":4715}]},{"term":"Vocal cord leukoplakia","organSystem":"Respiratory, thoracic and mediastinal disorders","sourceVocabulary":"MedDRA 21.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":4717},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":4715}]},{"term":"Vocal cord paralysis","organSystem":"Nervous system disorders","sourceVocabulary":"MedDRA 21.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":4717},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":4715}]},{"term":"Vulval abscess","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA 21.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":4717},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":4715}]},{"term":"Vulval cancer","organSystem":"Neoplasms benign, malignant and unspecified (incl cysts and polyps)","sourceVocabulary":"MedDRA 21.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":4717},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":4715}]},{"term":"Weight decreased","organSystem":"Investigations","sourceVocabulary":"MedDRA 21.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":4717},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":4715}]},{"term":"Weight increased","organSystem":"Investigations","sourceVocabulary":"MedDRA 21.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":4717},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":4715}]},{"term":"Wound evisceration","organSystem":"Injury, poisoning and procedural complications","sourceVocabulary":"MedDRA 21.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":4717},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":4715}]}]},"moreInfoModule":{"certainAgreement":{"piSponsorEmployee":false,"restrictionType":"OTHER","restrictiveAgreement":true,"otherDetails":"GSK agreements may vary with individual investigators, but will not prohibit any investigator from publishing. GSK supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial."},"pointOfContact":{"title":"GSK Response Center","organization":"GlaxoSmithKline","email":"GSKClinicalSupportHD@gsk.com","phone":"866-435-7343"}}},"documentSection":{"largeDocumentModule":{"largeDocs":[{"typeAbbrev":"Prot","hasProtocol":true,"hasSap":false,"hasIcf":false,"label":"Study Protocol","date":"2017-04-04","uploadDate":"2018-11-13T23:59","filename":"Prot_000.pdf","size":3247317},{"typeAbbrev":"SAP","hasProtocol":false,"hasSap":true,"hasIcf":false,"label":"Statistical Analysis Plan","date":"2017-11-30","uploadDate":"2018-11-14T00:02","filename":"SAP_001.pdf","size":762981}]}},"derivedSection":{"miscInfoModule":{"versionHolder":"2026-10-09"},"conditionBrowseModule":{"meshes":[{"id":"D003920","term":"Diabetes Mellitus"},{"id":"D003924","term":"Diabetes Mellitus, Type 2"}],"ancestors":[{"id":"D044882","term":"Glucose Metabolism Disorders"},{"id":"D008659","term":"Metabolic Diseases"},{"id":"D009750","term":"Nutritional and Metabolic Diseases"},{"id":"D004700","term":"Endocrine System Diseases"}]},"interventionBrowseModule":{"meshes":[{"id":"C534611","term":"rGLP-1 protein"}]}},"hasResults":true}